index	sentence	label
0	In the present study, we characterize @GENE$ inhibition activity of the brain-permeable compound AK7 and examine the efficacy of this small molecule in models of Parkinson's disease, amyotrophic lateral sclerosis and @DISEASE$.	0
1	Results after perturbing @GENE$ activity suggests its involvement in @DISEASE$ cell migration, proliferation, and cytoskeleton remodeling which makes it a potential therapeutic target for cancer treatments	1
2	@GENE$ is also known for its dual role in @DISEASE$ as pro- and anti-proliferative in addition to metastasis.	1
3	In this study, we conducted targeted sequencing in 246 clinically @DISEASE$ patients, mainly with early-onset and/or familial neurodegenerative dementia, using a custom-designed next-generation sequencing panel covering 27 genes known to harbor mutations that can cause different types of dementia, in addition to the detection of @GENE$ repeat expansions.	0
4	Identifying genetic risk alleles for ovarian @DISEASE$ has had a significant impact on disease prevention strategies; for example it is now routine clinical practice for individuals with germline @GENE$ and mitotic cytokinesis mutations to undergo risk reducing salpingo-oophorectomy.	0
5	Identifying genetic risk alleles for ovarian @DISEASE$ has had a significant impact on disease prevention strategies; for example it is now routine clinical practice for individuals with germline double-strand break repair via homologous recombination and @GENE$ mutations to undergo risk reducing salpingo-oophorectomy.	0
6	We then validated the anti-@GENE$ antibody specificity by analyzing additional 305 pediatric and adult @DISEASE$s of various subtypes and 15 non-meningioma clear cell tumors by SMARCE1 immunohistochemistry.	1
7	We then validated the anti-@GENE$ antibody specificity by analyzing additional 305 pediatric and adult meningiomas of various subtypes and 15 non-meningioma clear cell @DISEASE$ by SMARCE1 immunohistochemistry.	1
8	Machine learning search further revealed that the likelihood of @GENE$-positive breast @DISEASE$ is almost 100% in a patient with the high NRF1 expression combined with expression patterns of high E2F3, GSK3B, and protein phosphorylation, low or no change in E2F1 and FGFR1, and high or no change in positive regulation of protein phosphorylation.	1
9	Machine learning search further revealed that the likelihood of signal transduction-positive breast @DISEASE$ is almost 100% in a patient with the high NRF1 expression combined with expression patterns of high E2F3, GSK3B, and protein phosphorylation, low or no change in E2F1 and FGFR1, and high or no change in @GENE$.	1
10	Machine learning search further revealed that the likelihood of signal transduction-positive breast @DISEASE$ is almost 100% in a patient with the high NRF1 expression combined with expression patterns of high E2F3, GSK3B, and @GENE$, low or no change in E2F1 and FGFR1, and high or no change in positive regulation of protein phosphorylation.	1
11	In addition, we found using Bayesian network-based machine learning that 30 NRF1 motif-enriched genes including growth factor receptors-FGFR1, IGF1R; E2Fs transcription factor family-E2F1, E2F3; MAPK pathway-@GENE$, GRB2, MAPK1; PI3K-AKT-regulation of cell growth signaling pathway-PIK3CD, PIK3R1, PIK3R3, RPS6KB2; WNT signaling pathway-canonical Wnt signaling pathway, DLV1, DLV2, regulation of synaptic vesicle exocytosis, NRF1, and DDB2, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast @DISEASE$ cells, were associated with HER2-amplified breast cancer.	1
12	In addition, we found using Bayesian network-based machine learning that 30 NRF1 motif-enriched genes including growth factor receptors-FGFR1, IGF1R; E2Fs transcription factor family-E2F1, E2F3; MAPK pathway-MAPK cascade, GRB2, MAPK1; PI3K-AKT-@GENE$ signaling pathway-PIK3CD, PIK3R1, PIK3R3, RPS6KB2; WNT signaling pathway-canonical Wnt signaling pathway, DLV1, DLV2, regulation of synaptic vesicle exocytosis, NRF1, and DDB2, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast @DISEASE$ cells, were associated with HER2-amplified breast cancer.	1
13	In addition, we found using Bayesian network-based machine learning that 30 NRF1 motif-enriched genes including growth factor receptors-FGFR1, IGF1R; E2Fs transcription factor family-E2F1, E2F3; MAPK pathway-MAPK cascade, GRB2, MAPK1; PI3K-AKT-regulation of cell growth signaling pathway-PIK3CD, PIK3R1, PIK3R3, RPS6KB2; WNT signaling pathway-@GENE$, DLV1, DLV2, regulation of synaptic vesicle exocytosis, NRF1, and DDB2, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast @DISEASE$ cells, were associated with HER2-amplified breast cancer.	1
14	In addition, we found using Bayesian network-based machine learning that 30 NRF1 motif-enriched genes including growth factor receptors-FGFR1, IGF1R; E2Fs transcription factor family-E2F1, E2F3; MAPK pathway-MAPK cascade, GRB2, MAPK1; PI3K-AKT-regulation of cell growth signaling pathway-PIK3CD, PIK3R1, PIK3R3, RPS6KB2; WNT signaling pathway-canonical Wnt signaling pathway, DLV1, DLV2, @GENE$, NRF1, and DDB2, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast @DISEASE$ cells, were associated with HER2-amplified breast cancer.	1
15	We found that both mRNA and protein levels of @GENE$ and its transcriptional activity were significantly higher in ER/PR -ve signal transduction +ve breast @DISEASE$ samples compared to normal breast tissues.	1
16	We found that both mRNA and protein levels of transcription by RNA polymerase II and its transcriptional activity were significantly higher in ER/PR -ve @GENE$ +ve breast @DISEASE$ samples compared to normal breast tissues.	1
17	Our findings show that a high percentage of known HER2+ breast @DISEASE$ susceptibility genes, including @GENE$, IGFR, and E2F1, are under transcriptional control of NRF1.	1
18	Promoters of several genes from the KEGG @GENE$+ breast @DISEASE$ pathway and 11 signaling pathways linked to 6 hallmarks of cancer contain the transcription by RNA polymerase II motif.	1
19	Promoters of several genes from the KEGG signal transduction+ breast @DISEASE$ pathway and 11 signaling pathways linked to 6 hallmarks of cancer contain the @GENE$ motif.	1
20	Clinical confirmation of our machine learned Bayesian networks will have significant impact on our understanding of the role of @GENE$ as a valuable biomarker for breast @DISEASE$ diagnosis and prognosis as well as provide strong rationale for future studies to develop NRF1 signaling-based therapeutics to target HER2+ breast cancer	1
21	This case of adult-diagnosed @GENE$ deficiency was characterized by slowly progressive @DISEASE$ neuropathy masquerading CMT in addition to muscular symptoms.	1
22	@GENE$ deficiency should be considered in patients with the combination of @DISEASE$ neuropathy and recurrent rhabdomyolysis	1
23	An oncogenic role for CHD4, a NuRD component, is defined for initiating and supporting tumor suppressor gene (@GENE$) silencing in human colorectal @DISEASE$.	1
24	CHD4 knockdown activates silenced @GENE$s, revealing their role for blunting colorectal @DISEASE$ cell proliferation, invasion, and metastases.	1
25	To date, researchers have discovered that @GENE$ deletion results in high susceptibility and severity of insults in various models of respiratory diseases, including bronchopulmonary dysplasia (BPD), respiratory infections, acute respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (COPD), asthma, idiopathic pulmonary fibrosis (IPF), and lung @DISEASE$.	1
26	We generated a transgenic rat strain with a missense mutation in V286L (V286L-TG), in the gene encoding the neuronal nicotinic acetylcholine receptor β2 subunit (@GENE$) found in patients with autosomal dominant @DISEASE$ frontal lobe epilepsy (ADNFLE).	1
27	We generated a transgenic rat strain with a missense mutation in V286L (V286L-TG), in the gene encoding the neuronal nicotinic acetylcholine receptor β2 subunit (@GENE$) found in patients with autosomal dominant nocturnal frontal lobe @DISEASE$ (ADNFLE).	1
28	Our findings provide exploratory evidence for hypermethylation of the key @DISEASE$ suppressor gene @GENE$ being implicated in smoking-associated colorectal carcinogenesis.	1
29	Our analyses identified 15 CpG sites within the @GENE$ 1A promoter that were significantly hypermethylated and 14 CpG loci within the NFATC1 gene body that were significantly hypomethylated (pLIS &lt; 1 × 10<sup>-5</sup> ) in the @DISEASE$s of active smokers.	1
30	Overall, our results suggest that PQQ neuroprotection may be mediated by the inhibition of @DISEASE$ and oxidative stress as well as by the gene modulation of @GENE$ and Ndufs4	0
31	Using clinical blood samples, we compared the diagnostic values of serum exosomal @GENE$ levels between malignant pancreatic @DISEASE$ patients (n = 24) and benign pancreatic disease patients (n = 32, AUC = .89), and between biliary disease patients (n = 32, AUC = .8112) and healthy controls (n = 46, AUC = .8931).	1
32	In conclusion, exosomal @GENE$ promotes @DISEASE$ growth and is a novel diagnostic biomarker for pancreatic cancer	1
33	By combining meta-analysis results and identification of two unrelated HCM patients with homozygous @GENE$ truncating variants, we suggest that the association of CSRP3 as a validated HCM-causing gene require additional studies and those CSRP3 variants could result in HCM with an @DISEASE$ inheritance rather than with an autosomal dominant transmission as usually reported on HCM (OMIM 612124)	0
34	The aim of this study was to explore the relationship between @GENE$ and the prognosis of patients with ovarian @DISEASE$ (OC).	1
35	In survival analyses, we found that @GENE$ was positively linked to prognosis in patients with OC, particularly in those with serous ovarian @DISEASE$ (SOC).	1
36	c.886G&gt;T is a novel idiopathic congenital @DISEASE$‑inducing mutation in the @GENE$ gene.	1
37	The known pathogenic molecules involved in ichthyosis syndromes with prominent @DISEASE$ include SPINK5, ERCC2, @GENE$, GTF2H5, MPLKIP, ST14, CLDN1 and MBTPS2.	1
38	A @GENE$ complex mutation analogous to a lysosomal transport allele causing progressive cerebello-@DISEASE$ type 2 (PCCA2) in humans exhibits similar, albeit weaker, phenotypes in yeast, providing mechanistic insights into disease pathogenesis.	1
39	A cation transport complex mutation analogous to a @GENE$ allele causing progressive cerebello-@DISEASE$ type 2 (PCCA2) in humans exhibits similar, albeit weaker, phenotypes in yeast, providing mechanistic insights into disease pathogenesis.	0
40	A rare syndromic form of @DISEASE$ with impaired speech was recently found associated with mutations in @GENE$ (chromosome alignment-maintaining phosphoprotein 1), the protein product of which is directly involved in microtubule-kinetochore attachment.	1
41	Through whole-exome sequencing in six unrelated nonconsanguineous families having a @DISEASE$ case of intellectual disability, we identified six novel de novo truncating mutations in @GENE$: c.1880C&gt;G p.(Ser627*), c.1489C&gt;T; p.(Arg497*), c.1876_1877delAG; p.(Ser626Leufs*4), c.1043G&gt;A; p.(Trp348*), c.1002G&gt;A; p.(Trp334*), and c.958_959delCC; p.(Pro320*).	1
42	The four large extracellular domains of @GENE$ and its association with the extracellular matrix makes it an attractive target for future @DISEASE$ therapies.	1
43	Translational research suggests that @GENE$ may be targeted with antibodies to improve tumor control and survival in a variety of murine models and @DISEASE$ types.	1
44	In humans, mutations in several genes involved in the Notch pathway are associated with SDV, with both @DISEASE$ (@GENE$, skeletal system development, LFNG, HES7) and autosomal dominant (negative regulation of transcription by RNA polymerase II) inheritance.	1
45	In humans, mutations in several genes involved in the Notch pathway are associated with SDV, with both @DISEASE$ (regulation of transcription by RNA polymerase II, skeletal system development, LFNG, HES7) and autosomal dominant (@GENE$) inheritance.	0
46	In humans, mutations in several genes involved in the Notch pathway are associated with SDV, with both @DISEASE$ (regulation of transcription by RNA polymerase II, @GENE$, LFNG, HES7) and autosomal dominant (negative regulation of transcription by RNA polymerase II) inheritance.	1
47	The correlation between the @DISEASE$ size and the amount of @GENE$ secretion could be examined in this study, and showed a significant positive correlation in a tumor size-dependent manner.	1
48	We expand the knowledge about @GENE$ deficiency, describing a patient with the mild phenotype of TTC7A deficiency but presenting overlapping features of SD/THE and MIA-CID: intestinal atresia and inflammatory bowel disease evocative of MIA-CID, but also @DISEASE$, huge forehead, liver abnormalities, autoimmune thyroiditis and hypogammaglobulinemia, evocative of SD/THE	1
49	There are two different phenotypes of patients with @GENE$ mutations: the severe form, caused by null mutations and leading to the classical MIA-CID; and the mild form, caused by missense mutations and leading to predominant features of VEO-IBD, less severe immunological involvement and @DISEASE$.	1
50	We identified novel ALK fusions in a @DISEASE$ (BEND5-ALK) and an astrocytoma (PPP1CB-ALK), novel @GENE$ fusions in an astrocytoma (BCAS1-BRAF) and a ganglioglioma (TMEM106B-BRAF), and a novel PAX3-smoothened signaling pathway fusion in a rhabdomyosarcoma.	0
51	We identified novel ALK fusions in a @DISEASE$ (BEND5-ALK) and an astrocytoma (PPP1CB-ALK), novel protein phosphorylation fusions in an astrocytoma (BCAS1-BRAF) and a ganglioglioma (TMEM106B-BRAF), and a novel PAX3-@GENE$ fusion in a rhabdomyosarcoma.	0
52	We identified novel ALK fusions in a neuroblastoma (BEND5-ALK) and an @DISEASE$ (PPP1CB-ALK), novel protein phosphorylation fusions in an astrocytoma (BCAS1-BRAF) and a ganglioglioma (TMEM106B-BRAF), and a novel PAX3-@GENE$ fusion in a rhabdomyosarcoma.	0
53	We identified novel ALK fusions in a neuroblastoma (BEND5-ALK) and an @DISEASE$ (PPP1CB-ALK), novel @GENE$ fusions in an astrocytoma (BCAS1-BRAF) and a ganglioglioma (TMEM106B-BRAF), and a novel PAX3-smoothened signaling pathway fusion in a rhabdomyosarcoma.	1
54	A MMP9 inhibitor significantly inhibited cell invasion and migration in @GENE$-HIF-1α axis-induced lung @DISEASE$.	1
55	Haploinsufficiency of @GENE$ in females has been associated with ID and congenital malformations that include heart defects, scoliosis, dental abnormalities, anal atresia, polydactyly, Dandy Walker malformation and @DISEASE$.	1
56	Its restricted expression in normal tissues and unique early upregulation during @DISEASE$ development make @GENE$ an excellent candidate as a new clinical marker of HCC	1
57	Mutations have previously been reported in several members of the TRAPP complex of proteins, including @GENE$, TRAPPC9 and protein complex oligomerization, resulting in disorders involving skeletal abnormalities, intellectual disability, speech impairment and @DISEASE$.	1
58	Mutations have previously been reported in several members of the TRAPP complex of proteins, including @GENE$, TRAPPC9 and protein complex oligomerization, resulting in disorders involving skeletal abnormalities, intellectual disability, @DISEASE$ and developmental delay.	1
59	Mutations have previously been reported in several members of the TRAPP complex of proteins, including @GENE$, TRAPPC9 and protein complex oligomerization, resulting in disorders involving skeletal abnormalities, @DISEASE$, speech impairment and developmental delay.	1
60	Mutations have previously been reported in several members of the TRAPP complex of proteins, including regulation of transcription, DNA-templated, TRAPPC9 and @GENE$, resulting in disorders involving @DISEASE$, intellectual disability, speech impairment and developmental delay.	1
61	In addition, forced expression of @GENE$-c in ER-negative breast @DISEASE$ cell lines inhibited stimuli-induced peripheral nervous system development-κB activation and attenuated migration, invasion, colony formation, and adhesion of cancer cells.	1
62	In addition, forced expression of positive regulation of DNA-binding transcription factor activity-c in ER-negative breast @DISEASE$ cell lines inhibited stimuli-induced @GENE$-κB activation and attenuated migration, invasion, colony formation, and adhesion of cancer cells.	1
63	Additional protein interaction characterization revealed epidermal growth factor receptor (EGFR) as a novel interacting partner for RANK-c in breast @DISEASE$ cells with a negative effect on EGFR phosphorylation and @GENE$-dependent downstream signaling pathway activation.	1
64	The @GENE$-c-mediated inhibition of @DISEASE$ cell aggressiveness and nuclear factor-κB (NF-κB) activation in breast cancer cells seems to rely on a RANK-c/TNF receptor-associated factor-2 (cellular response to DNA damage stimulus) protein interaction.	1
65	The positive regulation of DNA-binding transcription factor activity-c-mediated inhibition of cancer cell @DISEASE$ and nuclear factor-κB (NF-κB) activation in breast cancer cells seems to rely on a RANK-c/TNF receptor-associated factor-2 (@GENE$) protein interaction.	1
66	The @GENE$/RANKL axis emerges as a key regulator of breast @DISEASE$ initiation, progression, and metastasis.	1
67	Patients did not present with @DISEASE$ as observed in a previously reported SPG57 family (c.316C&gt;T (p.(Arg106Cys)) in coiled-coil domain), suggesting unique contributions of the PB1 and coiled-coil domains in @GENE$ complex formation/function and a possible phenotype correlation to variant location.	1
68	Our study expands the genetic @DISEASE$ of @GENE$ and RTT-like phenotypes.	1
69	In zebrafish, downregulation of @GENE$ expression leads to an @DISEASE$ phenotype and defective light-induced locomotor response.	1
70	However, the underlying mechanism of @GENE$ function is unclear in endometrial hyperplasia and @DISEASE$.	1
71	In an effort to identify new mutations responsible for DBA, we performed whole-exome sequencing analysis of 48 patients with no documented mutations/deletions in our first screening and identified a de novo splicing error mutation in @GENE$ and a frameshift deletion in RPS27 in @DISEASE$ patients with DBA.	1
72	The purpose of the present study was to evaluate the expression of Lin28A, let-7a, and @GENE$ in human @DISEASE$ (PTC) and to investigate their potential mechanisms in the progression of PTC.	1
73	BACKGROUND @GENE$ is a gene involved in many biological processes, including development, glucose metabolism, and @DISEASE$igenesis.	1
74	Depletion of ASS1 led to inhibition of @DISEASE$ growth and decreased cell invasion via induction of autophagy-lysosome machinery, resulting in degradation of active β-catenin, @GENE$, and negative regulation of transcription, DNA-templated.	1
75	Depletion of ASS1 led to inhibition of @DISEASE$ growth and decreased cell invasion via induction of autophagy-lysosome machinery, resulting in degradation of active β-catenin, negative regulation of transcription by RNA polymerase II, and @GENE$.	0
76	Mutations in @GENE$, a Na<sup>+</sup> dependent OH<sup>-</sup> transporter, cause congenital hereditary endothelial dystrophy (CHED) and Fuchs' endothelial @DISEASE$ (FECD), the two most common forms of endothelial degeneration.	1
77	A further XX male, ascertained because of @DISEASE$, carried a de novo cryptic duplication at Xq27.1, involving @GENE$.	1
78	We analyzed, by conventional and molecular cytogenetics, 19 novel @GENE$-negative unrelated 46,XX subjects both familial and @DISEASE$, with isolated DSD.	1
79	However, there was no research elucidating the genetic association of entire @GENE$ pathway with ovarian @DISEASE$ susceptibility.	1
80	Therefore, we conducted genotyping for 17 SNPs of six NER core genes (<i>XPA, XPC, XPG, @GENE$, ERCC2</i>, and <i>ERCC4</i>) in 89 ovarian @DISEASE$ cases and 356 cancer-free controls.	1
81	However, no study has investigated the relationship between @GENE$ in living brains and personality traits including @DISEASE$.	1
82	Concerning @GENE$ G2548A polymorphism, our results showed that the OR of @DISEASE$ associated with 2548 AA/GG was 1.87[1.106-2.78] P = .028 vs 1.41[1.035-1.85] P = .045 for 223AA/GG polymorphism.	1
83	Here, we investigated the biological functions and clinical significance of @GENE$44 in human esophageal @DISEASE$ (HEC).	1
84	The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in @DISEASE$ cases; and MYH11 (myosin heavy chain 11), @GENE$ (leiomodin 1) and MYLK (myosin light chain (positive regulation of intracellular transport) kinase)-autosomal recessive inheritance), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.	0
85	The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and MYH11 (myosin heavy chain 11), positive regulation of actin filament polymerization (leiomodin 1) and MYLK (myosin light chain (@GENE$) kinase)-autosomal recessive @DISEASE$), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.	1
86	The genetic testing revealed a de novo heterozygous mutation of c.2452G &gt; A (p.Glu818Lys) in the @GENE$ gene, which was compatible with the clinical phenotype of CAPOS (cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural @DISEASE$)/CAOS syndrome.	1
87	The genetic testing revealed a de novo heterozygous mutation of c.2452G &gt; A (p.Glu818Lys) in the @GENE$ gene, which was compatible with the clinical phenotype of CAPOS (cerebellar ataxia, @DISEASE$, pes cavus, optic atrophy, and sensorineural hearing loss)/CAOS syndrome.	1
88	The genetic testing revealed a de novo heterozygous mutation of c.2452G &gt; A (p.Glu818Lys) in the @GENE$ gene, which was compatible with the clinical phenotype of CAPOS (cerebellar @DISEASE$, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss)/CAOS syndrome.	1
89	Mutations in the gene encoding the single transmembrane receptor multiple epidermal growth factor-like domain 10 (@GENE$) cause an @DISEASE$ congenital muscle disease in humans.	1
90	The copy number variations and mutations were also used to identify single nucleotide variations (SNVs) in crystallin mu (CRYM), RAB3 GTPase activating protein catalytic subunit 1 (@GENE$) and Wnt family member 10A (canonical Wnt signaling pathway), implicated in deafness, @DISEASE$ and tooth/skin abnormalities, respectively.	1
91	The copy number variations and mutations were also used to identify single nucleotide variations (SNVs) in crystallin mu (CRYM), RAB3 GTPase activating protein catalytic subunit 1 (regulation of GTPase activity) and Wnt family member 10A (@GENE$), implicated in deafness, @DISEASE$ and tooth/skin abnormalities, respectively.	1
92	The present findings did not identify copy number variation and mutations in @GENE$; therefore, excluding the possibility of EDA‑initiated @DISEASE$ syndrome.	1
93	The @GENE$ p.G213S mutation was confirmed to be the etiological cause of tooth agenesis and @DISEASE$ as previously described.	1
94	The present study screened pathogenic genes, ectodysplasin A (@GENE$) and lamin A/C (LMNA), in a patient with suspected syndromic hearing impairment and various other symptoms including tooth and @DISEASE$.	1
95	All these findings implied the important roles of @GENE$ expression in lung @DISEASE$ development and progression and the potential use of the methylation status detected in FBP1 promoter region as a novel predictor for prognosis and therapeutic target for NSCLC patients	1
96	Moreover, a series of @GENE$ gain-of-function and rescore experiments were carried out in breast cancer MCF7 cells expressing endogenous wt-p53, showing that ectopic expression of p53 decreases aerobic glycolysis, cell proliferation, migration, invasion and @DISEASE$ formation of breast cancer cells and that restoration of the expression of LDHA in p53-overexpressing cells could abolish the suppressive effect of p53 on aerobic glycolysis and other malignant phenotypes.	0
97	We found that NTS inhibits @GENE$- or @DISEASE$ cell-mediated osteoclastogenesis via blockade of TRAF6 and NF-κB activation.	0
98	Here, we show that ablating or silencing the transcription factor @GENE$ ameliorates pathology in several forms of @DISEASE$.	1
99	Mutations of the five genes (ARHGEF5, @GENE$, ZNF595, ZNF812, MYO18B) may be potential germline mutations of lung @DISEASE$.	1
100	These analyses revealed significantly higher methylation frequencies in high-grade @DISEASE$s relative to low-intermediate-grade tumors for the ATP5G2, @GENE$ and VAX2 genes (P&lt;0.05), and similarly significant increases in mean levels of methylation in high-grade tumors for the ATP5G2, VAX2, INSRR, PRDM14, VSX1, TFAP2b, PRRX1, and HIST1H4F genes (P&lt;0.05).	1
101	Here we present a case of a 3-year-old boy with compound heterozygous missense mutations in the @GENE$ gene manifesting features of both JBTS and NPHP syndromes, with neonatal onset of end-stage renal disease (ESRD) and associated @DISEASE$.	1
102	EEF1A2 gene is highly expressed in the @DISEASE$ nervous system and @GENE$ knockout mice show the neuronal degeneration.	0
103	Novel targets ANTXR1 and @GENE$ were confirmed to be suppressed by miR-493 directly, and overexpression of ANTXR1 and RSPO2 could restore @DISEASE$igenesis in miR-493 treated HCC cell.	0
104	These findings suggest that @GENE$-493 acts as a negative regulator in @DISEASE$ progression and may be a potential therapeutic target for HCC	1
105	Moreover, Wnt/β-catenin signaling pathway, which was reported to be activated by @GENE$ and RSPO2, was also inhibited by miR-493 overexpression and might be involved in anti-@DISEASE$ function of miR-493.	0
106	Mutations in POMT1, @GENE$, POMGNT1, FKTN, protein O-linked mannosylation, LARGE, GDP-mannose biosynthetic process, TMEM5 and COL4A1 and protein O-linked mannosylation lead to a wide spectrum of phenotypes of congenital @DISEASE$ with or without eye and brain abnormalities.	1
107	Mutations in POMT1, protein O-linked mannosylation, POMGNT1, FKTN, @GENE$, LARGE, GDP-mannose biosynthetic process, TMEM5 and COL4A1 and protein O-linked mannosylation lead to a wide spectrum of phenotypes of congenital @DISEASE$ with or without eye and brain abnormalities.	1
108	Mutations in POMT1, protein O-linked mannosylation, POMGNT1, FKTN, protein O-linked mannosylation, LARGE, @GENE$, TMEM5 and COL4A1 and protein O-linked mannosylation lead to a wide spectrum of phenotypes of congenital @DISEASE$ with or without eye and brain abnormalities.	1
109	Mutations in POMT1, protein O-linked mannosylation, POMGNT1, FKTN, protein O-linked mannosylation, LARGE, GDP-mannose biosynthetic process, TMEM5 and COL4A1 and @GENE$ lead to a wide spectrum of phenotypes of congenital @DISEASE$ with or without eye and brain abnormalities.	1
110	Besides, we screened for all the known genes related to axonal @DISEASE$ Charcot-Marie-Tooth disease (CMT2A2/HMSN2A2/MFN2, CMT2B1/LMNA, CMT2B2/MED25, CMT2B5/NEFL, ARCMT2F/dHMN2B/HSPB1, CMT2K/GDAP1, CMT2P/LRSAM1, CMT2R/TRIM2, CMT2S/IGHMBP2, CMT2T/HSJ1, CMTRID/COX6A1, ARAN-NM/HINT and GAN/GAN), for the genes related to autosomal recessive hereditary spastic paraplegia with thin corpus callosum and axonal peripheral neuropathy (SPG7/PGN, SPG15/ZFYVE26, SPG21/ACP33, SPG35/FA2H, SPG46/GBA2, SPG55/C12orf65 and SPG56/CYP2U1), as well as for the causative gene of peripheral neuropathy with or without agenesis of the corpus callosum (@GENE$).	0
111	@GENE$ potentially controls @DISEASE$ metastasis through regulation of negative regulation of retrograde protein transport, ER to cytosol levels.	1
112	protein polyubiquitination potentially controls @DISEASE$ metastasis through regulation of @GENE$ levels.	1
113	Loss of @GENE$ was also detected in primary tumours and it was highly associated with prognostic factors including high Gleason score, clinical stage, prostate-specific antigen (PSA) and extent of disease, as well as poor patient survival, suggesting that FBXL4 loss contributes to prostate @DISEASE$ progression.	0
114	The enriched genes included @GENE$, SERPINE2, response to bacterium, aging, and RASA3 in basal @DISEASE$s, and PPARG, LY6E, CTSE, cellular response to DNA damage stimulus, and negative regulation of transcription by RNA polymerase II in luminal tumors.	1
115	The enriched genes included proteolysis, SERPINE2, @GENE$, aging, and RASA3 in basal @DISEASE$s, and PPARG, LY6E, CTSE, cellular response to DNA damage stimulus, and negative regulation of transcription by RNA polymerase II in luminal tumors.	1
116	The enriched genes included proteolysis, SERPINE2, response to bacterium, @GENE$, and RASA3 in basal @DISEASE$s, and PPARG, LY6E, CTSE, cellular response to DNA damage stimulus, and negative regulation of transcription by RNA polymerase II in luminal tumors.	1
117	The enriched genes included proteolysis, SERPINE2, response to bacterium, aging, and RASA3 in basal @DISEASE$s, and PPARG, LY6E, CTSE, @GENE$, and negative regulation of transcription by RNA polymerase II in luminal tumors.	1
118	The enriched genes included proteolysis, SERPINE2, response to bacterium, aging, and RASA3 in basal @DISEASE$s, and PPARG, LY6E, CTSE, cellular response to DNA damage stimulus, and @GENE$ in luminal tumors.	0
119	@GENE$ phosphorylates purine nucleobase metabolic process/2, converts PRPS1/2 hexamers to monomers, and inhibits PRPS1/2 activity and subsequent nucleotide and NAD synthesis to maintain @DISEASE$ cell growth and survival.	1
120	lipid biosynthetic process phosphorylates @GENE$/2, converts PRPS1/2 hexamers to monomers, and inhibits PRPS1/2 activity and subsequent nucleotide and NAD synthesis to maintain @DISEASE$ cell growth and survival.	0
121	Knock-in of nonphosphorylatable @GENE$/2 mutants, which have uninhibited activity, in brain @DISEASE$ cells under energy stress exhausts cellular ATP and NADPH and increases reactive oxygen species levels, thereby promoting cell apoptosis.	1
122	Mutations in ganglioside-induced differentiation-associated-protein 1 (@GENE$) have been associated with both subtypes of Charcot-Marie-Tooth (CMT) disease, @DISEASE$ (CMT4A and AR-CMT2K) and autosomal dominant (AD-CMT2K).	1
123	Our study expands the mutational spectrum of @GENE$-related CMT disease with the identification of new and unreported GDAP1 variants and demonstrates the predominance of the axonal form of @DISEASE$ in CMT disease associated with GDAP1.	1
124	Here, a novel animal model was used to study how @GENE$-6 affects @DISEASE$ development.	1
125	The KSHV viral homolog of interleukin-6 gene (@GENE$-6) may play a significant role in @DISEASE$ development and may serve as a new anti-cancer target, but its role in tumor formation is only partially understood.	1
126	The KSHV viral homolog of interleukin-6 gene (@GENE$-6) may play a significant role in tumor development and may serve as a new anti-@DISEASE$ target, but its role in tumor formation is only partially understood.	1
127	Additional validation efforts and functional studies are warranted to demonstrate whether @GENE$ is a novel @DISEASE$ suppressor gene and a potential therapeutic target for pancreatic cancer	1
128	In a two-stage study, we analyzed the existing genome-wide association study dataset of 868 pancreatic @DISEASE$ patients from MD Anderson Cancer Center in relation to overall survival using @GENE$ regression.	1
129	FGD is a @DISEASE$ disorder for which causal mutations have been identified in MC2R, MRAP, @GENE$ and TXNRD2.	1
130	Here, we summarize the cellular functions of @GENE$, its roles in the nervous system, and its link to multiple @DISEASE$, with a particular focus dedicated to recent lysosome-related mechanistic developments	1
131	<i>In silico</i> human gene expression analysis confirmed the down regulation of PrKD1 in metastatic prostate @DISEASE$ correlated inversely with the expression of MAX, but not MYC, and positively with @GENE$, a competing heterodimer of MAX, suggesting that the dimerization of MAX with either MYC or MXD1 regulates <i>PrKD1</i> gene expression.	1
132	Because we had demonstrated that @GENE$ is the only known kinase to phosphorylate threonine 120 (T120) of beta-catenin in prostate @DISEASE$ resulting in increased nuclear beta-catenin, we explored the role of beta-catenin in gene regulation of <i>PrKD1</i>.	1
133	Down regulation of Protein Kinase D1 (@GENE$), a novel serine threonine kinase, in prostate, gastric, breast and colon @DISEASE$s in humans leads to disease progression.	1
134	Somatic genetic rearrangements that juxtapose the @GENE$ DNA binding domain to the transcriptional activation domain of other transcription factors deregulate PAX3 function and contribute to the pathogenesis of the soft tissue cancers alveolar @DISEASE$ and biphenotypic sinonasal sarcoma.	0
135	Overexpression of @GENE$ in rodent models recapitulates several aspects of @DISEASE$, and reduction of Pmp22 in such models results in amelioration of the neuropathy phenotype.	1
136	Mutations of the succinate dehydrogenase (@GENE$) complex subunits (A, B, C, D, and SDHAF2) have been implicated in predicting metastatic behavior and in identifying possible @DISEASE$ syndromes.	1
137	Genome-wide association studies have identified SNPs near @GENE$ at 10q21.2 that are associated with both breast @DISEASE$ risk and mammographic density.	1
138	Luciferase assays did not identify SNPs that affect transactivation of @GENE$, but identified a protective haplotype in iCHAV2, associated with silencing of the NRBF2 promoter, implicating this gene in the etiology of breast @DISEASE$.	0
139	Glycine cleavage system (GCS) catalyzes the degradation of glycine and disruption of its components encoded by @GENE$, AMT and GCSH are the only known causes of glycine encephalopathy, also known as non-ketotic @DISEASE$ (NKH).	1
140	Different @DISEASE$ are caused by mutations in the CHST6, KRT3, @GENE$, receptor-mediated endocytosis, SLC4A11, TACSTD2, TGFBI, and vitamin K biosynthetic process genes.	1
141	Different @DISEASE$ are caused by mutations in the CHST6, KRT3, visual perception, @GENE$, SLC4A11, TACSTD2, TGFBI, and vitamin K biosynthetic process genes.	1
142	Different @DISEASE$ are caused by mutations in the CHST6, KRT3, visual perception, receptor-mediated endocytosis, SLC4A11, TACSTD2, TGFBI, and @GENE$ genes.	1
143	By using three human tumor cell lines of different tissue origin (epidermoid HEp-3 and prostate PC-3 @DISEASE$ and HT-1080 fibrosarcoma) and several metastasis models conducted in both mammalian and avian settings, we show that @GENE$ is involved in the early dissemination of primary cancer cells, namely in the intravasation step of the metastatic cascade.	0
144	By using three human tumor cell lines of different tissue origin (epidermoid HEp-3 and prostate PC-3 carcinomas and HT-1080 fibrosarcoma) and several metastasis models conducted in both mammalian and avian settings, we show that @GENE$ is involved in the early dissemination of primary @DISEASE$ cells, namely in the intravasation step of the metastatic cascade.	1
145	@GENE$ was dispensable in the late steps of carcinoma cell metastasis that follow @DISEASE$ cell intravasation, including vascular arrest, extravasation, and tissue colonization.	0
146	Knockdown of @GENE$ in all tested cell lines led to significant inhibition of @DISEASE$ cell intravasation, but did not affect primary tumor growth.	1
147	All @DISEASE$ were positive for @GENE$-bicarbonate transport, CK18, PAX 8, antimitochondrial antigen, and SDHB.	1
148	All @DISEASE$ were positive for anion transport-@GENE$, CK18, PAX 8, antimitochondrial antigen, and SDHB.	1
149	HOT should be considered as an emerging renal entity because it does not meet the diagnostic criteria for other recognized eosinophilic renal @DISEASE$, such as oncocytoma, chromophobe renal cell carcinoma (RCC), positive regulation of cell adhesion and @GENE$ RCC, choline catabolic process-deficient RCC, and eosinophilic solid and cystic RCC	1
150	HOT should be considered as an emerging renal entity because it does not meet the diagnostic criteria for other recognized eosinophilic renal tumors, such as oncocytoma, chromophobe @DISEASE$ (RCC), positive regulation of cell adhesion and positive regulation of transcription by RNA polymerase II RCC, @GENE$-deficient RCC, and eosinophilic solid and cystic RCC	0
151	HOT should be considered as an emerging renal entity because it does not meet the diagnostic criteria for other recognized eosinophilic renal tumors, such as oncocytoma, chromophobe @DISEASE$ (RCC), @GENE$ and positive regulation of transcription by RNA polymerase II RCC, choline catabolic process-deficient RCC, and eosinophilic solid and cystic RCC	0
152	HOT should be considered as an emerging renal entity because it does not meet the diagnostic criteria for other recognized eosinophilic renal tumors, such as oncocytoma, chromophobe @DISEASE$ (RCC), positive regulation of cell adhesion and @GENE$ RCC, choline catabolic process-deficient RCC, and eosinophilic solid and cystic RCC	0
153	Altogether, our data strongly suggest that mutations in @GENE$ cause a previously undescribed clinical entity of a ciliary nature characterized by @DISEASE$ and deafness but clearly distinct from Usher syndrome, a condition for which visual impairment is due to retinitis pigmentosa.	1
154	Altogether, our data strongly suggest that mutations in @GENE$ cause a previously undescribed clinical entity of a ciliary nature characterized by blindness and @DISEASE$ but clearly distinct from Usher syndrome, a condition for which visual impairment is due to retinitis pigmentosa.	1
155	Our most significant AM association was upstream of @GENE$, a gene implicated in ovarian and breast @DISEASE$s (rs11604207, p = 1.6×10⁻⁰⁶).	1
156	Accordingly, overexpression of the Aα mutants in EC cells harboring wild-type PPP2R1A increased anchorage-independent growth and @DISEASE$ formation, and triggered hyperphosphorylation of oncogenic PP2A-B56/B' substrates in the GSK3β, @GENE$, and mTOR/p70S6K signaling pathways.	0
157	By pooling genetic findings across multiple studies, we have identified six individuals with severe developmental delay (6/6), refractory @DISEASE$ (5/6), and similar dysmorphic features (3/6), each harboring a de novo mutation in @GENE$.	1
158	Several gene encoding proteins related to collagen metabolism have been described in some cases of @DISEASE$ OI (including CRTAP, LEPRE1, PPIB, FKBP65, negative regulation of angiogenesis, BMP1, @GENE$, protein peptidyl-prolyl isomerization).	1
159	Several gene encoding proteins related to collagen metabolism have been described in some cases of @DISEASE$ OI (including CRTAP, LEPRE1, PPIB, FKBP65, negative regulation of angiogenesis, BMP1, positive regulation of cell proliferation, @GENE$).	1
160	Several gene encoding proteins related to collagen metabolism have been described in some cases of @DISEASE$ OI (including CRTAP, LEPRE1, PPIB, FKBP65, @GENE$, BMP1, positive regulation of cell proliferation, protein peptidyl-prolyl isomerization).	1
161	Recently, @GENE$, a gene that encodes TRIC-B, a monovalent cation-specific channel involved in calcium flux from intracellular stores and in cell differentiation, has been associated with @DISEASE$ OI.	1
162	Mutations in the mitochondrial alanyl-transfer (t)RNA synthetase 2 (@GENE$; OMIM 612035) have been linked to @DISEASE$ recently.	1
163	We report a case with novel @GENE$ gene mutations with developed striking cerebellar atrophy and leukoencephalopathy, which helps to further understand the clinical and genetic @DISEASE$ of AARS2-L	0
164	Here we report a patient with a congenital syndrome consisting of severe global developmental delay, microcephaly, heart defects, @DISEASE$ and liver disease with a previously unreported homozygous NM_015352.1: c.485C&gt;T variant (p.Ser162Leu) in @GENE$ detected by exome sequencing.	1
165	OBJECTIVES We hypothesised that p16 @GENE$ methylation might have a role in @DISEASE$ development driven by HPV16, mainly in the presence of intact E1/E2 genes.	1
166	BACKGROUND Epigenetic modifications in host cells, like p16 @GENE$ methylation, have been considered as putative complementary mechanisms for @DISEASE$ development.	1
167	Antiepileptic drugs remain the treatment of choice for PKD and episodic @DISEASE$ type 1, benzodiazepines are often useful for @GENE$, and episodic ataxia type 2 benefits from acetazolamide regardless of the genetic etiology	0
168	Chemical inhibition of epigenetic regulatory proteins BrdT and @GENE$ is emerging as a promising therapeutic strategy in contraception, @DISEASE$, and heart disease.	1
169	However, all experimental models of electrolytic @DISEASE$, tissue factor-induced pulmonary embolism, transient focal brain ischaemic stroke, or skin-wound healing showed largely similar phenotypes between @GENE$T/T mice and wild-type mice.	1
170	DNA was extracted from paraffin-embedded @DISEASE$ specimens from the patients and peripheral blood lymphocytes from the controls and used for @GENE$/fat cell differentiation genotyping.	0
171	DNA was extracted from paraffin-embedded @DISEASE$ specimens from the patients and peripheral blood lymphocytes from the controls and used for regulation of cysteine-type endopeptidase activity/@GENE$ genotyping.	0
172	Cervical @DISEASE$ patients with genotypes GA/AA in @GENE$ SNP rs12918952 were associated with parametrium invasion and pelvic lymph node metastasis.	1
173	Whole-genome sequencing documented two rare truncating variants in @GENE$, a gene associated with a type of @DISEASE$ AOS that recurrently features periventricular calcification and impaired neurodevelopment.	1
174	Our findings establish that defective @GENE$ function underlies a recognizable @DISEASE$ and drives accelerated microtubule polymerization and enhanced microtubule stability, underscoring an additional cause of altered microtubule dynamics with impact on neuronal function and survival in the developing brain	1
175	To understand the importance of chr11q22.3-23.2 region in the development of cervical @DISEASE$, we have studied the genetic and epigenetic alterations of the candidate genes protein phosphorylation, apoptotic process involved in morphogenesis, @GENE$ and T cell mediated cytotoxicity in cervical intraepithelial neoplasia (CIN) and cervical carcinoma (CACX) samples.	1
176	To understand the importance of chr11q22.3-23.2 region in the development of cervical cancer, we have studied the genetic and epigenetic alterations of the candidate genes @GENE$, apoptotic process involved in morphogenesis, tricarboxylic acid cycle and T cell mediated cytotoxicity in cervical intraepithelial @DISEASE$ (CIN) and cervical carcinoma (CACX) samples.	1
177	To understand the importance of chr11q22.3-23.2 region in the development of cervical cancer, we have studied the genetic and epigenetic alterations of the candidate genes protein phosphorylation, @GENE$, tricarboxylic acid cycle and T cell mediated cytotoxicity in cervical intraepithelial @DISEASE$ (CIN) and cervical carcinoma (CACX) samples.	1
178	To understand the importance of chr11q22.3-23.2 region in the development of cervical cancer, we have studied the genetic and epigenetic alterations of the candidate genes protein phosphorylation, apoptotic process involved in morphogenesis, tricarboxylic acid cycle and @GENE$ in cervical intraepithelial @DISEASE$ (CIN) and cervical carcinoma (CACX) samples.	1
179	The alterations of ATM and @GENE$ are associated with the progression of @DISEASE$ from CIN to Stage I/II, thus implying their role in early invasiveness.	1
180	@GENE$, a mitochondrial serine/threonine kinase, is the product of a gene mutated in an @DISEASE$ form of Parkinson disease.	1
181	Transcriptomic analysis revealed significant alterations in a number of genes associated with @DISEASE$, such as adsl, mbd5, @GENE$, and tsc1b.	1
182	Conversely, Th17 cells and their effector molecules interleukin 17A (IL-17A), IL-17F, interferon (@GENE$)γ, @DISEASE$ necrosis factor (TNF)α, and granulocyte-macrophage colony-stimulating factor (GM-CSF) are implicated in the pathology of rheumatoid arthritis (RA).	1
183	Our data suggest that mutations of the @GENE$ gene are the main causes of posterior @DISEASE$ and seem to affect the semen quality of adult patients, whereas mutations in AR and androgen biosynthetic process gene were rare in these hypospadias patients.	1
184	Our data suggest that mutations of the androgen metabolic process gene are the main causes of posterior @DISEASE$ and seem to affect the semen quality of adult patients, whereas mutations in AR and @GENE$ gene were rare in these hypospadias patients.	0
185	Recently, it has been demonstrated that, mutations of @GENE$ are associated with @DISEASE$ nonsyndromic hearing impairment at the sensory perception of sound locus.	0
186	Recently, it has been demonstrated that, mutations of sensory perception of sound are associated with profound nonsyndromic @DISEASE$ at the @GENE$ locus.	0
187	A third proband was doubly heterozygous for inherited rare variants in additional components of complex I, @GENE$ and mitochondrial respiratory chain complex I assembly, confirming that Histiocytoid CM is genetically @DISEASE$.	0
188	A third proband was doubly heterozygous for inherited rare variants in additional components of complex I, mitochondrial respiratory chain complex I assembly and @GENE$, confirming that Histiocytoid CM is genetically @DISEASE$.	0
189	Today, more than a dozen human @GENE$ missense mutations have been described, all found in patients with severe @DISEASE$.	1
190	Hypomorphic @GENE$ mutations in males are typically associated with anhidrotic @DISEASE$ with immunodeficiency (EDA-ID).	1
191	As rare polymorphisms have been described in IKBKG and @DISEASE$ remains an option in the presented case, this study emphasizes the need for thorough functional and genetic evaluation when encountering and interpreting suspected disease-causing @GENE$-ID variants	0
192	Monogenic @DISEASE$ is the result of mutations in genes that regulate the metabolism of triglyceride rich lipoproteins (eg fatty acid metabolic process, APOC2, triglyceride metabolic process, triglyceride metabolic process, @GENE$).	1
193	Monogenic @DISEASE$ is the result of mutations in genes that regulate the metabolism of triglyceride rich lipoproteins (eg @GENE$, APOC2, triglyceride metabolic process, triglyceride metabolic process, positive regulation of lipoprotein lipase activity).	1
194	Monogenic @DISEASE$ is the result of mutations in genes that regulate the metabolism of triglyceride rich lipoproteins (eg fatty acid metabolic process, APOC2, @GENE$, triglyceride metabolic process, positive regulation of lipoprotein lipase activity).	1
195	Monogenic @DISEASE$ is the result of mutations in genes that regulate the metabolism of triglyceride rich lipoproteins (eg fatty acid metabolic process, APOC2, triglyceride metabolic process, @GENE$, positive regulation of lipoprotein lipase activity).	1
196	Consistent with this pattern of activity, polr1c and @GENE$ homozygous mutant zebrafish exhibit cartilage hypoplasia and cranio@DISEASE$ characteristic of humans with Treacher Collins syndrome.	1
197	Somewhat arbitrarily, three disorders were successively put forward as the underlying cause of HIES: autosomal dominant (AD) @GENE$ deficiency, the only disorder corresponding to the original definition of HIES, and @DISEASE$ (AR) DOCK8 and PGM3 deficiencies, in which atopy and high serum IgE levels occur in a context of manifestations not seen in patients with typical HIES.	0
198	In this report, we describe a patient with a phenotype compatible with MOTA syndrome (aberrant anterior hair line, hypertelorism, @DISEASE$ anophthalmia, and bifid and broad nasal tip) in whom two novel @GENE$ mutations (c.305 A &gt; G, p.Asp102Gly; and c.2626delG, p.Val876Tyrfs*16) were identified in the compound heterozygous state, thus broadening the mutational spectrum of the disease.	1
199	We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, @GENE$, HURP, protein phosphorylation), DNA damage repair (mitotic cell cycle, γ-H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (protein polyubiquitination) and PI3K signaling pathway (negative regulation of protein phosphorylation, phospho-regulation of cell growth) in a tissue microarray of 50 adenomas and 43 @DISEASE$ that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.	1
200	We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, ubiquitin-dependent protein catabolic process, HURP, @GENE$), DNA damage repair (mitotic cell cycle, γ-H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (protein polyubiquitination) and PI3K signaling pathway (negative regulation of protein phosphorylation, phospho-regulation of cell growth) in a tissue microarray of 50 adenomas and 43 @DISEASE$ that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.	1
201	We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, ubiquitin-dependent protein catabolic process, HURP, protein phosphorylation), DNA damage repair (@GENE$, γ-H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (protein polyubiquitination) and PI3K signaling pathway (negative regulation of protein phosphorylation, phospho-regulation of cell growth) in a tissue microarray of 50 adenomas and 43 @DISEASE$ that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.	1
202	We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, ubiquitin-dependent protein catabolic process, HURP, protein phosphorylation), DNA damage repair (mitotic cell cycle, γ-H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (@GENE$) and PI3K signaling pathway (negative regulation of protein phosphorylation, phospho-regulation of cell growth) in a tissue microarray of 50 adenomas and 43 @DISEASE$ that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.	1
203	We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, ubiquitin-dependent protein catabolic process, HURP, protein phosphorylation), DNA damage repair (mitotic cell cycle, γ-H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (protein polyubiquitination) and PI3K signaling pathway (@GENE$, phospho-regulation of cell growth) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based @DISEASE$ grade.	0
204	We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, ubiquitin-dependent protein catabolic process, HURP, protein phosphorylation), DNA damage repair (mitotic cell cycle, γ-H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (protein polyubiquitination) and PI3K signaling pathway (@GENE$, phospho-regulation of cell growth) in a tissue microarray of 50 adenomas and 43 @DISEASE$ that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.	1
205	We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, ubiquitin-dependent protein catabolic process, HURP, protein phosphorylation), DNA damage repair (mitotic cell cycle, γ-H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (protein polyubiquitination) and PI3K signaling pathway (negative regulation of protein phosphorylation, phospho-@GENE$) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based @DISEASE$ grade.	1
206	IGF-2 and proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, @GENE$, HURP, NEK2), DNA damage proteins (PBK, γ-H2AX), regulators of telomeres (DAXX, nucleosome assembly), and beta-catenin revealed characteristic expression profiles enabling the distinction of @DISEASE$ from adenomas.	1
207	IGF-2 and proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, ubiquitin-dependent protein catabolic process, HURP, NEK2), DNA damage proteins (PBK, γ-H2AX), regulators of telomeres (DAXX, @GENE$), and beta-catenin revealed characteristic expression profiles enabling the distinction of @DISEASE$ from adenomas.	1
208	Mutations in @GENE$, which codes for an enzyme early in brain ganglioside biosynthesis, result in an early-onset @DISEASE$ disorder with profound motor and cognitive decay, whereas mutations in B4GALNT1, a gene encoding a later step, result in hereditary spastic paraplegia accompanied by intellectual deficits.	1
209	Possible candidate genes in 6q14 for @DISEASE$ might be FILIP1, @GENE$, HTR1B, and SNX14	1
210	@GENE$ plays a protective role in mouse models of neurodegenerative disease, and in humans, mutations in CHIP cause spinocerebellar ataxia @DISEASE$ type 16 (SCAR16), a fatal neurodegenerative disease characterized by truncal and limb ataxia that results in gait instability.	0
211	TNF-related apoptosis-inducing ligand (@GENE$) was initially described to induce apoptosis of @DISEASE$ cells and/or virally infected cells, although sparing normal cells, and has been implicated in the pathogenesis of HIV disease.	1
212	In the present study, we evaluated the association of SENPs polymorphism with susceptibility as well as clinicopathologic features and patients' response of breast @DISEASE$ (BC) in a Chinese population.We genotyped @GENE$ (rs61918808), protein desumoylation (rs6762208), SENP7 (rs61697963) by sequencing in a case-control study including 210 BC patients and 225 healthy volunteers.	0
213	In the present study, we evaluated the association of SENPs polymorphism with susceptibility as well as clinicopathologic features and patients' response of breast @DISEASE$ (BC) in a Chinese population.We genotyped activation of cysteine-type endopeptidase activity involved in apoptotic process (rs61918808), @GENE$ (rs6762208), SENP7 (rs61697963) by sequencing in a case-control study including 210 BC patients and 225 healthy volunteers.	0
214	Notably, in two lung cancer models with @GENE$ amplification, the anti@DISEASE$ efficacy was higher, suggesting that the simultaneous inhibition of VEGF and FGF receptors in FGFR1 dependent tumors can be therapeutically advantageous.	1
215	In cell assays, lucitanib potently inhibited the growth of @DISEASE$ cell lines with amplified @GENE$ or mutated/amplified FGFR2.	1
216	Lucitanib is a small molecule inhibitor of vascular endothelial growth factor (VEGF) receptors 1 to 3 (VEGFR1 to 3), platelet derived growth factor α/β (PDGFRα/β) and @GENE$-3 tyrosine kinases and has demonstrated activity in a phase I/II clinical study, with objective RECIST responses in breast @DISEASE$ patients with FGFR1 or FGF3/4/19 gene amplification, as well as in patients anticipated to benefit from anti-angiogenic agents.	0
217	Increasing evidence has shown that WT1-interacting protein (@GENE$) plays important roles both physiologically and pathologically in humans; however, the role of WTIP in @DISEASE$ is unknown.	0
218	Here, we investigated the role and mechanism of @GENE$ in cell proliferation and tumorigenesis of non-small-cell lung @DISEASE$ (NSCLC).	1
219	IL17RD expression was increased in ulcerative colitis @DISEASE$s, and miR-193a-3p treatment decreased growth and @GENE$ signaling of HCT116 cells in xenografts expressing both IL17RD with WT 3'UTR compared with cells expressing IL17RD with mutant 3'UTR.<b>Conclusions:</b> miR-193a-3p is downregulated in ulcerative colitis neoplasia, and its loss promotes carcinogenesis through upregulation of IL17RD.	0
220	Several studies have demonstrated that N-butyldeoxynojirimycin (NB-DNJ, also known as miglustat), an inhibitor of the enzyme glucosylceramide synthase (@GENE$), successfully delays the onset of motor deficits, improves longevity, and rescues some of the @DISEASE$ (e.g., Purkinje cell death) seen in another lysosomal disease known as Niemann-Pick type C (NPC).	0
221	We identified a highly significant enrichment of de novo variants in @GENE$, establishing their role in early-onset @DISEASE$, and we provide additional support for the prior assignment of L-glutamate transmembrane transport.	1
222	We identified a highly significant enrichment of de novo variants in regulation of neuron differentiation, establishing their role in early-onset @DISEASE$, and we provide additional support for the prior assignment of @GENE$.	1
223	The brains of <i>@GENE$</i><sup>-/-</sup> mice had @DISEASE$, enlarged ventricles, and decreased thickness of the somatosensory cortex.	1
224	A heterozygous mutation (c.643C&gt;A; p.Q215X) in the monocarboxylate transporter 12-encoding gene @GENE$ (also known as SLC16A12) that mediates creatine transport was recently identified as the cause of a syndrome with juvenile @DISEASE$, microcornea, and glucosuria in a single family.	1
225	The @DISEASE$ cells resembled pro-B cells, and were CD19<sup>+</sup>IgM<sup>-</sup>IgD<sup>-</sup>CD93<sup>+</sup>CD43<sup>+</sup>CD21<sup>-</sup>CD23<sup>-</sup>VpreB<sup>+</sup>CXCR4<sup>+</sup> Consistent with the pro-B-cell stage of B-cell development, microarray analysis revealed enrichment of transcripts, including Rag1, Rag2, CD93, Vpreb1, Vpreb3, and @GENE$ We confirmed V(D)J recombination expression in Tg26 tumors, and hypothesized that HIV-1 matrix protein p17 may directly induce RAG1 in B cells.	0
226	The @DISEASE$ cells resembled pro-B cells, and were CD19<sup>+</sup>IgM<sup>-</sup>IgD<sup>-</sup>CD93<sup>+</sup>CD43<sup>+</sup>CD21<sup>-</sup>CD23<sup>-</sup>VpreB<sup>+</sup>CXCR4<sup>+</sup> Consistent with the pro-B-cell stage of B-cell development, microarray analysis revealed enrichment of transcripts, including Rag1, Rag2, CD93, Vpreb1, Vpreb3, and leukocyte migration We confirmed @GENE$ expression in Tg26 tumors, and hypothesized that HIV-1 matrix protein p17 may directly induce RAG1 in B cells.	0
227	SNORD115-TAF1 and SNORD-DPM2 dysfunction introduce possible clues to the parkinsonism and increased creatinine phosphokinase in NMS, while abnormalities of SNORD115-@GENE$ suggest links to both anti-NMDAR @DISEASE$ and the proven predisposing catatonic SHANK3 gene.	1
228	The polo family serine threonine kinase @GENE$ has been proposed as a therapeutic target in advanced @DISEASE$s based on increased expression in primary human cancers, facilitation of tumor growth in murine xenograft models, and centrosomal amplification induced by its overexpression.	1
229	The polo family serine threonine kinase @GENE$ has been proposed as a therapeutic target in advanced cancers based on increased expression in primary human cancers, facilitation of @DISEASE$ growth in murine xenograft models, and centrosomal amplification induced by its overexpression.	1
230	Our results validate Plk4 as a therapeutic target in @DISEASE$ patients and reveal a new role for Plk4 in regulating @GENE$/3-mediated actin cytoskeletal rearrangement.	0
231	Polymorphisms in the @GENE$ gene have been linked to congenital heart anomalies and @DISEASE$.	1
232	@GENE$ encodes a complex I-specific assembly factor and mutations in this gene result in complex I deficiency, @DISEASE$ encephalomyopathy and Leigh syndrome.	1
233	Our data, for the first time, functionally link Jalili syndrome gene CNNM4 to @GENE$ gene IQCB1, providing important insights into the molecular pathogenic mechanism of @DISEASE$ in Jalili syndrome	0
234	In fact, @GENE$ has been considered as a candidate @DISEASE$ susceptibility gene.	1
235	We show that genetic defects in @GENE$ cause moderate-to-severe sensorineural @DISEASE$.	1
236	It has been proposed that transcobalamin 2 (@GENE$) and the transcobalamin 2 receptor (TCN2R) are associated with idiopathic recurrent @DISEASE$ (RSA).	1
237	The present study was designed to survey the mutation spectrum of common pathogenic genes (@GENE$, OPA3 and mtDNA genes) and to analyze the genotype-phenotype characteristics of Chinese patients with suspected childhood-onset hereditary optic @DISEASE$.	0
238	This study expanded the @GENE$ mutation spectrum, and our results showed that OPA1 mutation is another common cause of childhood-onset hereditary optic @DISEASE$ in Chinese pediatric patients, especially those with disease onset during preschool age	1
239	Finally, we demonstrate that @GENE$ expression is elevated in luminal breast @DISEASE$ cells and luminal breast cancer tissues as compared with other breast cancer subtypes.	1
240	We report four individuals from three unrelated families who have homozygous missense or compound heterozygous truncating mutations in @GENE$ and persistent hypotonia, @DISEASE$, growth failure, and severe intellectual disability.	1
241	T cell-produced TNF and IL-17A further contribute to bone loss in @DISEASE$, while T cell production of the anabolic Wingless integration site (Wnt) ligand, @GENE$, promotes bone formation in response to anabolic parathyroid hormone and the immunomodulatory costimulation inhibitor cytotoxic T lymphocyte-associated protein-4-IgG (abatacept).	0
242	We hypothesized therefore that some children with @DISEASE$ and kidney stones harbor a @GENE$ variant that inappropriately increases gene expression.	1
243	Our data suggest that children with the @GENE$ binding site within the calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules risk haplotype have a higher likelihood of @DISEASE$ and kidney stones.	1
244	Our data suggest that children with the negative regulation of transcription by RNA polymerase II binding site within the @GENE$ risk haplotype have a higher likelihood of @DISEASE$ and kidney stones.	1
245	To test this hypothesis, we sequenced the @GENE$ risk haplotype in a cohort of children with idiopathic @DISEASE$ and kidney stones.	1
246	Feingold syndrome is a @DISEASE$ caused by loss-of-function mutations of either @GENE$ (type 1) or MIR17HG that encodes miR-17-92 microRNAs (type 2).	1
247	uPA may enhance the migratory and invasive capabilities of endometrial @DISEASE$ cells by the phosphorylation of ERK1/2, @GENE$ and p38 molecules.	1
248	@GENE$ mutations are associated with a distinct form of early-onset @DISEASE$ characterized by rapid and severe disease progression and early cognitive decline; the pathological features were striking and reminiscent of diffuse Lewy body disease.	1
249	Targeted deletion of @GENE$ in mesenchymal progenitors led to spontaneous fractures due to impaired osteoblast function and @DISEASE$, mimicking the severe OI phenotype in humans with homozygous positive regulation of cell proliferation mutations.	1
250	Targeted deletion of positive regulation of cell proliferation in mesenchymal progenitors led to spontaneous fractures due to impaired osteoblast function and @DISEASE$, mimicking the severe OI phenotype in humans with homozygous @GENE$ mutations.	0
251	Finally, we report that 9 retained cytotoxicity against several pediatric @DISEASE$ cell lines with EC<sub>50</sub> values comparable to @GENE$ inhibitor (BETi) clinical candidates	0
252	Taken together, our data provide insight into the molecular pathways of dominantly and recessively acting @GENE$ missense mutations suggesting that the site of subcellular protein quality control as well as the rate and degree of mutant protein degradation are ultimately responsible for the distinct @DISEASE$ phenotypes in BD and ARB	0
253	Herein, we report a third patient (not related to the previously reported family) with bilateral colobomatous @DISEASE$ and developmental delay in whom genetic studies identified a homozygous @GENE$ splicing mutation c.2968-2A&gt;T (p.Val990Cysfs*13).	1
254	Herein, we report a third patient (not related to the previously reported family) with bilateral colobomatous microphthalmia and @DISEASE$ in whom genetic studies identified a homozygous @GENE$ splicing mutation c.2968-2A&gt;T (p.Val990Cysfs*13).	1
255	In a recent study combining autozygome and exome analysis, a homozygous loss of function mutation in @GENE$ (previously named ODZ3) was reported in two siblings with isolated bilateral colobomatous @DISEASE$ from a consanguineous Saudi family.	1
256	RESULTS A nonsynonymous mutation at ovine Chr3:193,691,195, which generated a glycine-to-arginine amino acid change within the predicted @GENE$ protein, was significantly associated with @DISEASE$ and predicted to be deleterious.	0
257	@GENE$ deficiency is a syndromic condition of X-linked intellectual disability (ID) characterized by typical dysmorphic features that include synophrys, prominent supraorbital ridges, almond-shaped, and deep-set eyes, @DISEASE$, wide mouth, myxedematous appearance, hirsutism, micropenis, and onychodystrophy.	1
258	@GENE$ deficiency is a syndromic condition of X-linked intellectual disability (ID) characterized by typical dysmorphic features that include synophrys, prominent supraorbital ridges, almond-shaped, and @DISEASE$, large ears, wide mouth, myxedematous appearance, hirsutism, micropenis, and onychodystrophy.	1
259	@GENE$ deficiency is a syndromic condition of X-linked intellectual disability (ID) characterized by typical dysmorphic features that include synophrys, prominent supraorbital ridges, almond-shaped, and deep-set eyes, large ears, wide mouth, myxedematous appearance, @DISEASE$, micropenis, and onychodystrophy.	1
260	These results expand the genetic @DISEASE$ of EKVP and the human disease phenotypes associated with @GENE$ mutations.	0
261	Erythrokeratodermia variabilis et progressiva (EKVP) is a genodermatosis with clinical and genetic @DISEASE$, most often transmitted in an autosomal dominant manner, caused by mutations in GJB3 and @GENE$ genes encoding connexins (Cx)31 and 30.3, respectively.	1
262	@GENE$-R142C is a mutation that was reported to be associated with @DISEASE$ (ASD) and atrioventricular (AV) block in 13-patients from one family.	1
263	Up to this time, only heterozygous mutations of @GENE$ gene have been reported in human and related to: (1) multiple @DISEASE$ type 3, (2) susceptibility to an intervertebral disc disease, and (3) hearing loss.	1
264	In clinical specimens, elevated LAMB3 expression correlated with poorer survival in lung @DISEASE$ patients with an oncogenic @GENE$ gene signature, suggesting a novel candidate biomarker in this disease setting.	1
265	Silencing of FAK or @GENE$ recapitulated the synthetic lethal effects of miR-1298 expression in KRAS-driven @DISEASE$ cells, whereas coexpression of both proteins was critical to rescue miR-1298-induced cell death.	1
266	Mutations in @GENE$ (PARK14) cause neurodegenerative disorders in humans, including autosomal recessive neuroaxonal dystrophy and early-onset @DISEASE$.	1
267	@GENE$ knockout ferrets exhibit severe @DISEASE$ (25-40% decreases in brain weight), reflecting reduced cortical surface area without significant change in cortical thickness, as has been found in human patients<sup>3,4</sup>, suggesting that loss of 'cortical units' has occurred.	1
268	We demonstrate spatial genomic @DISEASE$ in more than 75% of patients, including inactivation of @GENE$ and TP53, and mutations affecting mitogen-activated protein kinase genes.	1
269	Recently, the roles of FAM83H in @DISEASE$igenesis have been interested and increased expression of FAM83H and @GENE$ in hepatocellular carcinoma (HCC) have been reported.	0
270	In conclusion, we present an oncogenic role of FAM83H in liver @DISEASE$, which is closely associated with the oncogene @GENE$.	1
271	@GENE$ overexpression rescued the inhibition of liver @DISEASE$ cell proliferation, migration, and invasion by miR‑498, indicating that ZEB2 acts as a downstream effector of miR‑498 in liver cancer cells.	1
272	Heterozygous missense mutations in @GENE$ have been associated with @DISEASE$ spectrum disorder.	1
273	Although the 4 PKPs displayed different levels and patterns of subcellular distribution in @DISEASE$s, there was a positive correlation between immunoreactivity for @GENE$ and PKP3, as well as for PKP2 and p0071, suggesting possible functional similarities associated with differentiation, tumor growth, and disease prognosis.	1
274	In contrast, strong @GENE$ immunoreactivity was observed in 85.7% of metastatic @DISEASE$s.	1
275	Our association analysis revealed a uniform pattern of Warburg effect mutations influencing prognosis across all @DISEASE$ types, while copy number alterations in the electron transport chain gene SCO2, fatty acid uptake (CAV1, CD36) and lipogenesis (negative regulation of transcription by RNA polymerase II, @GENE$, MLXIPL) genes were enriched in metastatic tumors.	0
276	Our association analysis revealed a uniform pattern of Warburg effect mutations influencing prognosis across all @DISEASE$ types, while copy number alterations in the electron transport chain gene SCO2, fatty acid uptake (CAV1, CD36) and lipogenesis (@GENE$, positive regulation of transcription, DNA-templated, MLXIPL) genes were enriched in metastatic tumors.	0
277	This includes unaffected women who have completed their family and have RAD51C, @GENE$, or BRIP1 gene mutations; first-degree relatives of women with invasive epithelial ovarian @DISEASE$; BRCA mutation-negative women from high-risk breast-and-ovarian cancer or ovarian-cancer-only families.	0
278	@GENE$ mutations, first reported to be the cause of the Prader-Willi like syndrome with @DISEASE$ by Schaaf et al. (2013) Nature Genetics, 45: 1405-1408 show the wide range of phenotypic spectrum from lethal arthrogryposis multiplex congenital to autism spectrum disorder (ASD) and mild intellectual disability (ID).	1
279	Our results indicate that @GENE$ mutations cause multiple congenital anomalies and @DISEASE$ accompanied by arthrogryposis multiplex congenita and various endocrinologic abnormalities, supporting that the view that clinical phenotypes of MAGEL2 mutations are variable	1
280	Using human @DISEASE$ SH-SY5Y cells, we found that the neuroprotective function of @GENE$ is blocked by CHRNA7 knockdown using RNA interference.	1
281	Mutations in human crumbs 1 (<i>@GENE$</i>) are a major cause of retinal diseases that lead to @DISEASE$.	1
282	by reactivating pre-existing anti-@DISEASE$ immune responses against @GENE$ antigens.	0
283	After exclusive analysis of 10 common variations of three @DISEASE$-related genes, GJB2, mtDNA12srRNA and SLC26A4, a novel truncated variant of @GENE$, c.87dupA (p.Gly30Argfs*12) (NCBI ClinVar Submission ID: SUB3136126), was identified by whole-exome sequencing.	0
284	In this study, the correlation between H19 and vitamin D receptor (@GENE$) signaling and the underlying mechanisms in colon @DISEASE$ were investigated both in vitro and in vivo.	1
285	In conclusion, @GENE$ 4217C&gt;A polymorphism may not be associated with the development of @DISEASE$ in Japanese population	1
286	Polymorphisms in the genes encoding carbamoyl-phosphate synthase 1 (@GENE$) and N-acetylglutamate synthase (NAGS) were recently reported to be risk factors for the development of @DISEASE$ during valproic acid-based therapy.	1
287	@GENE$-CDG (COG5 subunit deficiency) is a multisystem disease with dysmorphic features, @DISEASE$ of variable degree, seizures, acquired microcephaly, sensory defects and autistic behavior.	1
288	Xenograft pancreatic @DISEASE$s derived from high biological_process-@GENE$ expression PC cells exhibited attenuated growth compared to tumors from low B7-H5 expression cells after transfusion with T lymphocytes in immune-deficient mice.	1
289	Xenograft pancreatic @DISEASE$s derived from high @GENE$-positive regulation of cell proliferation expression PC cells exhibited attenuated growth compared to tumors from low B7-H5 expression cells after transfusion with T lymphocytes in immune-deficient mice.	1
290	Mutations in the D40/KNL1/CASC5 gene, which was initially characterized as a gene involved in chromosomal translocation in leukemia and as a member of the @DISEASE$/testis gene family, was later found to encode a kinetochore protein essential for mitotic cell division and to cause @GENE$.	0
291	Although overlapping features with Bohring-Opitz and Bainbridge-Ropers syndromes exist, features that distinguish the ASXL2-associated condition from @GENE$- and transcription, DNA-templated-related disorders are macrocephaly, absence of growth retardation, and more variability in the degree of @DISEASE$.	1
292	Although overlapping features with Bohring-Opitz and Bainbridge-Ropers syndromes exist, features that distinguish the ASXL2-associated condition from @GENE$- and transcription, DNA-templated-related disorders are @DISEASE$, absence of growth retardation, and more variability in the degree of intellectual disabilities.	1
293	Although overlapping features with Bohring-Opitz and Bainbridge-Ropers syndromes exist, features that distinguish the ASXL2-associated condition from monoubiquitinated histone H2A deubiquitination- and @GENE$-related disorders are @DISEASE$, absence of growth retardation, and more variability in the degree of intellectual disabilities.	1
294	Although overlapping features with Bohring-Opitz and Bainbridge-Ropers syndromes exist, features that distinguish the ASXL2-associated condition from monoubiquitinated histone H2A deubiquitination- and @GENE$-related disorders are macrocephaly, absence of growth retardation, and more variability in the degree of @DISEASE$.	1
295	Our findings open new opportunities for targeted therapy, as @DISEASE$ with @GENE$ oncogenic activation, and subsequent PTCH1 overexpression, might be sensitive to sonic hedgehog pathway inhibitors	1
296	During drug discovery efforts targeting inhibition of cytochrome P450 11B2 (@GENE$)-mediated production of aldosterone as a therapeutic approach for the treatment of chronic kidney disease and @DISEASE$, (<i>S</i>)-6-(5-fluoro-4-(1-hydroxyethyl)pyridin-3-yl)-3,4-dihydro-1,8-naphthyridine-1(<i>2H</i>)-carboxamide (1) was identified as a potent and selective inhibitor of CYP11B2.	1
297	In order to address these questions, we searched for alterations in @GENE$, adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway, and EDN1 in patients with typical Auriculocondylar syndrome (n = 3), Pierre Robin sequence-plus (n = 3), @DISEASE$ with additional craniofacial malformations (n = 4), or non-specific auricular dysplasia (n = 1), which could represent subtypes of Auriculocondylar syndrome.	1
298	In order to address these questions, we searched for alterations in G protein-coupled receptor signaling pathway, @GENE$, and EDN1 in patients with typical Auriculocondylar syndrome (n = 3), Pierre Robin sequence-plus (n = 3), @DISEASE$ with additional craniofacial malformations (n = 4), or non-specific auricular dysplasia (n = 1), which could represent subtypes of Auriculocondylar syndrome.	1
299	Methylation profiling, metabolite assessment and additional analyses were also performed in selected cases.<b>Results:</b> One of the 11 tumors was found to carry a known cancer-predisposing @DISEASE$ in <i>IDH1</i> A variant in <i>@GENE$</i>, c.357A&gt;T, found in a patient with multiple tumors, was associated with higher tumor mRNA and protein expression levels, increased GOT2 enzymatic activity in lymphoblastic cells, and altered metabolite ratios both in tumors and in GOT2 knockdown HeLa cells transfected with the variant.	0
300	Methylation profiling, metabolite assessment and additional analyses were also performed in selected cases.<b>Results:</b> One of the 11 tumors was found to carry a known cancer-predisposing somatic mutation in <i>IDH1</i> A variant in <i>@GENE$</i>, c.357A&gt;T, found in a patient with multiple tumors, was associated with higher @DISEASE$ mRNA and protein expression levels, increased GOT2 enzymatic activity in lymphoblastic cells, and altered metabolite ratios both in tumors and in GOT2 knockdown HeLa cells transfected with the variant.	1
301	The novel potential @DISEASE$ susceptibility genes @GENE$ and epidermal growth factor receptor signaling pathway were uncovered and warrant further genetic and functional analyses.	1
302	The novel potential @DISEASE$ susceptibility genes phosphatidylserine biosynthetic process and @GENE$ were uncovered and warrant further genetic and functional analyses.	1
303	These results highlight CRAFT as a systems-level framework for target discovery and suggest @GENE$ blockade as a novel therapeutic strategy in @DISEASE$.	1
304	Subsequently, we identified another homozygous variant in 2 of the 10 probands with @DISEASE$ we specifically screened for mutations in @GENE$.	1
305	Our data support the very recent and independent identification of @GENE$ as a disease gene in @DISEASE$.	1
306	This report identifies the first breast @DISEASE$ risk locus specific to a @GENE$ mutation background.	1
307	We replicated previously reported breast @DISEASE$ susceptibility alleles in these BRCA2 mutation carriers and for several regions (including @GENE$, MAP3K1, CDKN2A/B, and PTHLH) identified SNPs that have stronger evidence of association than those previously published.	1
308	DNA samples from 3,881 breast @DISEASE$ affected and 4,330 unaffected BRCA2 mutation carriers from 47 studies belonging to the Consortium of Investigators of Modifiers of @GENE$/2 were genotyped and available for analysis.	1
309	This comprehensive update of novel and previously reported breast @DISEASE$ susceptibility loci contributes to the establishment of a panel of SNPs that modify breast cancer risk in @GENE$ mutation carriers.	1
310	To comprehensively identify breast @DISEASE$ risk modifying loci for @GENE$ mutation carriers, we conducted a deep replication of an ongoing GWAS discovery study.	1
311	Misregulation of vascular endothelial growth factor A (@GENE$‑A) has been implicated in numerous types of ovarian disease, such as polycystic ovarian syndrome, ovarian hyperstimulation syndrome, endometriosis and ovarian @DISEASE$.	1
312	Through the examination of 48 candidate genes known to be responsible for @DISEASE$ SPG, we identified a novel homozygous 4-bp deletion, c.914_917delGTAA, p.Ser305Ilefs*2 in exon2 of the DDHD1 gene encoding phosphatidic acid-preferring phospholipase A1 (@GENE$).	1
313	Spastic paraplegia (SPG) type 28 is an @DISEASE$ SPG caused by mutations in the @GENE$ gene.	1
314	Therefore our study identifies a compartmentalized PtdIns(3,4,5)P<sub>3</sub>/AKT/GSK3β signaling axis at cilia in @GENE$-dependent @DISEASE$ that is regulated by protein processing involved in protein targeting to mitochondrion to maintain tumor cell cilia, promote SHH signaling and thereby medulloblastoma progression	1
315	Therefore our study identifies a compartmentalized PtdIns(3,4,5)P<sub>3</sub>/AKT/GSK3β signaling axis at cilia in positive regulation of cell proliferation-dependent medulloblastoma that is regulated by @GENE$ to maintain @DISEASE$ cell cilia, promote SHH signaling and thereby medulloblastoma progression	1
316	PI3-kinase inhibition or expression of wild-type, but not catalytically inactive HA-@GENE$ partially rescued cilia loss in Inpp5e-null @DISEASE$ cells in vitro.	1
317	Conditional deletion of @GENE$ in a murine model of constitutively active Smoothened-driven @DISEASE$ slowed tumor progression, suppressed cell proliferation, reduced SHH signaling and promoted tumor cell cilia loss.	1
318	Sonic Hedgehog (@GENE$) signaling at primary cilia drives the proliferation and progression of a subset of medulloblastomas, the most common malignant paediatric brain @DISEASE$.	1
319	Here, we reveal INPP5E promotes @GENE$ signaling in SHH medulloblastoma by negatively regulating a cilia-compartmentalized PI3-kinase signaling axis that maintains primary cilia on @DISEASE$ cells.	1
320	In addition, we also found that upregulation of the @GENE$l gene resulted in the inhibition of @DISEASE$ cell invasion and metastasis.	1
321	However, there is no study concerning the specific role of @GENE$1 in the development and progression of lung @DISEASE$.	1
322	In the present study, we found that the @GENE$l gene was significantly downregulated in human lung @DISEASE$ and lung cancer cells.	1
323	When the @GENE$l gene was upregulated, we found that the proliferation of lung @DISEASE$ cells was significantly inhibited, the cells were arrested in the G0/G1 phase, the apoptosis of cells was observed, the expression of the caspase family of genes was altered with mainly the activation of caspase-3 and -9, and Bcl-2/Bax ratio was significantly imbalanced.	1
324	As a brand new tumor-suppressor gene, the expression of @GENE$1 gene has been revealed to be downregulated or absent in many malignant @DISEASE$.	1
325	In dogs, @DISEASE$ is associated with mutations in @GENE$.	1
326	Recently, loss-of-function mutations in @GENE$ were reported in association with severe developmental delay, deafness and @DISEASE$.	1
327	<b>Results</b>: @GENE$ overexpression was significantly associated with advanced @DISEASE$ status (<i>P</i>=0.001), advanced nodal status (<i>P</i>=0.036), increased vascular invasion (<i>P</i>=0.026) and increased perineural invasion (<i>P</i>=0.004).	1
328	Uveal melanomas are molecularly distinct from @DISEASE$ and lack mutations in @GENE$, NRAS, KIT, and NF1.	1
329	Six genes (ACOX2, @GENE$, visual perception, PSPH, sterol biosynthetic process, TYMS) were differentially expressed by race among Luminal A breast @DISEASE$s and were associated with survival (HR &lt;0.8, HR &gt;1.25).	1
330	Six genes (ACOX2, DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest, @GENE$, PSPH, sterol biosynthetic process, TYMS) were differentially expressed by race among Luminal A breast @DISEASE$s and were associated with survival (HR &lt;0.8, HR &gt;1.25).	1
331	Six genes (ACOX2, DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest, visual perception, PSPH, @GENE$, TYMS) were differentially expressed by race among Luminal A breast @DISEASE$s and were associated with survival (HR &lt;0.8, HR &gt;1.25).	1
332	Overexpression of @GENE$ in gastric @DISEASE$ was verified at both transcriptional and translational levels.	1
333	In addition, we verified the co-expression of and interplay between Rab3IP and @GENE$ during gastric @DISEASE$ progression.	1
334	Cellular studies showed that @GENE$ could induce an aggressive phenotype in gastric @DISEASE$ cells and that its expression was correlated with markers of the epithelial-mesenchymal transition (EMT).	1
335	Exome and targeted sequencing has recently identified four new genes causing @DISEASE$: TGM6, @GENE$, biological_process, and rundataxin.	1
336	Exome and targeted sequencing has recently identified four new genes causing @DISEASE$: TGM6, cation transport, @GENE$, and rundataxin.	1
337	Only a few genes, including SMARCA4, @GENE$, ZNF44 and muscle organ development, were recurrently and specifically mutated in the SS group, confirming the low recurrence of common mutations in this @DISEASE$.	0
338	Only a few genes, including SMARCA4, polyamine catabolic process, ZNF44 and @GENE$, were recurrently and specifically mutated in the SS group, confirming the low recurrence of common mutations in this @DISEASE$.	0
339	It is reported the expression of HCRP1 is inversely related to epidermal growth factor receptor (@GENE$) in breast @DISEASE$ and lead to resistance to cetuximab in ovarian cancer.	1
340	PKD1 and @GENE$ germline mutations are found in patients with autosomal dominant polycystic @DISEASE$ (ADPKD).	1
341	Biallelic @GENE$ mutations cause infantile hypotonia with psychomotor retardation and characteristic facies 2 (IHPRF2), which is characterized by hypotonia, developmental delay (DD)/@DISEASE$ (ID), intrauterine growth retardation, postnatal growth retardation and characteristic facial features.	1
342	The importance of PKC enzymes in Purkinje neuron health is apparent as mutations in @GENE$ (encoding PKCγ) cause @DISEASE$.	1
343	Using mouse models of spino@DISEASE$ type 1 (@GENE$) and 2 (SCA2) we identify an increase in PKC-mediated substrate phosphorylation in two different forms of inherited cerebellar ataxia.	0
344	RHOA, @GENE$, transforming growth factor beta receptor signaling pathway, SMAD5, negative regulation of SMAD protein complex assembly, BMPR1A, SMAD7 and negative regulation of transcription by RNA polymerase II-, which thereby emerge as candidate genes to play an important role in CRC @DISEASE$ metastasis	1
345	RHOA, transforming growth factor beta receptor signaling pathway, @GENE$, SMAD5, negative regulation of SMAD protein complex assembly, BMPR1A, SMAD7 and negative regulation of transcription by RNA polymerase II-, which thereby emerge as candidate genes to play an important role in CRC @DISEASE$ metastasis	1
346	RHOA, transforming growth factor beta receptor signaling pathway, transforming growth factor beta receptor signaling pathway, SMAD5, @GENE$, BMPR1A, SMAD7 and negative regulation of transcription by RNA polymerase II-, which thereby emerge as candidate genes to play an important role in CRC @DISEASE$ metastasis	1
347	RHOA, transforming growth factor beta receptor signaling pathway, transforming growth factor beta receptor signaling pathway, SMAD5, negative regulation of SMAD protein complex assembly, BMPR1A, SMAD7 and @GENE$-, which thereby emerge as candidate genes to play an important role in CRC @DISEASE$ metastasis	1
348	Recent studies have linked mutations in the @GENE$ (sensory perception of smell) and SLC24A5 (ion transport5) genes to amylogenesis imperfecta (AI) and non-syndromic oculocutaneous @DISEASE$ (OCA6), respectively.	0
349	Recent studies have linked mutations in the sensory perception of smell (@GENE$) and SLC24A5 (ion transport5) genes to amylogenesis imperfecta (AI) and non-syndromic oculocutaneous @DISEASE$ (OCA6), respectively.	0
350	Recent studies have linked mutations in the sensory perception of smell (sensory perception of smell) and SLC24A5 (@GENE$5) genes to amylogenesis imperfecta (AI) and non-syndromic oculocutaneous @DISEASE$ (OCA6), respectively.	1
351	This arrangement is required for filament formation and is directed by an ordered ZP-N/ZP-C linker that is not observed in ZP2 but is conserved in the sequence of @DISEASE$/Crohn's disease-associated homopolymeric glycoproteins α-tectorin (@GENE$) and glycoprotein 2 (GP2).	1
352	Gain-of-function mutations in the human @GENE$ gene cause three clinical types of autosomal dominant @DISEASE$ arthrogryposis.	1
353	Gain-of-function mutations in the human @GENE$ gene cause three clinical types of autosomal dominant distal @DISEASE$.	1
354	Pathogenic sequence variants in the Sorting Nexin 10 (@GENE$) gene have been associated with @DISEASE$ osteopetrosis (ARO) in human.	1
355	In our study, we aim to investigate whether variants of KCNA1, KCNA2, and @GENE$ genes influence susceptibility to genetic generalized @DISEASE$ (GGEs) and the efficacy of AEDs.	1
356	These results suggest that @GENE$ and MAFF play critical roles in the anti@DISEASE$ effects of retinoids by regulating the expression of retinoid target genes such as blood coagulation and can be promising for developing therapies to combat HCC invasion	1
357	These results suggest that negative regulation of erythrocyte differentiation and MAFF play critical roles in the anti@DISEASE$ effects of retinoids by regulating the expression of retinoid target genes such as @GENE$ and can be promising for developing therapies to combat HCC invasion	0
358	In the present study, we sought to identify the factors involved in the RAR&amp;alpha;-mediated transcriptional regulation of the @DISEASE$ suppressor gene and the tissue factor pathway inhibitor 2 (@GENE$) in hepatocellular carcinoma (HCC).	0
359	The musculo-aponeurotic @DISEASE$ oncogene homolog B (@GENE$) significantly enhanced the activation of the TFPI2 promoter via RAR&amp;alpha; while MAFF inhibited it.	1
360	In human breast cancer xenografts in humanized mice, blocking the recruitment of naive CD4<sup>+</sup> T cells into @DISEASE$ by knocking down the expression of @GENE$, a CCL18 receptor, significantly reduces intratumoral Tregs and inhibits tumor progression.	1
361	Inhibiting naive CD4<sup>+</sup> T cell recruitment into @DISEASE$s by interfering with @GENE$ recognition of CCL18 may be an attractive strategy for anticancer immunotherapy	1
362	Fungal immunomodulatory protein from <i>Nectria haematococca</i> (@GENE$-nha) has potential as a lung cancer therapeutic; as such, illuminating its anti-@DISEASE$ mechanism is expected to facilitate novel treatment options.	1
363	To evaluate the role of constitutive epigenetic changes in normal body cells of BRCA1/BRCA2-mutation negative patients, we have developed a deep bisulfite sequencing assay targeting the promoter regions of 8 @DISEASE$ suppressor (TS) genes (BRCA1, BRCA2, RAD51C, ATM, @GENE$, TP53, MLH1, RB1) and the estrogene receptor gene (ESR1), which plays a role in tumor progression.	1
364	Perhaps unusually for @DISEASE$ diseases, heterozygotes for mutations in @GENE$ manifest many biological variations.	1
365	Mice lacking @GENE$ in the liver exhibit @DISEASE$ and reduced levels of liver triglycerides, along with impaired hepatic lipogenesis.	1
366	The progressive @DISEASE$, congenital hypopituitarism and post-retinal visual pathway dysfunction in affected individuals demonstrates for the first time the essential role of @GENE$ in the development of the hypothalamo-pituitary axis, post-natal brain growth, and visual and renal function in humans.	0
367	Here we describe novel sequence variants in @GENE$ (c.1168C&gt;G and c.2209_2210del) as the potential causative mutations in two siblings with severe axonal neuropathy, hearing loss, @DISEASE$ and bulbar features.	1
368	Our findings enlarge the spectrum of tubulinopathies and emphasize that mutations of @GENE$ should be considered in patients with congenital non-progressive @DISEASE$.	1
369	Here we show that mitochondrial Sirtuin5 (@GENE$), which mediates lysine desuccinylation, deglutarylation, and demalonylation, plays a role in colorectal @DISEASE$ (CRC) glutamine metabolic rewiring.	1
370	High expression of Chemokine receptor 4 (@GENE$) is important in tumor invasion, metastasis, drug-resistance and maintenance of stemness in non-small cell lung @DISEASE$ (NSCLC).	1
371	Friedreich's @DISEASE$ (FRDA) is an autosomal recessive neurodegenerative disorder resulting from reduced expression of the protein frataxin (@GENE$).	1
372	In the present article, we describe an infant who smelt of ketones during examination and who was diagnosed with transient NDM caused by a @GENE$ mutation, accompanied by @DISEASE$.	1
373	TRAPPC9 gene mutations have been linked recently to @DISEASE$ mental retardation 13 (@GENE$; MIM#613192) with only eight families reported world-wide.	1
374	The @DISEASE$ cells with immunoreactivity to CK7, CK19, Cam5.2, COX2, EMA, @GENE$, MOC-31 and AE1/AE3, supported a diagnosis of intrahepatic cholangiocarcinoma.	1
375	Mutations in @GENE$ cause a wide spectrum of phenotypes in humans ranging from mild X-linked @DISEASE$ to a severe microcephaly (MC) and pontocerebellar hypoplasia syndrome.	1
376	These results demonstrate that Piccolo contributes to tumor @DISEASE$ in ESCC, likely by stabilizing @GENE$ and promoting EGFR-dependent signaling.	1
377	These results indicated that the HFD aggravates BDE47-inhibited testosterone production through @DISEASE$, and the accumulation of testicular BDE47 that induces the up-regulation of DAX-1 and the subsequent down-regulation of steroidogenic proteins, i.e., @GENE$ and 3β-HSD, in Leydig cells	0
378	In a cohort of Australians of European descent, consisting of 385 @DISEASE$ cases and 396 controls, we screened 21 keratoconus candidate genes: regulation of signal transduction by p53 class mediator, CAST, COL4A3, glomerular basement membrane development, negative regulation of endodermal cell differentiation, FOXO1, FNDC3B, neutrophil apoptotic process, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, regulation of GTPase activity, RAD51, negative regulation of transcription by RNA polymerase II, sodium ion transport, SOD1, TF and @GENE$.	1
379	In a cohort of Australians of European descent, consisting of 385 @DISEASE$ cases and 396 controls, we screened 21 keratoconus candidate genes: regulation of signal transduction by p53 class mediator, CAST, COL4A3, glomerular basement membrane development, negative regulation of endodermal cell differentiation, FOXO1, FNDC3B, neutrophil apoptotic process, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, regulation of GTPase activity, RAD51, @GENE$, sodium ion transport, SOD1, TF and regulation of transcription by RNA polymerase II.	1
380	In a cohort of Australians of European descent, consisting of 385 @DISEASE$ cases and 396 controls, we screened 21 keratoconus candidate genes: regulation of signal transduction by p53 class mediator, CAST, COL4A3, glomerular basement membrane development, @GENE$, FOXO1, FNDC3B, neutrophil apoptotic process, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, regulation of GTPase activity, RAD51, negative regulation of transcription by RNA polymerase II, sodium ion transport, SOD1, TF and regulation of transcription by RNA polymerase II.	1
381	In a cohort of Australians of European descent, consisting of 385 @DISEASE$ cases and 396 controls, we screened 21 keratoconus candidate genes: regulation of signal transduction by p53 class mediator, CAST, COL4A3, glomerular basement membrane development, negative regulation of endodermal cell differentiation, FOXO1, FNDC3B, neutrophil apoptotic process, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, regulation of GTPase activity, RAD51, negative regulation of transcription by RNA polymerase II, @GENE$, SOD1, TF and regulation of transcription by RNA polymerase II.	1
382	In a cohort of Australians of European descent, consisting of 385 @DISEASE$ cases and 396 controls, we screened 21 keratoconus candidate genes: regulation of signal transduction by p53 class mediator, CAST, COL4A3, @GENE$, negative regulation of endodermal cell differentiation, FOXO1, FNDC3B, neutrophil apoptotic process, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, regulation of GTPase activity, RAD51, negative regulation of transcription by RNA polymerase II, sodium ion transport, SOD1, TF and regulation of transcription by RNA polymerase II.	1
383	In a cohort of Australians of European descent, consisting of 385 @DISEASE$ cases and 396 controls, we screened 21 keratoconus candidate genes: regulation of signal transduction by p53 class mediator, CAST, COL4A3, glomerular basement membrane development, negative regulation of endodermal cell differentiation, FOXO1, FNDC3B, @GENE$, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, regulation of GTPase activity, RAD51, negative regulation of transcription by RNA polymerase II, sodium ion transport, SOD1, TF and regulation of transcription by RNA polymerase II.	1
384	In a cohort of Australians of European descent, consisting of 385 @DISEASE$ cases and 396 controls, we screened 21 keratoconus candidate genes: @GENE$, CAST, COL4A3, glomerular basement membrane development, negative regulation of endodermal cell differentiation, FOXO1, FNDC3B, neutrophil apoptotic process, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, regulation of GTPase activity, RAD51, negative regulation of transcription by RNA polymerase II, sodium ion transport, SOD1, TF and regulation of transcription by RNA polymerase II.	1
385	In a cohort of Australians of European descent, consisting of 385 @DISEASE$ cases and 396 controls, we screened 21 keratoconus candidate genes: regulation of signal transduction by p53 class mediator, CAST, COL4A3, glomerular basement membrane development, negative regulation of endodermal cell differentiation, FOXO1, FNDC3B, neutrophil apoptotic process, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, @GENE$, RAD51, negative regulation of transcription by RNA polymerase II, sodium ion transport, SOD1, TF and regulation of transcription by RNA polymerase II.	1
386	In gene-level analyses, @GENE$, SCC1/RAD21, TLK2, and SMC6L1 were associated (P &lt; 0.05) with overall breast @DISEASE$ risk, CDC6, CDC27, SUMO3, RASSF1, KIF2, and CDC14A were associated with high grade breast cancer risk, and EIF3S10 and CDC25A were associated with both.	1
387	Functional inhibition of @GENE$ and its receptors abrogated HMGB1-induced angiogenic properties of ECs co-cultured with @DISEASE$ cells.	1
388	Together, our findings suggest that in CRC @GENE$ suppresses @DISEASE$ progression by regulating YAP/TAZ activity	1
389	A case with @GENE$ deficiency (homozygous c.64dupG mutation) presented with neurodevelopmental delay, rare @DISEASE$, behavioral disturbances, and mild hypotonia, posing diagnostic challenges.	1
390	In addition, reduced hair follicles (HFs) while the enlarged and increased number of sebaceous glands (SGs) were also found in the @GENE$<sup>-/-</sup> rabbits, showing that the disrupted balance between HFs and SGs may respond to @DISEASE$ of ECTD-9 in an animal model and clinically.	0
391	Here, the homozygous @GENE$<sup>-/-</sup> rabbits showed complete loss of hair on the head and dorsum, whereas @DISEASE$ in the limbs and tail were determined in the Hoxc13<sup>-/-</sup> rabbits.	0
392	We present a family in which we found both germline and @DISEASE$ for @GENE$.	1
393	This study illustrates that germline mosaicism is important to consider in apparently @DISEASE$ de novo @GENE$ mutations, because of its particular importance for genetic counseling, specifically when evaluating the risk for family members and when considering the possibility of somatic mosaicism in the parent with germline mosaicism	1
394	This study illustrates that germline mosaicism is important to consider in apparently sporadic de novo @GENE$ mutations, because of its particular importance for genetic counseling, specifically when evaluating the risk for family members and when considering the possibility of @DISEASE$ in the parent with germline mosaicism	0
395	Studying consanguineous families with Ghosal hematodiaphyseal dysplasia syndrome (GHDD), a disorder of @DISEASE$, we identified mutations in TBXAS1, which encodes thromboxane synthase (@GENE$).	1
396	Various genes (eg, @GENE$, Golgi organization, PNPLA6) traditionally rooted in either the @DISEASE$ or hereditary spastic paraplegia classification system have now been shown to cause ataxia on the one end of the disease continuum and hereditary spastic paraplegia on the other.	1
397	Various genes (eg, regulation of mitochondrial membrane permeability, @GENE$, PNPLA6) traditionally rooted in either the @DISEASE$ or hereditary spastic paraplegia classification system have now been shown to cause ataxia on the one end of the disease continuum and hereditary spastic paraplegia on the other.	1
398	Genetic rearrangements involving androgen-regulated transmembrane protease serine 2 (TMPRSS2) and genes from the ETS transcription factor family, most commonly @GENE$ and ETV1, result in alteration that responsible for oncogenic activity in prostate @DISEASE$ (PC).	1
399	Furthermore, cardiovascular risk factors such @DISEASE$, hypertension and redox homeostasis have been identified to modulate @GENE$ driven gene regulatory networks.	1
400	We describe a female proband with primordial dwarfism, @DISEASE$, facial dysmorphism, extreme dyslipidaemic insulin resistance and fatty liver associated with a novel homozygous frameshift mutation in @GENE$, predicted to affect two of the three protein products of the gene.	1
401	Pre-NACT core needle biopsies and postoperative @DISEASE$ samples were immunohistochemically stained for nuclear factor erythroid 2-related factor 2 (@GENE$), Kelch-like ECH-associated protein 1 (proteasomal ubiquitin-independent protein catabolic process), thioredoxin (Trx), and peroxiredoxin I (Prx I).	1
402	Pre-NACT core needle biopsies and postoperative @DISEASE$ samples were immunohistochemically stained for nuclear factor erythroid 2-related factor 2 (positive regulation of transcription by RNA polymerase II), Kelch-like ECH-associated protein 1 (@GENE$), thioredoxin (Trx), and peroxiredoxin I (Prx I).	1
403	Mutations in @GENE$ are a rare cause of childhood @DISEASE$ accounting for ∼2% of disease in this cohort, and the majority of LCA5 mutations are likely null.	1
404	MVA due to biallelic @GENE$ mutations, or of unknown cause, is not associated with embryonal @DISEASE$s and cells from these individuals show minimal SAC deficiency.	0
405	Following examination of the association of the identified SNPs to serum concentrations of triglycerides, HDL‑cholesterol, or LDL‑cholesterol, linkage disequilibrium of the SNPs, and results of previous genome‑wide association studies, we newly identified chromosomal region 19p12 as a susceptibility locus for @DISEASE$, eight loci (MOB3C‑TMOD4, @GENE$, EHD3, COL6A3, ZNF860‑CACNA1D, COL6A5, DCLRE1C, ZNF77) for hypo‑HDL‑cholesterolemia, and three loci (KIAA0319‑FAM65B, UBD, LOC105375015) for hyper‑LDL‑cholesterolemia.	0
406	Additional functional analyses suggested that @GENE$ played an oncogenic role in bladder @DISEASE$ by inducing cell proliferation and suppressing apoptosis.	1
407	The rs2042329 risk allele was also related to significantly increased expression levels of @GENE$ mRNA and protein in bladder @DISEASE$ tissues from Chinese patients.	1
408	To evaluate the effectiveness of @GENE$ and MPS on screening @DISEASE$ NSHL patients, we recruited 63 unrelated sporadic NSHL probands, who had various levels of HL and were excluded for mutations in GJB2, fatty acid biosynthetic process-transcription, DNA-templated, and SLC26A4 genes.	1
409	To evaluate the effectiveness of peptide cross-linking and MPS on screening @DISEASE$ NSHL patients, we recruited 63 unrelated sporadic NSHL probands, who had various levels of HL and were excluded for mutations in GJB2, @GENE$-transcription, DNA-templated, and SLC26A4 genes.	0
410	To evaluate the effectiveness of peptide cross-linking and MPS on screening @DISEASE$ NSHL patients, we recruited 63 unrelated sporadic NSHL probands, who had various levels of HL and were excluded for mutations in GJB2, fatty acid biosynthetic process-@GENE$, and SLC26A4 genes.	0
411	We examined the effects of a mutation in the @GENE$ gene (Sh3pxd2b(nee)) on the progression of otitis media and @DISEASE$ at various developmental stages.	1
412	Our study suggests that miR-9 functions as a @DISEASE$ suppressor in HCC progression by inhibiting a series of target genes, including the newly validated miR-9/@GENE$/AKT&amp;ERK axis, thus providing potential therapeutic targets and novel prognostic biomarkers for HCC patients.	0
413	Mechanically, miR-9 plays a @DISEASE$ suppressive role partially through a functional miR-9/@GENE$/AKT&amp;ERK axis.	0
414	Nuclear receptor small heterodimer partner (@GENE$/Nr0b2) is a hepatic @DISEASE$ suppressor and a critical regulator of liver function.	0
415	However, more recently, inherited SWI/SNF-deficiency has been linked to several benign syndromic tumors including a subset of familial schwannomatosis (linked to SMARCB1) and multiple @DISEASE$ (linked to @GENE$) as well as others.	1
416	Approximately one-third of pediatric malignant rhabdoid @DISEASE$ are linked to germline SWI/SNF alterations (@GENE$/INI1, rarely nucleosome disassembly) resulting in occasional familial clustering of these highly aggressive malignancies (so-called rhabdoid tumor predisposition syndrome, RTPS, types 1 and 2, respectively).	1
417	Approximately one-third of pediatric malignant rhabdoid @DISEASE$ are linked to germline SWI/SNF alterations (nucleosome disassembly/INI1, rarely @GENE$) resulting in occasional familial clustering of these highly aggressive malignancies (so-called rhabdoid tumor predisposition syndrome, RTPS, types 1 and 2, respectively).	1
418	Approximately one-third of pediatric malignant rhabdoid tumors are linked to germline SWI/SNF alterations (@GENE$/INI1, rarely nucleosome disassembly) resulting in occasional familial clustering of these highly aggressive malignancies (so-called rhabdoid @DISEASE$ predisposition syndrome, RTPS, types 1 and 2, respectively).	0
419	This chapter focuses on the current data covering the etiology and epidemiology, clinical presentation, and pathogenesis of four monogenic forms of isolated @DISEASE$: DYT-@GENE$, DYT-THAP1, DYT-tetrahydrobiopterin biosynthetic process, and DYT-GNAL	1
420	This chapter focuses on the current data covering the etiology and epidemiology, clinical presentation, and pathogenesis of four monogenic forms of isolated @DISEASE$: DYT-protein homooligomerization, DYT-THAP1, DYT-@GENE$, and DYT-GNAL	1
421	Interestingly, @DISEASE$ nuclear RNA (hnRNA) for insulin and INS-@GENE$, both originating from the INS promoter, were essentially undetectable in T1D pancreata, arguing for a silent INS promoter.	1
422	As poor differentiation and low apoptosis are closely associated with poor survival rates and a poor response to radio/chemotherapy in patients with @DISEASE$, the prognostic value of @GENE$ expression was examined in the present study and its correlation with response to temozolomide (TMZ) chemotherapy was analyzed in patients with glioma.	0
423	High expression of @GENE$, which was significantly associated with high pathological tumor grade and poor response to TMZ chemotherapy, was demonstrated to be an unfavorable independent prognostic factor and predicted poor survival in patients with newly diagnosed @DISEASE$.	1
424	@GENE$ expression was analyzed by immunohistochemistry in 157 samples of newly diagnosed glioma and 63 recurrent @DISEASE$ cases that relapsed during TMZ chemotherapy.	1
425	Mutations in @GENE$ were shown to cause hypomagnesemia, @DISEASE$ and intellectual disability.	1
426	@GENE$ staining was weakly positive in &lt;5% of tumor cells in 4 of 66 (6%) low-grade endometrial stromal @DISEASE$s and 1 of 18 (6%) endometrial stromal nodules and weakly to moderately positive in &lt;5-40% of tumor cells in 6 of 31 (19%) leiomyosarcomas.	1
427	Strong diffuse nuclear @GENE$ staining (defined as &gt;95% of @DISEASE$ cells) was seen in the round cell component of all 20 (100%) classic MAPK cascade-NUTM2 high-grade endometrial stromal sarcomas and the 3 unusual high-grade endometrial stromal sarcomas which prompted FISH studies confirming YWHAE rearrangement in 2 tumors.	1
428	Strong diffuse nuclear @GENE$ staining (defined as &gt;95% of tumor cells) was seen in the round cell component of all 20 (100%) classic MAPK cascade-NUTM2 high-grade endometrial stromal sarcomas and the 3 unusual high-grade endometrial stromal sarcomas which prompted FISH studies confirming YWHAE rearrangement in 2 @DISEASE$.	0
429	Strong diffuse nuclear histone H2A monoubiquitination staining (defined as &gt;95% of @DISEASE$ cells) was seen in the round cell component of all 20 (100%) classic @GENE$-NUTM2 high-grade endometrial stromal sarcomas and the 3 unusual high-grade endometrial stromal sarcomas which prompted FISH studies confirming YWHAE rearrangement in 2 tumors.	0
430	Strong diffuse nuclear histone H2A monoubiquitination staining (defined as &gt;95% of tumor cells) was seen in the round cell component of all 20 (100%) classic @GENE$-NUTM2 high-grade endometrial stromal sarcomas and the 3 unusual high-grade endometrial stromal sarcomas which prompted FISH studies confirming YWHAE rearrangement in 2 @DISEASE$.	1
431	@GENE$ immunoexpression was studied in these @DISEASE$ and their morphologic mimics to assess its diagnostic utility.	1
432	@GENE$ immunohistochemical staining is a highly sensitive marker for YWHAE-NUTM2 high-grade endometrial stromal @DISEASE$ with both classic and unusual morphology and identifies a subset of high-grade endometrial stromal sarcoma with BCOR alterations, including BCOR rearrangement and internal tandem duplication	1
433	Morphologic features of @GENE$-NUTM2 high-grade endometrial stromal @DISEASE$ may overlap with other uterine sarcoma types.	1
434	Our data suggest that increased expressions in certain mt genes and elevated levels of @GENE$ may potentially play a critical role in the colorectal @DISEASE$s evolving from adenopolyps to malignant lesions	1
435	Inactivating mutations in @GENE$ or Edar cause hypohidrotic @DISEASE$ (HED), a condition characterized by malformations of the teeth, hair and glands, with milder deficiencies affecting only the teeth.	1
436	Citrin deficiency is an @DISEASE$ metabolic disorder, which is caused by pathogenic mutations in the @GENE$ gene on chromosome 7q21.3, as the causative gene that encodes the liver type aspartate/glutamate carrier isoform 2 (AGC2).	1
437	These results indicate that @GENE$ acts as a @DISEASE$ suppressor by activating negative regulation of intracellular estrogen receptor signaling pathway, and then suppressing the expression of estrogen receptor, in addition to tumor migration and invasion.	1
438	These results indicate that transforming growth factor beta receptor signaling pathway acts as a @DISEASE$ suppressor by activating @GENE$, and then suppressing the expression of estrogen receptor, in addition to tumor migration and invasion.	1
439	@GENE$ has recently been identified as a @DISEASE$ suppressor gene in a variety of cancers, yet the role of Smad4 in renal cell carcinoma (RCC) remained to be elusive.	1
440	Tubulin alpha 8 (@GENE$) is highly abundant in murine liver @DISEASE$ suggesting a role in hepatocellular carcinoma (HCC).	1
441	The review then discusses the diseases associated with @GENE$‑2, including degeneration of the retina, Sjögren's syndrome, age‑related cataracts, degeneration of the testes, azoospermia, lung cancer, constipation, repair of impaired intestinal mucosa barrier, leukemia, cystic fibrosis, @DISEASE$, epilepsy and diabetes mellitus.	1
442	Weight gain and growth failure, the hallmarks of @DISEASE$ in pediatrics, may be inconsistent, especially in @GENE$-independent forms of CS.	1
443	Recently, @GENE$ was reported to be implicated in cancer development, and many researchers investigated its biological function in the @DISEASE$igenesis of various cancers.	1
444	High expression of @GENE$ was positively associated with lymph node metastasis, pTNM stage and shorter overall survival (OS) in pancreatic @DISEASE$ patients.	0
445	In this study, we found that the expression of @GENE$ was increased in pancreatic @DISEASE$ samples compared to peri-tumor tissues.	1
446	The student's t-test was used to compare @GENE$ expression in the @DISEASE$ and the adjacent normal tissues.	1
447	On the whole, our findings indicated that @GENE$ exhibited low expression in pancreatic @DISEASE$, and upregulation of KLF9 may inhibit the progression of pancreatic cancer.	1
448	The purpose of the present study was to investigate the expression and functional significance of @GENE$ in vitro, by assessing the expression of KLF9 in pancreatic @DISEASE$ tissue samples and its association with the total survival of patients and clinicopathological data.	1
449	Using western blot analyses, we assessed @GENE$ expression in human pancreatic @DISEASE$ cell lines.	1
450	In PANC-1 and BxPC-3 cells, @GENE$ overexpression decreased the proliferation of pancreatic @DISEASE$ cells, induced apoptosis, blocked the cell cycle at the S phase, and inhibited the migration and invasion of tumor cells.	1
451	With the first @GENE$ (BFSP1) mutation now having been reported to cause a recessive @DISEASE$ phenotype, there is the suggestion that the mutation could predispose heterozygote carriers to the early onset of age-related nuclear cataract.	1
452	We originally discovered @GENE$ as a potential @DISEASE$ suppressor protein based upon reduced expression in bladder and prostate cancer specimens and growth inhibition of tumor cell lines/xenografts upon ectopic expression.	1
453	We originally discovered @GENE$ as a potential tumor suppressor protein based upon reduced expression in bladder and prostate @DISEASE$ specimens and growth inhibition of tumor cell lines/xenografts upon ectopic expression.	1
454	Vitamin K-2 is involved in mitochondrial electron transport, @GENE$ nuclear hormone receptor signaling and redox cycling: together these functions may form the basis for @DISEASE$ suppressor function.	1
455	In vivo, @GENE$ is expressed in the stroma of solid @DISEASE$s and is routinely detectable in peripheral blood of cancer patients after chemotherapy.	1
456	Strikingly, @GENE$ reprograms the expression profile of @DISEASE$ cells, causing prominent epithelial-endothelial transition (EET), a phenotypic switch mediated by EGFR signaling but hitherto rarely reported for a SASP factor.	1
457	These findings designate @GENE$ as a predictor of therapy response and as a @DISEASE$ cell-autonomous detoxification mechanism that must be overcome to prevent drug resistance	1
458	A novel hereditary disorder encompassing high blood Mn levels, @DISEASE$, polycythemia, distinctive @GENE$ hyperintense signals in the basal ganglia on magnetic resonance imaging (MRI) brain, and chronic liver disease was recently described.	0
459	Our results suggested that variants in @GENE$ are not common risk factors for Chinese @DISEASE$ ALS and that the frequency of variants of unknown significance in the cohort study was 0.39%	1
460	It has been reported that @GENE$ downstream regulated gene 1 (DNA damage response, signal transduction by p53 class mediator) is related to the prognosis of non-small cell lung @DISEASE$ (NSCLC), and associated with c-Myc degradation in NSCLC cell lines.	1
461	It has been reported that positive regulation of gene expression downstream regulated gene 1 (@GENE$) is related to the prognosis of non-small cell lung @DISEASE$ (NSCLC), and associated with c-Myc degradation in NSCLC cell lines.	1
462	We demonstrated that <i>linc-ADAL</i> interacts with @DISEASE$ nuclear ribonucleoprotein U (@GENE$) and insulin-like growth factor 2 mRNA binding protein 2 (IGF2BP2) at distinct subcellular locations to regulate adipocyte differentiation and lipogenesis	1
463	myocilin (@GENE$), optineurin (positive regulation of autophagy), WDR36 and neurotrophin-4 (ganglion mother cell fate determination) in primary open angle @DISEASE$ (POAG) and CYP1B1 and LTBP2 in congenital and developmental glaucomas.	1
464	myocilin (osteoblast differentiation), optineurin (@GENE$), WDR36 and neurotrophin-4 (ganglion mother cell fate determination) in primary open angle @DISEASE$ (POAG) and CYP1B1 and LTBP2 in congenital and developmental glaucomas.	1
465	myocilin (osteoblast differentiation), optineurin (positive regulation of autophagy), WDR36 and neurotrophin-4 (@GENE$) in primary open angle @DISEASE$ (POAG) and CYP1B1 and LTBP2 in congenital and developmental glaucomas.	1
466	We show here that another member of the CLCA gene family, @GENE$, is expressed in mammary epithelial cells and is similarly downregulated in breast tumors and in breast @DISEASE$ cell lines.	1
467	In breast @DISEASE$, @GENE$ facilitates invasion of surrounding tissues and correlates closely with cancer metastasis and relapse.	1
468	Clinically, low expression of @GENE$ signaled lower relapse-free survival in basal and luminal B breast @DISEASE$s.	1
469	Our results identify @GENE$ as both a partner and regulator of Wnt signaling, with an important role in suppressing colon @DISEASE$ development.	1
470	The mechanism of TMEM98 in conferring chemoresistance of @DISEASE$ might be possibly through activation of the @GENE$ pathway and deactivation of p53.	1
471	@GENE$ mRNA in @DISEASE$ tissues was significantly higher than nontumor tissues of patients with hepatocellular carcinoma (P &lt; 0.0001).	1
472	We have revealed significant association of @GENE$ and cellular response to mechanical stimulus polymorphisms with breast @DISEASE$.	1
473	We have revealed significant association of positive regulation of cell proliferation and @GENE$ polymorphisms with breast @DISEASE$.	1
474	The Random Forest algorithm selected FGFR2, @GENE$ and age as important breast @DISEASE$ predictors.	1
475	Homozygous @GENE$ mutations cause a syndrome of 46,XX disorder of sexual development (DSD), palmoplantar keratoderma (PPK), and predisposition to @DISEASE$.	1
476	This study allowed the identification of the genetic cause of the @DISEASE$ and the establishment of a correct diagnosis in four families, including a large heterozygous deletion in @GENE$, typically considered one of the pitfalls of this method.	1
477	ME attenuated the influence of APOB rs512535 and @GENE$ rs361525 on @DISEASE$ risk in FMP.	1
478	Furthermore, a high level of @GENE$ in patients with @DISEASE$ acted as an independent biomarker to predict reduced survival (P = 0.026).	1
479	In A549 lung @DISEASE$ cells, which endogenously express @GENE$, the depletion of REEP5 and REEP6 significantly reduced growth and invasion by downregulating IL-8-stimulated ERK phosphorylation, actin polymerization and the expression of genes related to metastasis.	1
480	Though @GENE$ has been identified to be the causal gene of DDD, the @DISEASE$ of this disease was displayed: for example, protein O-linked glycosylation and protein O-linked glycosylation were recently identified and confirmed to be additional pathogenic genes of DDD.	0
481	Though epidermis development has been identified to be the causal gene of DDD, the @DISEASE$ of this disease was displayed: for example, @GENE$ and protein O-linked glycosylation were recently identified and confirmed to be additional pathogenic genes of DDD.	0
482	Though epidermis development has been identified to be the causal gene of DDD, the @DISEASE$ of this disease was displayed: for example, protein O-linked glycosylation and @GENE$ were recently identified and confirmed to be additional pathogenic genes of DDD.	0
483	Defects of @GENE$, calcium- and integrin-binding protein 2, have been reported to cause isolated @DISEASE$, positive regulation of cytosolic calcium ion concentration and Usher syndrome type-IJ, characterized by congenital profound deafness, balance defects and blindness.	1
484	Defects of @GENE$, calcium- and integrin-binding protein 2, have been reported to cause isolated deafness, positive regulation of cytosolic calcium ion concentration and Usher syndrome type-IJ, characterized by congenital profound deafness, balance defects and @DISEASE$.	1
485	Defects of positive regulation of cytosolic calcium ion concentration, calcium- and integrin-binding protein 2, have been reported to cause isolated deafness, @GENE$ and Usher syndrome type-IJ, characterized by congenital @DISEASE$ deafness, balance defects and blindness.	0
486	We report here two new nonsense mutations (pGln12* and pTyr110*) in <i>@GENE$</i> patients displaying nonsyndromic profound @DISEASE$, with no evidence of vestibular or retinal dysfunction.	1
487	In a screen of pancreatic @DISEASE$ cell lines, AsPC-1 and BxPC-3 cells expressed high levels of Gremlin 1, but only AsPC-1 cells exhibited a high expression level of @GENE$.	1
488	Based on the data from the present study, it was concluded that an abnormal expression level of Gremlin 1 in pancreatic @DISEASE$ was induced by @GENE$ signaling, and that the overexpression of Gremlin 1 enabled pancreatic cancer progression	1
489	Primary human PSCs and pancreatic @DISEASE$ cell lines were exposed to SHH, cyclopamine, GLI family zinc finger-1 (@GENE$-1) small interfering RNA (siRNA), and Gremlin 1 siRNA to examine their associations and effects using an MTT assay, reverse transcription-quantitative polymerase chain reaction analysis, western blot analysis, and migration or invasion assays.	1
490	Consequently, the disruption of @GENE$ in zebrafish led to a @DISEASE$, like that in mammals.	1
491	The importance of this process is highlighted in a patient with mitochondrial disease caused by biallelic pathogenic variants in @GENE$, characterized by muscle-restricted mtDNA deletions and chronic @DISEASE$ external ophthalmoplegia (CPEO) plus syndrome.	0
492	We present the native 3D structures of normal and PCD-causing @GENE$-mutant human respiratory cilia in unprecedented detail; this allows comparisons of cilia structure across evolutionarily distant species and reveals the previously unknown primary defect and the @DISEASE$ secondary defects in RSPH1-mutant cilia.	0
493	Our data provide evidence for structural and functional @DISEASE$ in radial spokes, suggest a mechanism for the milder @GENE$ PCD phenotype and demonstrate that cryo-electron tomography can be applied to human disease by directly imaging patient samples.	1
494	The possible involvement of haploinsufficiency for @GENE$, a DNA replication complex protein, in the @DISEASE$ of the patient and her mother requires further studies.	1
495	TMPRSS2-ERG rearrangement and PTEN loss, events sensitizing to PARPi, occurred frequently along with @DISEASE$ loss of DNA repair factors 53BP1, @GENE$ and Rev7 (all studied here for the first time in CaP) whose defects may cause resistance to PARPi.	1
496	These results imply that PPI might be modulated by four genotypes - COMT rs4680 (primarily in males), GRIK3 rs1027599, @GENE$ rs9960767, and PRODH rs385440 - indicating a role of these gene variations in the development of early information processing deficits in @DISEASE$.	1
497	This close biochemical relationship indicates an oncogenic role for @GENE$ in the physiology of @DISEASE$ pathology by increasing YAP/TAZ stability	1
498	We find that @GENE$ controls @DISEASE$ growth by boosting signals that stabilize the YAP/TAZ complex via a mechanism mediated by the endocytic/endosomal system.	1
499	We found that the impaired homeostatic synaptic downscaling in Fmr1 KO neurons is caused by loss-of-function dephosphorylation of an @DISEASE$-associated ubiquitin E3 ligase, neural precursor cell expressed developmentally down-regulated gene 4-2, @GENE$.	1
500	Humans who carry @GENE$ mutations develop @DISEASE$ renal abnormalities, including multicystic dysplastic kidneys, glomerulocystic kidney disease, renal agenesis, renal hypoplasia, and renal interstitial fibrosis.	1
501	Since the original description of the @GENE$-related cataracts, growth hormone deficiency, sensory @DISEASE$, sensorineural hearing loss, skeletal dysplasia syndrome (CAGSSS; OMIM 616007) in an extended consanguineous family of French-Canadian descent, no further patients have been reported.	1
502	We present her clinical features and particularly highlight her skeletal findings, which confirm the presence of a primary @GENE$ @DISEASE$ in a growing list of mitochondrial-related disorders including CAGSSS, CODAS, EVEN-PLUS, and X-linked SEMD-MR syndromes	1
503	Recent clinical, morphological and molecular investigations of CMT families with @DISEASE$ inheritance allowed the identification of many genes such as GDAP1, MTMR2, myelination, NDRG1, @GENE$, SH3TC2, PRX, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, HINT1, GDAP1, LRSAM1, neurofilament bundle assembly, regulation of protein phosphorylation and MFN2 in axonal forms (ARCMT2).	0
504	Recent clinical, morphological and molecular investigations of CMT families with @DISEASE$ inheritance allowed the identification of many genes such as GDAP1, MTMR2, myelination, NDRG1, positive regulation of transcription by RNA polymerase II, SH3TC2, PRX, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, @GENE$, HINT1, GDAP1, LRSAM1, neurofilament bundle assembly, regulation of protein phosphorylation and MFN2 in axonal forms (ARCMT2).	0
505	Recent clinical, morphological and molecular investigations of CMT families with @DISEASE$ inheritance allowed the identification of many genes such as GDAP1, MTMR2, myelination, NDRG1, positive regulation of transcription by RNA polymerase II, SH3TC2, PRX, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, HINT1, GDAP1, LRSAM1, @GENE$, regulation of protein phosphorylation and MFN2 in axonal forms (ARCMT2).	0
506	Recent clinical, morphological and molecular investigations of CMT families with @DISEASE$ inheritance allowed the identification of many genes such as GDAP1, MTMR2, myelination, NDRG1, positive regulation of transcription by RNA polymerase II, SH3TC2, PRX, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or @GENE$), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, HINT1, GDAP1, LRSAM1, neurofilament bundle assembly, regulation of protein phosphorylation and MFN2 in axonal forms (ARCMT2).	0
507	Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive @DISEASE$ allowed the identification of many genes such as GDAP1, MTMR2, myelination, NDRG1, positive regulation of transcription by RNA polymerase II, SH3TC2, PRX, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, HINT1, GDAP1, LRSAM1, neurofilament bundle assembly, @GENE$ and MFN2 in axonal forms (ARCMT2).	0
508	Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive @DISEASE$ allowed the identification of many genes such as GDAP1, MTMR2, myelination, NDRG1, positive regulation of transcription by RNA polymerase II, SH3TC2, PRX, cytoskeleton organization, and @GENE$, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, HINT1, GDAP1, LRSAM1, neurofilament bundle assembly, regulation of protein phosphorylation and MFN2 in axonal forms (ARCMT2).	0
509	Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive @DISEASE$ allowed the identification of many genes such as GDAP1, MTMR2, @GENE$, NDRG1, positive regulation of transcription by RNA polymerase II, SH3TC2, PRX, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, HINT1, GDAP1, LRSAM1, neurofilament bundle assembly, regulation of protein phosphorylation and MFN2 in axonal forms (ARCMT2).	0
510	Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive @DISEASE$ allowed the identification of many genes such as GDAP1, MTMR2, myelination, NDRG1, @GENE$, SH3TC2, PRX, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, HINT1, GDAP1, LRSAM1, neurofilament bundle assembly, regulation of protein phosphorylation and MFN2 in axonal forms (ARCMT2).	0
511	Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive @DISEASE$ allowed the identification of many genes such as GDAP1, MTMR2, myelination, NDRG1, positive regulation of transcription by RNA polymerase II, SH3TC2, PRX, @GENE$, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, HINT1, GDAP1, LRSAM1, neurofilament bundle assembly, regulation of protein phosphorylation and MFN2 in axonal forms (ARCMT2).	0
512	Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive @DISEASE$ allowed the identification of many genes such as GDAP1, MTMR2, myelination, NDRG1, positive regulation of transcription by RNA polymerase II, SH3TC2, PRX, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and @GENE$, regulation of transcription by RNA polymerase II, HINT1, GDAP1, LRSAM1, neurofilament bundle assembly, regulation of protein phosphorylation and MFN2 in axonal forms (ARCMT2).	0
513	We successfully showed that the combination of immune cell therapy and CPA was safe, might induce @DISEASE$-specific immune responses and clinical efficacy, and was accompanied by a decreased ratio of Tregs in patients with @GENE$-positive advanced solid tumors	1
514	Further, two SNPs independent of previously reported signals in @GENE$ [rs12525163 odds ratio (OR) = 1.15, P = 4.9 × 10(-) (4)] and 19p13.1 (rs1864112 OR = 0.84, P = 1.8 × 10(-) (9)) were associated with TN breast @DISEASE$.	1
515	Associations with TN breast @DISEASE$ were confirmed for 10 loci (LGR6, MDM4, CASP8, 2q35, 2p24.1, TERT-rs10069690, @GENE$, TOX3, 19p13.1, cholesterol homeostasis), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &lt; 0.05: PEX14, 2q24.1, 2q31.1, ADAM29, multicellular organism development, negative regulation of transcription by RNA polymerase II, 11q13.1, 11q24.3, 12p13.1, skeletal system development, biological_process, 12q24, BRCA2, RAD51L1-rs2588809, MKL1).	1
516	Associations with TN breast @DISEASE$ were confirmed for 10 loci (LGR6, MDM4, CASP8, 2q35, 2p24.1, TERT-rs10069690, transcription by RNA polymerase II, TOX3, 19p13.1, cholesterol homeostasis), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &lt; 0.05: PEX14, 2q24.1, 2q31.1, ADAM29, @GENE$, negative regulation of transcription by RNA polymerase II, 11q13.1, 11q24.3, 12p13.1, skeletal system development, biological_process, 12q24, BRCA2, RAD51L1-rs2588809, MKL1).	0
517	Associations with TN breast @DISEASE$ were confirmed for 10 loci (LGR6, MDM4, CASP8, 2q35, 2p24.1, TERT-rs10069690, transcription by RNA polymerase II, TOX3, 19p13.1, cholesterol homeostasis), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &lt; 0.05: PEX14, 2q24.1, 2q31.1, ADAM29, multicellular organism development, @GENE$, 11q13.1, 11q24.3, 12p13.1, skeletal system development, biological_process, 12q24, BRCA2, RAD51L1-rs2588809, MKL1).	0
518	Associations with TN breast @DISEASE$ were confirmed for 10 loci (LGR6, MDM4, CASP8, 2q35, 2p24.1, TERT-rs10069690, transcription by RNA polymerase II, TOX3, 19p13.1, cholesterol homeostasis), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &lt; 0.05: PEX14, 2q24.1, 2q31.1, ADAM29, multicellular organism development, negative regulation of transcription by RNA polymerase II, 11q13.1, 11q24.3, 12p13.1, skeletal system development, @GENE$, 12q24, BRCA2, RAD51L1-rs2588809, MKL1).	0
519	Associations with TN breast @DISEASE$ were confirmed for 10 loci (LGR6, MDM4, CASP8, 2q35, 2p24.1, TERT-rs10069690, transcription by RNA polymerase II, TOX3, 19p13.1, @GENE$), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &lt; 0.05: PEX14, 2q24.1, 2q31.1, ADAM29, multicellular organism development, negative regulation of transcription by RNA polymerase II, 11q13.1, 11q24.3, 12p13.1, skeletal system development, biological_process, 12q24, BRCA2, RAD51L1-rs2588809, MKL1).	1
520	Associations with TN breast @DISEASE$ were confirmed for 10 loci (LGR6, MDM4, CASP8, 2q35, 2p24.1, TERT-rs10069690, transcription by RNA polymerase II, TOX3, 19p13.1, cholesterol homeostasis), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &lt; 0.05: PEX14, 2q24.1, 2q31.1, ADAM29, multicellular organism development, negative regulation of transcription by RNA polymerase II, 11q13.1, 11q24.3, 12p13.1, @GENE$, biological_process, 12q24, BRCA2, RAD51L1-rs2588809, MKL1).	0
521	The downstream pathways of Nodal-@GENE$ play a critical role not only in L-R determination in the lateral plate mesoderm but also in myocardial specification and differentiation in the AHF, suggesting that TGA is a phenotype in @DISEASE$ as well as the primary developmental defect of the AHF.	0
522	However, @GENE$<sup>f/Y;</sup> Cnp<sup>Cre/+</sup> mice showed reduced fiber density and signs of @DISEASE$ in both sciatic and optic nerves from 6 months of age.	1
523	However, as a classical cell surface adhesion molecule, we found @GENE$ correlated negatively with the migration and invasion of ICC cell lines, which differs from other malignant @DISEASE$s.	0
524	To investigate @GENE$-associated proteins that might participate in the responses of breast @DISEASE$ cells to altered levels of SCRIB, we used mass spectrometry and confocal microscopy.	1
525	Focusing on NOS1AP, we observed that NOS1AP colocalizes with both SCRIB and @GENE$ along cellular protrusions in metastatic breast @DISEASE$ cells, but does not colocalize with either SCRIB or VANGL1 at cell junctions in normal breast cells.	1
526	Experimentally, we found that reducing expression of @GENE$ by short-hairpin RNAs (shRNAs) reduces the growth of human breast @DISEASE$ cells in xenograft assays.	1
527	In addition, the coexistence of high MACC1 and low NM23-@GENE$ expression and @DISEASE$ budding was associated with short OS (p &lt; 0.001).	0
528	We suggest that the combination of reduced @GENE$-H1, induced positive regulation of transcription by RNA polymerase II, and the presence of @DISEASE$ budding are promising biomarkers for the prediction of recurrence and may aid the stratification of patients with stage II colon cancer for adjuvant chemotherapy	0
529	We suggest that the combination of reduced @GENE$-H1, induced positive regulation of transcription by RNA polymerase II, and the presence of tumor budding are promising biomarkers for the prediction of recurrence and may aid the stratification of patients with stage II colon @DISEASE$ for adjuvant chemotherapy	1
530	We suggest that the combination of reduced positive regulation of DNA binding-H1, induced @GENE$, and the presence of tumor budding are promising biomarkers for the prediction of recurrence and may aid the stratification of patients with stage II colon @DISEASE$ for adjuvant chemotherapy	1
531	We suggest that the combination of reduced positive regulation of DNA binding-H1, induced @GENE$, and the presence of @DISEASE$ budding are promising biomarkers for the prediction of recurrence and may aid the stratification of patients with stage II colon cancer for adjuvant chemotherapy	0
532	The aims of the present study were to evaluate the relation of dysregulated MACC1, c-MET, and NM23-@GENE$ expression with the histopathological features of @DISEASE$s in recurrence formation in eCC cases.	1
533	Recent studies in RAS wild-type (WT) metastatic colorectal @DISEASE$ (mCRC) suggest that the survival benefits of therapy using anti-epidermal growth factor receptor (anti-EGFR) and anti-vascular endothelial growth factor (anti-@GENE$) antibodies combined with chemotherapy are maximized when the anti-EGFR antibody is given as first-line, followed by subsequent anti-VEGF antibody therapy.	0
534	Genes harboring the most significant mutations include @GENE$, protein monoubiquitination, DCAF4L1, and VHL in @DISEASE$ HBs, and ZNF814, G2/M transition of mitotic cell cycle, acrosomal vesicle exocytosis, PNN, and MUC7 in familial HBs.	0
535	Genes harboring the most significant mutations include homophilic cell adhesion via plasma membrane adhesion molecules, @GENE$, DCAF4L1, and VHL in @DISEASE$ HBs, and ZNF814, G2/M transition of mitotic cell cycle, acrosomal vesicle exocytosis, PNN, and MUC7 in familial HBs.	1
536	Genes harboring the most significant mutations include homophilic cell adhesion via plasma membrane adhesion molecules, protein monoubiquitination, DCAF4L1, and VHL in @DISEASE$ HBs, and ZNF814, G2/M transition of mitotic cell cycle, @GENE$, PNN, and MUC7 in familial HBs.	0
537	Genes harboring the most significant mutations include homophilic cell adhesion via plasma membrane adhesion molecules, protein monoubiquitination, DCAF4L1, and VHL in @DISEASE$ HBs, and ZNF814, @GENE$, acrosomal vesicle exocytosis, PNN, and MUC7 in familial HBs.	0
538	Five genes, including OTOGL, PLCB4, SCEL, THSD4, and @GENE$, have CNVs in the six patients with @DISEASE$ HBs, and three genes, including ABCA6, mRNA splicing, via spliceosome, and LAMA2, have CNVs in the five patients with familial HBs.	1
539	Five genes, including OTOGL, PLCB4, SCEL, THSD4, and negative regulation of Wnt signaling pathway, have CNVs in the six patients with @DISEASE$ HBs, and three genes, including ABCA6, @GENE$, and LAMA2, have CNVs in the five patients with familial HBs.	0
540	Analyses of our original @GENE$NA expression signatures indicated that both strands of miR-144 (miR-144-5p, the passenger strand; miR-144-3p, the guide strand) showed decreased expression in @DISEASE$ tissues.	1
541	Our results demonstrated that the overall expression of @GENE$ significantly correlated with clinical stage (P=0.027), @DISEASE$ classification (P=0.012), pathological differentiation (P=0.023), as well as with the expression levels of estrogen receptor (P&lt;0.001), progesterone receptor (P=0.001), and Ki-67 (P&lt;0.001).	1
542	@GENE$ expression was shown to be significantly higher in breast @DISEASE$ cells and tissues than in normal breast epithelial cells and tissues, at both mRNA and protein levels.	1
543	To investigate the presence of specific chromosomal and gene alterations, @GENE$ protein expression, and their relationship with distant progression free survival (DPFS), we analyzed tumor samples from 63 UM patients (40 men and 23 women, with a median age of 64 years), who underwent eye enucleation by a single @DISEASE$ ophthalmologist from December 2005 to June 2016.	0
544	As an important multifunctional protein involved in regulation of @DISEASE$ metabolism, @GENE$ was identified as a causative gene for Parkinson's disease (PD), yet the relationship between CHCHD2 and neurodegenerative dementia is not well understood.	1
545	The @DISEASE$ test, sensitivity analysis, and publication bias test was performed by Review Manager 5.3 software.Overall, 22 case-control studies with 5049 cases and 4157 controls were included in this meta-analysis, which contained 20 studies of MTHFR C677T polymorphism, 12 studies of MTHFR A1298C polymorphism and 4 studies of @GENE$ A66G polymorphism.	0
546	Here we report a consanguineous Arab family from Qatar with three children having an early lethal form of @DISEASE$ multiplex congenita and a novel frameshift mutation in @GENE$.	1
547	The @GENE$ gene has been reported as a positive regulator of autophagy which is an essential mechanism for maintaining neuron homeostasis and survival and plays a key role in major adult and pediatric @DISEASE$.	1
548	Our exome analysis indicated the proband as a compound heterozygote for two missense variants in the @GENE$ gene according to a recessive @DISEASE$.	1
549	Importantly, @GENE$ inhibitor Kenpaullone sensitizes breast @DISEASE$ cells and xenograft tumors to Paclitaxel and improves therapeutic effects.	1
550	Epidermal growth factor receptor tyrosine kinase inhibitors (@GENE$-TKIs) are approved for second-line treatment of <i>EGFR</i> wild-type (<i>EGFR</i>-wt) nonsmall cell lung @DISEASE$ (NSCLC).	1
551	Further analysis revealed a reduced @GENE$ expression and a complete loss of negative regulation of cell proliferation expression in @DISEASE$ cells.	1
552	Further analysis revealed a reduced nucleosome disassembly expression and a complete loss of @GENE$ expression in @DISEASE$ cells.	1
553	Pharmacological manipulation of peripheral CB1 signaling regulates @DISEASE$ in an adipocyte @GENE$-dependent manner.	1
554	Conversely, @GENE$, 6, 14, and 20 are consistently up-regulated in @DISEASE$s (P = 0.005, P &lt; 0.0001, P = 0.003, and P = 0.001, respectively).	1
555	Genetic modification of a human prostate @DISEASE$ cell line to induce @GENE$-101 and suppress CENPF decreased cell migration and invasion.	1
556	Polymorphisms rs2910164 in miR-146a and rs486907 in the @GENE$ gene have both independently been associated with the risk of different cancers, and an interaction between them has been observed in non@DISEASE$ skin cancer.	1
557	Polymorphisms rs2910164 in miR-146a and rs486907 in the @GENE$ gene have both independently been associated with the risk of different @DISEASE$s, and an interaction between them has been observed in nonmelanoma skin cancer.	1
558	In this study, we evaluated the possible interaction between miR-146a and one of its putative targets ribonuclease L (@GENE$) in the risk of sporadic @DISEASE$.	1
559	The results reported in the present study suggest a sex-specific interaction between @GENE$-146a and RNASEL genes in @DISEASE$ skin cancer susceptibility, and could account for possible discordant results in association studies when stratification according to sex is not performed	1
560	The results reported in the present study suggest a sex-specific interaction between @GENE$-146a and RNASEL genes in melanoma skin @DISEASE$ susceptibility, and could account for possible discordant results in association studies when stratification according to sex is not performed	1
561	Polo-like kinase 1 (@GENE$) is overexpressed in a wide spectrum of human @DISEASE$, being frequently considered as an oncogene and an attractive cancer target.	1
562	Two of these genes were independently mutated in more than one family with similar phenotypes, which substantiates their link to human disease (@GENE$ in @DISEASE$ and UBR4 in early dementia).	1
563	The KEGG enrichment analysis of DEGs showed significantly enriched pathways in @DISEASE$, extracellular matrix (ECM)-receptor interaction pathway, and cyclic adenosine monophosphate (@GENE$) signaling pathway.	0
564	In addition, the expression of @GENE$-214 inhibited proliferation of ESCC cells in vitro and inhibit the growth of xenograft @DISEASE$ in vivo.	1
565	Targeted exome sequencing identified biallelic mutations in WDR19, encoding an IFT-A subunit previously associated with MZSDS-related chondrodysplasia, Jeune asphyxiating @DISEASE$ and cranioectodermal dysplasia, linked to primary cilia dysfunction, and in @GENE$ which encodes tektin-1 an uncharacterized member of the tektin family, mutations of which may cause ciliary dyskinesia.	0
566	Targeted exome sequencing identified biallelic mutations in WDR19, encoding an IFT-A subunit previously associated with MZSDS-related chondrodysplasia, Jeune asphyxiating thoracic dysplasia and cranioectodermal dysplasia, linked to primary cilia dysfunction, and in @GENE$ which encodes tektin-1 an uncharacterized member of the tektin family, mutations of which may cause @DISEASE$.	1
567	There were no statistically significant associations between phospho-@GENE$ expression and @DISEASE$ grade, presence of concurrent carcinoma in situ or hydronephrosis, or pN status.	1
568	Homozygous and compound heterozygous mutations in @GENE$ have recently been described to cause an @DISEASE$ syndromic form of intellectual disability, including agenesis/hypoplasia of the corpus callosum, optic coloboma, and intractable seizures.	1
569	Homozygous and compound heterozygous mutations in @GENE$ have recently been described to cause an autosomal recessive syndromic form of intellectual disability, including agenesis/hypoplasia of the corpus callosum, optic coloboma, and intractable @DISEASE$.	1
570	Mutations of the sigma subunit of the heterotetrameric adaptor-related protein complex 2 (AP2σ) impair signalling of the calcium-sensing receptor (@GENE$), and cause familial hypocalciuric @DISEASE$ type 3 (FHH3).	0
571	We hypothesized that additional rare AP2σ variants may also be associated with altered @GENE$ function and @DISEASE$, and sought for these by analysing &gt;111 995 exomes (&gt;60 706 from ExAc and dbSNP, and 51 289 from the Geisinger Health System-Regeneron DiscovEHR dataset, which also contains clinical data).	0
572	In addition, polymorphisms in apoptosis-related genes such as @GENE$, TULP1, and MERTK are associated with fibrosis progression, and DEPDC5 and T cell mediated cytotoxicity variants are associated with HCV-related @DISEASE$.	0
573	In addition, polymorphisms in apoptosis-related genes such as protein neddylation, TULP1, and MERTK are associated with fibrosis progression, and DEPDC5 and @GENE$ variants are associated with HCV-related @DISEASE$.	1
574	Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, @GENE$, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, centriole replication, CEP152, brain development, histone ubiquitination, positive regulation of cell-matrix adhesion, CENPE, centriole replication, lysophospholipid transport, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of @DISEASE$ genetic disorder.	1
575	Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, mitotic spindle organization, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, @GENE$, CEP152, brain development, histone ubiquitination, positive regulation of cell-matrix adhesion, CENPE, centriole replication, lysophospholipid transport, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of @DISEASE$ genetic disorder.	1
576	Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, mitotic spindle organization, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, centriole replication, CEP152, @GENE$, histone ubiquitination, positive regulation of cell-matrix adhesion, CENPE, centriole replication, lysophospholipid transport, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of @DISEASE$ genetic disorder.	1
577	Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, mitotic spindle organization, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, centriole replication, CEP152, brain development, @GENE$, positive regulation of cell-matrix adhesion, CENPE, centriole replication, lysophospholipid transport, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of @DISEASE$ genetic disorder.	1
578	Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, mitotic spindle organization, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, centriole replication, CEP152, brain development, histone ubiquitination, @GENE$, CENPE, centriole replication, lysophospholipid transport, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of @DISEASE$ genetic disorder.	1
579	Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, mitotic spindle organization, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, centriole replication, CEP152, brain development, histone ubiquitination, positive regulation of cell-matrix adhesion, CENPE, @GENE$, lysophospholipid transport, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of @DISEASE$ genetic disorder.	1
580	Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, mitotic spindle organization, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, centriole replication, CEP152, brain development, histone ubiquitination, positive regulation of cell-matrix adhesion, CENPE, centriole replication, @GENE$, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of @DISEASE$ genetic disorder.	1
581	There are several genetic mutations that lead to ALS development, such as chromosome 9 hexanucleotide repeat 72 (C9ORF72), transactive response DNA-binding protein (TARDBP), superoxide dismutase 1 (@GENE$) and fused in @DISEASE$ (FUS).	0
582	Targeted resequencing was used to screen 460 unselected @DISEASE$ patients for variants in @GENE$.	1
583	Previous reports have identified @GENE$ variants in patients with generalized @DISEASE$, such as myoclonic-atonic epilepsy and childhood absence epilepsy.	1
584	These findings demonstrate that SLC6A1 is an important contributor to childhood @DISEASE$ and that reduced @GENE$-1 function is a common consequence of epilepsy-causing SLC6A1 variants	0
585	To better understand the biology of this molecularly distinct @DISEASE$ subtype, we analyze the microRNA (@GENE$NA) expression profiles of Xp11 RCC compared with normal renal parenchyma using microarray and quantitative reverse-transcription polymerase chain reaction.	1
586	Mutations in Vps33 isoforms cause pigment dilution in mice (@GENE$, buff) and Drosophila (car) and the neurogenic @DISEASE$, renal dysfunction and cholestasis syndrome in humans (ARC1, vesicle-mediated transport).	0
587	Mutations in Vps33 isoforms cause pigment dilution in mice (vesicle-mediated transport, buff) and Drosophila (car) and the neurogenic @DISEASE$, renal dysfunction and cholestasis syndrome in humans (ARC1, @GENE$).	1
588	Liver-specific knockout of murine @GENE$ impaired ATR activation and exacerbated inflammation, fibrosis and @DISEASE$, which exhibited a trabecular architecture, closely resembling human HCC.	1
589	The in vivo impact of @GENE$ loss on liver @DISEASE$igenesis was determined using the hepatocellular carcinoma model induced by genotoxin Diethylnitrosamine.	1
590	Three subtypes, <i>PTPN11- , @GENE$-</i>, and <i>positive regulation of protein phosphorylation</i>-mutated JMML, are characterized by heterozygous somatic gain-of-function mutations in non syndromic children, while two subtypes, JMML in @DISEASE$ type 1 and in JMML in children with CBL syndrome, are characterized by germ line RAS disease and acquired biallelic inactivation of the respective tumor suppressor genes in hematopoietic cells.	0
591	Three subtypes, <i>PTPN11- , Ras protein signal transduction-</i>, and <i>@GENE$</i>-mutated JMML, are characterized by heterozygous somatic gain-of-function mutations in non syndromic children, while two subtypes, JMML in @DISEASE$ type 1 and in JMML in children with CBL syndrome, are characterized by germ line RAS disease and acquired biallelic inactivation of the respective tumor suppressor genes in hematopoietic cells.	0
592	We show that mice lacking @GENE$ develop a slowly progressive cerebellar @DISEASE$ linked to Purkinje cell dysfunction and mild exercise intolerance, recapitulating ARCA2.	1
593	In this study, we identified @GENE$ as upregulated in estrogen receptor positive (ER+) human breast @DISEASE$ in the TCGA and METABRIC cohorts, with copy number gains in nearly 50% of samples in both datasets.	1
594	@GENE$ expression is associated with reduced overall survival in patients with ER+ @DISEASE$ in TCGA and METABRIC datasets.	1
595	We demonstrated the necessity of @GENE$ for proliferation of tamoxifen-resistant ER+ breast @DISEASE$, but not ER- breast cancer cells.	1
596	In recent years, genetically determined forms of microangiopathy (e.g. @GENE$, CARASIL, Trex1-related microangiopathies, CARASAL, familial forms of cerebral amyloid angiopathy or CAA) have provided interesting cellular and molecular clues to the pathogenesis of @DISEASE$ microvascular disease such as arteriolosclerosis and AD-related CAA	1
597	Furthermore, we detected association of rs58978565 near @GENE$ (P = 2.3 × 10-8), rs28368872 near ATF7IP2 (P = 2.9 × 10-8) and rs142450006 near proteolysis (P = 0.0006) with progression to @DISEASE$ but not geographic atrophy.	1
598	Furthermore, we detected association of rs58978565 near extracellular matrix organization (P = 2.3 × 10-8), rs28368872 near ATF7IP2 (P = 2.9 × 10-8) and rs142450006 near @GENE$ (P = 0.0006) with progression to @DISEASE$ but not geographic atrophy.	1
599	The therapeutic capacity of fenretinide (N-[4-hydroxyphenyl] retinamide; 4-@GENE$) has been demonstrated for several conditions, including @DISEASE$, obesity, diabetes, and ocular disease.	1
600	Consistent with a conserved role for this gene in the cochlea, the genetic mapping data presented here support human @GENE$ as the gene affected at DFNB6, a non-syndromic @DISEASE$ locus.	1
601	Here, we present a familial case of a lethal early-onset epileptic @DISEASE$, associated with two novel compound heterozygous missense variants on the @GENE$ gene, which were detected by exome sequencing.	1
602	Three predicted driver genes (@GENE$, AKT1, RNF139) were found common in these three @DISEASE$s by comparative analysis.	1
603	Mutations in the human @GENE$ gene encoding tRNA nucleotidyltransferase (tRNA-NT), an essential enzyme responsible for addition of the CCA (cytidine-cytidine-adenosine) sequence to the 3'-termini of tRNAs, have been linked to disease phenotypes including congenital sideroblastic anemia with B-cell immunodeficiency, periodic fevers and developmental delay (SIFD) or retinitis pigmentosa with erythrocyte @DISEASE$.	1
604	Numerous studies have recently demonstrated that @GENE$ expression and activity are increased in @DISEASE$, such as autosomal dominant polycystic kidney disease (ADPKD), renal fibrosis, and acute kidney injury (AKI), among others.	1
605	In fact, @GENE$ inhibitors effectively limit the progression of @DISEASE$s, suggesting that targeting HDAC6 may provide a novel treatment approach.	1
606	@GENE$-positive cells were significantly lesser in organ-confined disease than in that with extra-capsular extensions, and GCNT2-negative @DISEASE$ were associated with significantly better prostate-specific antigen-free survival compared with GCNT2-positive tumors.	0
607	Focal cortical dysplasia (FCD) and @DISEASE$ (HME) are epileptogenic neurodevelopmental malformations caused by mutations in @GENE$ pathway genes.	1
608	In conclusion, truncating variants in TEX15 and @GENE$ are potential breast @DISEASE$ risk factors, warranting further investigations in other populations.	1
609	Mutations in the @GENE$ gene have been identified in patients with temporal lobe epilepsy and febrile @DISEASE$.	1
610	Our experiments demonstrate that these mutations in @GENE$ are deleterious and provide further evidence for the involvement of CPA6 mutations in the predisposition for several types of @DISEASE$.	0
611	@GENE$(Gt-ex13) homozygotes are early embryo lethal, but Matr3(Gt-ex13) heterozygotes exhibit incompletely penetrant BAV, CoA and PDA phenotypes similar to those in the human proband, as well as @DISEASE$ (VSD) and double-outlet right ventricle (DORV).	0
612	The 1p breakpoint disrupts the 5' UTR of @GENE$, which encodes AT-hook DNA-binding motif containing-1 protein, and AHDC1-truncating mutations have recently been described in a syndrome that includes @DISEASE$, but not congenital heart disease [Xia, F., Bainbridge, M.N., Tan, T.Y., Wangler, M.F., Scheuerle, A.E., Zackai, E.H., Harr, M.H., Sutton, V.R., Nalam, R.L., Zhu, W. et al. (2014) De Novo truncating mutations in AHDC1 in individuals with syndromic expressive language delay, hypotonia, and sleep apnea.	1
613	Other novel mutations detected in unclassified @DISEASE$ patients involve the SCN8A, CACNA1A, GABRB3, GABRA1, IQSEC2, @GENE$, VRK2, ATP1A2, PCDH19, SLC9A6 and CHD2 genes.	1
614	In the present study, we investigated the spatiotemporal distributions of RanGAP1 and 4 representative nucleoporins (GP210, @GENE$, NUP107 and regulation of glycolytic process) of NPCs in human Cu/Zn superoxide dismutase-1 mutation transgenic (SOD1-Tg) mice and @DISEASE$ ALS patients.	1
615	In the present study, we investigated the spatiotemporal distributions of RanGAP1 and 4 representative nucleoporins (GP210, nuclear pore complex assembly, NUP107 and @GENE$) of NPCs in human Cu/Zn superoxide dismutase-1 mutation transgenic (SOD1-Tg) mice and @DISEASE$ ALS patients.	1
616	The present study indicated that the mislocalization of these proteins of NPCs may underlie the pathogenesis of ALS both in SOD1-@GENE$ mice and human @DISEASE$ ALS patients, and these dysfunctions may be a fundamental pathway for ALS that is not specific only in cell killing-ALS but also in SOD1-ALS, which may be amenable to pharmacotherapeutic intervention	0
617	The present study indicated that the mislocalization of these proteins of NPCs may underlie the pathogenesis of ALS both in SOD1-thyroid gland development mice and human @DISEASE$ ALS patients, and these dysfunctions may be a fundamental pathway for ALS that is not specific only in @GENE$-ALS but also in SOD1-ALS, which may be amenable to pharmacotherapeutic intervention	0
618	Evidence for association with @DISEASE$ was also found for the AC genotype of the rs10859871 of @GENE$.	1
619	In this study, we investigated whether single nucleotide polymorphisms (SNPs) rs7521902, rs10859871 and rs11031006, mapping to @GENE$, VEZT and FSHB genetic loci, respectively, are associated with risk for @DISEASE$ in a Greek population.	1
620	Primary hyperoxaluria type 1 (PH1) is a rare but devastating @DISEASE$ inherited disease caused by mutations in gene @GENE$.	1
621	The A Desintegrin And Metalloproteinase 23 (@GENE$) gene is epigenetically silenced in different types of @DISEASE$, and silencing is often associated with advanced disease and metastasis.	1
622	Rather, we observed that, in @GENE$-heterotypic environments, ADAM23-negative cells promote @DISEASE$ growth and metastasis by enhancing the proliferation and invasion of adjacent A23-positive cells through the production of LGI4 (Leucine-rich Glioma Inactivated 4) and nitric oxide (NO).	0
623	Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: @GENE$-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, autophagosome maturation-associated autosomal-recessive @DISEASE$ and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and omega-hydroxylase P450 pathway caused by SPG11, ZFYVE26 and autophagy mutations, respectively.	0
624	Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: nucleotide transport-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, @GENE$-associated autosomal-recessive cerebellar ataxia and @DISEASE$ syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and omega-hydroxylase P450 pathway caused by SPG11, ZFYVE26 and autophagy mutations, respectively.	1
625	Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: nucleotide transport-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, autophagosome maturation-associated autosomal-recessive @DISEASE$ and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and omega-hydroxylase P450 pathway caused by SPG11, ZFYVE26 and @GENE$ mutations, respectively.	0
626	Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: nucleotide transport-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, autophagosome maturation-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary @DISEASE$, SPG11, SPG15 and @GENE$ caused by SPG11, ZFYVE26 and autophagy mutations, respectively.	1
627	Recent studies have reported that @GENE$ overexpression is observed in gastrointestinal @DISEASE$, and promotes migration and invasion of cancer cells.	1
628	By exome sequencing, we identified three different bi-allelic truncating mutations in @GENE$ in three unrelated individuals with infancy-onset episodic metabolic crises characterized by @DISEASE$, hypoglycemia, rhabdomyolysis, arrhythmias, and laboratory findings suggestive of a defect in mitochondrial fatty acid oxidation.	1
629	The present study aimed to explore @GENE$ expression in cervical cancer and the possible function in @DISEASE$ progression.	1
630	These results reveal that ARHGAP17 functions as a tumor suppressor in cervical @DISEASE$ that suppresses tumor growth, at least partly, through inhibition of PI3K/@GENE$ signaling and up-regulation of P21 and P27 expression	1
631	Manipulation of @GENE$ affected cell proliferation in vitro and @DISEASE$ growth in vivo.	1
632	Recently, a few @GENE$ GTPase activating proteins (RhoGAPs) have been identified as @DISEASE$ suppressors in some human cancers.	1
633	Recently, a few @GENE$ GTPase activating proteins (RhoGAPs) have been identified as tumor suppressors in some human @DISEASE$s.	1
634	Stepwise investigations demonstrated that @GENE$ suppressed malignant phenotype of cervical @DISEASE$ cells via inhibiting PI3K/positive regulation of protein phosphorylation signaling pathway.	1
635	Stepwise investigations demonstrated that regulation of small GTPase mediated signal transduction suppressed malignant phenotype of cervical @DISEASE$ cells via inhibiting PI3K/@GENE$ signaling pathway.	1
636	However, correlation between @GENE$-1 and prostate @DISEASE$ (PCa) remains still unclear.	1
637	The Cripto-1 (CR-1) derived @GENE$-post-chaperonin tubulin folding pathway family was overexpressed in @DISEASE$ development enhancing proliferation, epithelial-mesenchymal transition (EMT) and migration of tumor cells.	1
638	The Cripto-1 (CR-1) derived angiogenesis-@GENE$ family was overexpressed in @DISEASE$ development enhancing proliferation, epithelial-mesenchymal transition (EMT) and migration of tumor cells.	1
639	Immunohistochemistry was used to observe the @GENE$ expression and its correlation with clinicopathologic factors in oral tongue @DISEASE$.	1
640	In recent years, it has been demonstrated that @GENE$ plays an important role in human pathophysiological processes, including lipid metabolism, angiogenesis, N-glycosylation, cell apoptosis, chemoresistance in human @DISEASE$, and epithelial-mesenchymal transition.	1
641	Downregulation of @GENE$, Gli2, Gli3 and negative regulation of smoothened signaling pathway was demonstrated in clinical samples of @DISEASE$ and hydatidiform moles as well as choriocarcinoma cell lines when compared with normal placentas.	1
642	Downregulation of osteoblast differentiation, Gli2, Gli3 and @GENE$ was demonstrated in clinical samples of @DISEASE$ and hydatidiform moles as well as choriocarcinoma cell lines when compared with normal placentas.	1
643	Global @GENE$ deletion recapitulates learning impairment, hyper-@DISEASE$, and motor defects, all of which are insensitive to SK pharmacological targeting and not found in the protein import into nucleus-restricted deletion mouse.	1
644	Global smoothened signaling pathway deletion recapitulates learning impairment, hyper-@DISEASE$, and motor defects, all of which are insensitive to SK pharmacological targeting and not found in the @GENE$-restricted deletion mouse.	1
645	In this article, we report a clinically recognizable craniofacial disorder characterized by facial dysmorphisms, severe micrognathia, rhizomelic shortening, microcephalic @DISEASE$, and mild developmental delay due to loss-of-function heterozygous mutations in @GENE$, which encodes the coatomer subunit delta of COPI.	1
646	As a potential target for @DISEASE$ treatment, the @GENE$ high expresses abnormally in a variety of solid tumors and hematological malignancies in humans.	1
647	Our results provide evidence that inhibition of the denitrosylation of S-nitrosylated procaspase-3 mediated by the redox protein @GENE$ is a part of the microglial pro-tumoral activation pathway initiated by glioma @DISEASE$ cells	1
648	Furthermore, we identified the activity of nitric oxide synthase 2 (@GENE$, also known as iNOS) originating from the @DISEASE$ cells as a driving stimulus in the control of microglial caspase-3 activity.	1
649	However, the negative association between 25(OH)D and @GENE$ was modified by @DISEASE$ and sun exposure.	1
650	Results We demonstrated an association between six previously published single nucleotide polymorphisms (rs15869 [ BRCA2], rs1805389 [ LIG4], rs8079544 [ TP53], rs25489 [ XRCC1], rs1673041 [ POLD1], and rs11615 [ @GENE$]) and subsequent CNS @DISEASE$ in survivors of childhood cancer.	1
651	The human @GENE$ and histone acetylation genes are recurrently mutated in leukemia, non-hematologic malignancies, and multiple developmental disorders displaying @DISEASE$ and various other abnormalities.	1
652	The human protein acetylation and @GENE$ genes are recurrently mutated in leukemia, non-hematologic malignancies, and multiple developmental disorders displaying @DISEASE$ and various other abnormalities.	1
653	In addition, the @GENE$ gene is mutated in childhood leukemia and adult @DISEASE$.	1
654	We report a pair of siblings carrying a homozygous missense mutation p.P333L in @GENE$2 who exhibited global @DISEASE$, failure to thrive, dilated cardiomyopathy and epilepsy, ultimately leading to death in early childhood.	1
655	Here, we sought to find lncRNAs differentially regulated in @DISEASE$ cells resistant to either @GENE$-related apoptosis-inducing ligand (TRAIL) or the Mcl-1 inhibitor UMI-77, agents that act through the extrinsic and intrinsic apoptotic pathways, respectively.	1
656	This review focuses on the molecular basis of the pathogenesis of @DISEASE$ due to PRKAG2 mutation and will provide current overviews of the mechanism of glycogen regulation by @GENE$.	0
657	Ex vivo data showed that @GENE$ expression in GBM tissue samples was associated with @DISEASE$ recurrence after TMZ chemotherapy.	1
658	De novo heterozygous mutations in @GENE$/Munc18-1 cause early infantile epileptic encephalopathies (EIEE4, OMIM #612164) characterized by infantile @DISEASE$, developmental delay, intellectual disability, and can include autistic features.	1
659	De novo heterozygous mutations in @GENE$/Munc18-1 cause early infantile epileptic encephalopathies (EIEE4, OMIM #612164) characterized by infantile epilepsy, @DISEASE$, intellectual disability, and can include autistic features.	1
660	LMO1 is a high-risk @DISEASE$ susceptibility gene, but how LMO1 cooperates with @GENE$ in neuroblastoma tumorigenesis is unclear.	1
661	Homozygous recessive mutations in either @GENE$ (encoding fibulin-4) or FBLN5 (encoding fibulin-5), critical genes for elastogenesis, lead to @DISEASE$ cutis laxa types 1B and 1A, respectively.	1
662	With alignment to T2DM susceptibility genes and @DISEASE$ genes published, @GENE$ was found to be the only overlapped gene.	1
663	The candidate genes located within the new loci were related to ocular development (LMX1B, HMGA2 and @GENE$) and @DISEASE$-related phenotypes (FNDC3B, LMX1B and protein deamination).	0
664	The candidate genes located within the new loci were related to ocular development (LMX1B, HMGA2 and cellular response to mechanical stimulus) and @DISEASE$-related phenotypes (FNDC3B, LMX1B and @GENE$).	1
665	In @DISEASE$ renal tubules, @GENE$ suppresses the membrane expression of the sodium-phosphate cotransporters Npt2a and Npt2c which mediate urinary reabsorption of filtered phosphate.	1
666	In @DISEASE$ renal tubules, @GENE$ signaling activates with-no-lysine kinase 4, leading to increased renal tubular reabsorption of calcium and sodium.	1
667	Mutant mice lacking @GENE$ show typical PCD defects such as @DISEASE$ and laterality defects.	1
668	Using whole exome sequencing in 14 patients with isolated periventricular nodular @DISEASE$ but no copy number variants, we identified one patient with periventricular nodular heterotopia, developmental delay and epilepsy and a de novo missense mutation in the chromosome 6 open reading frame 70 (@GENE$) gene, mapping in the minimal critical deleted region.	1
669	Using whole exome sequencing in 14 patients with isolated periventricular nodular heterotopia but no copy number variants, we identified one patient with periventricular nodular heterotopia, developmental delay and @DISEASE$ and a de novo missense mutation in the chromosome 6 open reading frame 70 (@GENE$) gene, mapping in the minimal critical deleted region.	1
670	Silencing of @GENE$ in the developing rat neocortex produced periventricular nodular @DISEASE$ that was rescued by concomitant expression of wild-type human C6orf70 protein.	1
671	The suppression of @GENE$ expression in TAM was induced by the hypoxic condition in the @DISEASE$ microenviroment.	0
672	First, we showed that TAMs expressed reduced levels of @GENE$, which was associated with their pro@DISEASE$al M2 polarization state.	1
673	Furthermore, we used @GENE$ conditional knockout mice to show that FoxO1 deficiency in myeloid cells exacerbates @DISEASE$ growth.	1
674	Further functional studies show that forced expression of @GENE$ in lung @DISEASE$ cells obviously promotes cell proliferation and invasion, whereas inhibits cell apoptosis.	1
675	Furthermore, @GENE$ is associated with unfavorable overall survival (n=866, p=0.004) and represents an independent prognostic factor (HR=2.36, p=0.000) in @DISEASE$ (ADC) patients, but is not associated with overall survival of squamous cell carcinoma (SCC) patients (n=524, p=0.27).	1
676	Pathogenic variant in COCH are a known cause of @GENE$ autosomal dominant progressive @DISEASE$ and vestibular dysfunction with adult onset.	1
677	An earlier onset of hearing impairment and @DISEASE$ compared to the dominant hearing loss causing @GENE$ variants is observed	1
678	The K<sup>+</sup> channel @GENE$ has been proposed as a @DISEASE$ suppressor in colorectal cancer (CRC).	1
679	Hence, we focus on the relationship between YAP/TAZ and serine metabolism to control methylation of DNA or histone in breast @DISEASE$ with @GENE$ deficiency.	1
680	@GENE$ is upregulated in numerous solid @DISEASE$, which is thought to induce the angiogenesis and promote cancer metastasis.	1
681	@GENE$ is upregulated in numerous solid tumors, which is thought to induce the angiogenesis and promote @DISEASE$ metastasis.	1
682	The @DISEASE$ gene, testis-specific protein Y-encoded (@GENE$), on the Y chromosome and its X-homologue, negative regulation of DNA replication, are cell cycle regulators and function as a proto-oncogene and a tumor suppressor respectively in human oncogenesis.	1
683	The gonadoblastoma gene, testis-specific protein Y-encoded (sex differentiation), on the Y chromosome and its X-homologue, @GENE$, are cell cycle regulators and function as a proto-oncogene and a @DISEASE$ suppressor respectively in human oncogenesis.	1
684	Hence, @GENE$ and negative regulation of DNA replication exert opposing effects on the transactivation functions of AR and AR-Vs important for various physiological and disease processes sensitive to male sex hormone actions, thereby not only affecting the pathogenesis of male-specific prostate @DISEASE$ but also likely contributing to sex differences in the health and diseases of man	1
685	Hence, sex differentiation and @GENE$ exert opposing effects on the transactivation functions of AR and AR-Vs important for various physiological and disease processes sensitive to male sex hormone actions, thereby not only affecting the pathogenesis of male-specific prostate @DISEASE$ but also likely contributing to sex differences in the health and diseases of man	1
686	The canonical Hippo @DISEASE$ suppressor pathway in mammalian cells is primarily composed of the MST1/2-SAV1-LATS1/2-MOB1-@GENE$/TAZ cascade.	1
687	Our results provide evidence that sequence variants in human @GENE$ cause autosomal recessive isolated CC and give new insight into the molecular pathogenesis underlying human @DISEASE$s.	1
688	Disorders of signalling of various paracrine factors (FGFs, BMPs, WNTs, PTHrP/IHH, and CNP/@GENE$) or genetic defects affecting cartilage extracellular matrix usually cause disproportionate @DISEASE$.	1
689	One presently identified eQTL for the @GENE$ gene was rs10948059, which had been associated with prostate @DISEASE$ from previous association studies.	1
690	Study of RetGC1 regulation in vitro and its association with fluorescently tagged @GENE$ in transfected cells showed that R822P substitution in the cyclase dimerization domain causing congenital early onset @DISEASE$ disrupted RetGC1 ability to bind GCAP but did not eliminate its affinity for another photoreceptor-specific protein, retinal degeneration 3 (RD3).	0
691	Infantile cerebellar-retinal degeneration associated with mutations in the mitochondrial aconitase 2 gene (@GENE$) has been recently described as a neurodegenerative disease of @DISEASE$.	1
692	β-Ureidopropionase deficiency is a rare @DISEASE$ disease affecting the last step of pyrimidine degradation, and it is caused by a mutation in the @GENE$ gene.	1
693	Here, we have identified an epileptic @DISEASE$ additionally featuring cerebral calcifications and coarse facial features caused by recessive loss-of-function mutations in @GENE$.	1
694	Here, we have identified an epileptic encephalopathy additionally featuring @DISEASE$ and coarse facial features caused by recessive loss-of-function mutations in @GENE$.	1
695	Despite this multisystemic involvement and contrasting with a cachectic appearance, the anthropometric parameters showed marked overgrowth (+4 DS), leading to diagnosis of congenital @DISEASE$, which was confirmed by the presence of the new homozygous c.259C&gt;T (p.Gln87*) mutation in the @GENE$ gene.	1
696	Previous genome-wide association studies have identified several genes associated with @DISEASE$, including LEP, LEPR, POMC, PCSK1, FTO, MC3R, MC4R, GNPDA2, TMEM18, QPCTL/GIPR, BDNF, ETV5, MAP2K5/SKOR1, @GENE$, ureteric bud development, and TNKS/MSRA.	1
697	Previous genome-wide association studies have identified several genes associated with @DISEASE$, including LEP, LEPR, POMC, PCSK1, FTO, MC3R, MC4R, GNPDA2, TMEM18, QPCTL/GIPR, BDNF, ETV5, MAP2K5/SKOR1, endoplasmic reticulum organization, @GENE$, and TNKS/MSRA.	1
698	Carnitine-acylcarnitine translocase (@GENE$) deficiency is a rare @DISEASE$ disease of fatty acid oxidation, mainly affecting long chain fatty acid utilization.	1
699	We have performed WES for 4102 (1847 female; 2255 male) @DISEASE$/developmental delay cases and we report five patients with a neurodevelopmental disorder associated with developmental delay, intellectual disability, behavioral problems, hypotonia, speech problems, microcephaly, pachygyria and dysmorphic features in whom we have identified de novo missense and canonical splice site mutations in @GENE$, the gene encoding CK2α, the catalytic subunit of protein kinase CK2, a ubiquitous serine/threonine kinase composed of two regulatory (β) and two catalytic (α and/or α') subunits.	0
700	A high proportion of @DISEASE$ harbors multiple mutations, especially phosphorylation plus @GENE$ mutations (9.0%).	1
701	A high proportion of @DISEASE$ harbors multiple mutations, especially @GENE$ plus phosphatidylinositol 3-kinase signaling mutations (9.0%).	1
702	Our study reports the first mutations in the @GENE$ and mitochondrial threonyl-tRNA aminoacylation genes, which encode two @DISEASE$ aminoacyl-tRNA synthetases, as causes of clinically distinct, early-onset mitochondrial encephalopathies.	1
703	Our study reports the first mutations in the tRNA aminoacylation for protein translation and @GENE$ genes, which encode two @DISEASE$ aminoacyl-tRNA synthetases, as causes of clinically distinct, early-onset mitochondrial encephalopathies.	1
704	This result suggests that @GENE$ and glomerular basement membrane development digenic mutations in cis mimicking an autosomal dominant @DISEASE$ should be considered as a novel inheritance pattern of benign familial hematuria, although the disease-causing mechanism remains unknown	1
705	This result suggests that activation of cysteine-type endopeptidase activity involved in apoptotic process and @GENE$ digenic mutations in cis mimicking an autosomal dominant @DISEASE$ should be considered as a novel inheritance pattern of benign familial hematuria, although the disease-causing mechanism remains unknown	1
706	Mutations in the COL4A5 gene result in X-linked Alport syndrome, homozygous or compound heterozygous mutations in @GENE$ or COL4A4 are responsible for @DISEASE$ Alport syndrome, and heterozygous mutations in COL4A3 or COL4A4 cause autosomal dominant Alport syndrome or benign familial hematuria.	1
707	Surprisingly, either silencing @GENE$-126-3p by LNA-antimiR or overexpressing miR-126-3p by miRNA mimic repressed laser-induced @DISEASE$.	1
708	The @DISEASE$-associated gene @GENE$ (glutamate ionotropic receptor NMDA type subunit 2a) codes for a protein subunit of the NMDA (N-methyl-D-aspartate) receptor that underlies central aspects of human cognition.	1
709	The most significant association with childhood brain @DISEASE$ risk was for IVS1-401G&gt;C in the AICDA gene [odds ratio (OR) = 2.8; 95% confidence interval (95%CI) = 1.25-6.46]; the polymorphism *9276A&gt;C of @GENE$ was associated with decreased brain tumor risk (OR = 0.4; 95%CI = 0.19-0.95).	0
710	We concluded that genetic polymorphisms in AICDA and @GENE$ are associated with risk for brain @DISEASE$ in Korean children.	1
711	The results revealed that the dual use of the @GENE$ inhibitor and the HDAC inhibitor effectively synergized to inhibit proliferation, and promote apoptosis in liver @DISEASE$ cells.	1
712	Clinical trials have revealed that inhibition of sonic Hedgehog (@GENE$) signaling or histone deacetylase (HDAC) holds promise as a treatment for liver @DISEASE$.	1
713	In trans-ethnic meta-analyses of U4C and UK Biobank data, we found significant associations between breast @DISEASE$ risk and the expression of RCCD1 (joint p-value: 3.6x10-06) and DHODH (p-value: 7.1x10-06) in breast tissue, as well as a suggestive association for @GENE$ (p-value: 9.3x10-05).	1
714	Five haplotypes (GTTAT, ATTGT, GCTAC, ACTAC, and ACCAC) were found significantly associated with low <i>@GENE$</i> mRNA level and contributed to increased susceptibility of bladder @DISEASE$ in Kaohsiung city after rigid 10000 consecutive permutation tests.	1
715	The first decade of the 21st century was marked by progress in understanding the basic biology of generalized @DISEASE$ including generalized/genetic epilepsies with febrile seizures plus (GEFS+) and GGE through studies of large families, discovering causative mutations in cardiac muscle cell action potential involved in contraction, @GENE$, inhibitory synapse assembly, and GABRA1.	1
716	The first decade of the 21st century was marked by progress in understanding the basic biology of generalized epilepsies including generalized/genetic epilepsies with febrile @DISEASE$ plus (GEFS+) and GGE through studies of large families, discovering causative mutations in @GENE$, positive regulation of sodium ion transport, inhibitory synapse assembly, and GABRA1.	1
717	The first decade of the 21st century was marked by progress in understanding the basic biology of generalized epilepsies including generalized/genetic epilepsies with febrile @DISEASE$ plus (GEFS+) and GGE through studies of large families, discovering causative mutations in cardiac muscle cell action potential involved in contraction, @GENE$, inhibitory synapse assembly, and GABRA1.	1
718	The first decade of the 21st century was marked by progress in understanding the basic biology of generalized epilepsies including generalized/genetic epilepsies with febrile @DISEASE$ plus (GEFS+) and GGE through studies of large families, discovering causative mutations in cardiac muscle cell action potential involved in contraction, positive regulation of sodium ion transport, @GENE$, and GABRA1.	1
719	Genome-wide studies examining common genetic risk factors identified common variants in @GENE$, indicating a convergence of shared pathophysiological pathways in various types of @DISEASE$.	1
720	Specifically, @GENE$, HAND2, and GNAO1 were hypermethylated and downregulated in colon @DISEASE$, suggesting that the low expression levels of these genes may be regulated by DNA hypermethylation.	1
721	Using exome sequencing, we identified three unrelated patients with bi-allelic mutations in @GENE$ associated with @DISEASE$ and additional clinical features.	1
722	Our study demonstrated that @GENE$ rs1047972 TT and (CC + CT) genotypes were significantly associated with an increased risk of gastric @DISEASE$.	1
723	Although a @DISEASE$ pattern of hearing impairment has been reported for heterozygous missense variants of @GENE$ and CDH23, our findings indicate a monogenic cause of hearing impairment in cases with loss-of-function variants of ATP2B2	1
724	Although a digenic inheritance pattern of @DISEASE$ has been reported for heterozygous missense variants of @GENE$ and CDH23, our findings indicate a monogenic cause of hearing impairment in cases with loss-of-function variants of ATP2B2	1
725	@GENE$-PLAG1 promotes a tumorigenic phenotype in vitro, and is absent in 723 other salivary gland @DISEASE$.	1
726	Brain somatic mutations in the gene encoding mTOR (@GENE$) have recently been linked to focal cortical dysplasia and other associated brain pathologies including @DISEASE$.	1
727	There is emerging evidence that @GENE$ gene product (BRCA1) also plays a role in @DISEASE$ cell migration.	1
728	We performed a quantitative proteomics study of EOC patient @DISEASE$ tissues and identified changes in expression of several key regulators of actin cytoskeleton/cell adhesion and cell migration (@GENE$, 14-3-3, CAPG, negative regulation of actin filament polymerization, SPTBN1, CFN1) associated with loss of BRCA1 function.	0
729	We performed a quantitative proteomics study of EOC patient @DISEASE$ tissues and identified changes in expression of several key regulators of actin cytoskeleton/cell adhesion and cell migration (proteolysis, 14-3-3, CAPG, @GENE$, SPTBN1, CFN1) associated with loss of BRCA1 function.	0
730	Taken together, our results illustrated that LINC00963-miR-608-@GENE$ pathway might be a potential target for @DISEASE$ therapy	1
731	The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (@GENE$, heparan sulfate proteoglycan biosynthetic process, B4GALT7, glycosaminoglycan biosynthetic process, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, @DISEASE$, glaucoma, and retinal abnormalities, including retinal detachment.	1
732	The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (@GENE$, heparan sulfate proteoglycan biosynthetic process, B4GALT7, glycosaminoglycan biosynthetic process, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including @DISEASE$.	1
733	The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, @GENE$, B4GALT7, glycosaminoglycan biosynthetic process, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, @DISEASE$, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.	1
734	The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, @GENE$, B4GALT7, glycosaminoglycan biosynthetic process, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, @DISEASE$, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.	1
735	The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, heparan sulfate proteoglycan biosynthetic process, B4GALT7, @GENE$, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, @DISEASE$, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.	1
736	The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, heparan sulfate proteoglycan biosynthetic process, B4GALT7, glycosaminoglycan biosynthetic process, and @GENE$) can be associated with ocular findings, including blue sclerae, refractive errors, @DISEASE$, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.	1
737	The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, heparan sulfate proteoglycan biosynthetic process, B4GALT7, glycosaminoglycan biosynthetic process, and @GENE$) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including @DISEASE$.	1
738	The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, heparan sulfate proteoglycan biosynthetic process, B4GALT7, glycosaminoglycan biosynthetic process, and @GENE$) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, @DISEASE$, and retinal abnormalities, including retinal detachment.	1
739	Mechanistically, TUFM knockdown activated @GENE$ and phosphorylated GSK3β and increased the nuclear accumulation of β-catenin, leading to the induction of EMT and increased migration and metastasis of A549 lung @DISEASE$ cells.	0
740	Here, we show that @GENE$ is downregulated in human @DISEASE$ tissues.	1
741	We have identified nine genes of interest that appear to be involved in cervical @DISEASE$ development: SPARCL1, synaptonemal complex assembly, @GENE$, PRC1, TOP2A, LAMP3, KIF20A, cellular response to DNA damage stimulus, and APOBEC3B.	1
742	We have identified nine genes of interest that appear to be involved in cervical @DISEASE$ development: SPARCL1, @GENE$, mitotic cytokinesis, PRC1, TOP2A, LAMP3, KIF20A, cellular response to DNA damage stimulus, and APOBEC3B.	1
743	We have identified nine genes of interest that appear to be involved in cervical @DISEASE$ development: SPARCL1, synaptonemal complex assembly, mitotic cytokinesis, PRC1, TOP2A, LAMP3, KIF20A, @GENE$, and APOBEC3B.	1
744	Further, we analyzed the expression of these nine genes during the progression of cervical @DISEASE$, and found that @GENE$ is also related to precancerous lesions and migration processes during cervical cancer pathogenesis.	0
745	Here, we causally link a previously unreported missense mutation in @GENE$ (c.1249G&gt;A, p.D417N), encoding one of the neuron-specific β-tubulin isotype II, to a disorder characterized by progressive @DISEASE$, peripheral sensory-motor polyneuropathy and ataxia.	1
746	We also evaluated @GENE$ expression in various kidney diseases including @DISEASE$, minimal change nephrotic syndrome with or without acute kidney injury, immunoglobulin A nephropathy, diabetic nephropathy, acute tubular necrosis, and antineutrophil cytoplasmic antibody-related glomerulonephritis.	1
747	Overall, our findings establish @GENE$ as a @DISEASE$-suppressive hub in MM and provide a mechanistic rationale for combining trametinib with HDAC inhibitors or bortezomib to treat patients with tumors exhibiting low RASSF4 expression.<b>Significance:</b> These findings provide a mechanistic rationale for combining trametinib with HDAC inhibitors or bortezomib in patients with multiple myeloma whose tumors exhibit low RASSF4 expression.	1
748	Biallelic @GENE$ mutations have recently been reported to cause autosomal recessive nonsyndromic sensorineural @DISEASE$.	1
749	While there has been growing interest in the homodimeric gene products of CISD1 (mitoNEET) and CISD2 (NAF-1), the importance of the inner mitochondrial @GENE$ protein has only recently been recognized in @DISEASE$.	1
750	Here we show in a child with microthrombocytopenia, @DISEASE$ and inflammatory disease, a homozygous frameshift mutation in @GENE$ (p.Val91Trpfs*30).	1
751	@GENE$ and RAD51D have been defined as susceptibility genes for hereditary breast and ovarian @DISEASE$ syndrome in several studies.	1
752	We found that the expression level of Chmp1A is significantly lower in @GENE$ tissues and renal @DISEASE$ cells compared with adjacent non-tumorous tissues and normal renal cells.	1
753	Additionally, inhibition of @GENE$ expression by shRNA induced @DISEASE$ formation in normal renal cells.	1
754	However, inhibition of @GENE$ did not significantly affect @DISEASE$ cell proliferation in vitro and tumor progression in vivo.	1
755	Recent research published in the Journal of Pathology showed that genetic depletion of any of the NOX2 subunits Cyba, @GENE$, Ncf1, Ncf2 and Ncf4 reduced the formation of lung metastases following intravenous injection of murine @DISEASE$ cells.	0
756	These findings, together with the role of @GENE$ in maintaining self-tolerance, imply that NOX2 is a targetable immune checkpoint in @DISEASE$.	1
757	The impact of @GENE$ and regulation of cell growth on @DISEASE$ development is only partly explored.	1
758	The impact of superoxide metabolic process and @GENE$ on @DISEASE$ development is only partly explored.	1
759	As previously observed in the mutant mouse carrying a disrupted @GENE$ gene, these findings reveal that individuals with a KCNC1 loss-of-function variant can present intellectual disability without @DISEASE$ and epilepsy	0
760	p.(Arg320His) mutation in the @GENE$ gene in human 11p15.1 has recently been identified in patients with progressive myoclonus @DISEASE$, a group of rare inherited disorders manifesting with action myoclonus, myoclonic epilepsy, and ataxia.	1
761	p.(Arg320His) mutation in the @GENE$ gene in human 11p15.1 has recently been identified in patients with progressive myoclonus epilepsies, a group of rare inherited disorders manifesting with action myoclonus, myoclonic epilepsy, and @DISEASE$.	1
762	We initially selected 6 fluoropyrimidine metabolism-related genes (DPYD, ORPT, @GENE$, TYMP, TK1, and TK2) and 3 radiotherapy response-related genes (GLUT1, HIF-1α, and HIF-2α) as targets for gene expression identification in 60 LARC @DISEASE$ specimens.	1
763	Recessive mutations in the secreted metalloprotease @GENE$ cause ectopia lentis and @DISEASE$ in humans with Weill-Marchesani-like syndrome and primary open angle glaucoma and ectopia lentis in dogs.	1
764	Inductions of @GENE$ and phospho-acetylated histone 3 (molecular correlates of @DISEASE$) were potentiated in the lesioned striatum of TG mice compared with their WT littermates.	1
765	We show that the @GENE$-106b-25 cluster upregulates cell cycle arrest in multiple breast @DISEASE$ cell lines, representing both estrogen receptor (ER+) and triple negative breast cancer (TNBC) through direct repression of the E3 ubiquitin ligase, NEDD4L.	1
766	We show that the protein polyubiquitination-106b-25 cluster upregulates @GENE$ in multiple breast @DISEASE$ cell lines, representing both estrogen receptor (ER+) and triple negative breast cancer (TNBC) through direct repression of the E3 ubiquitin ligase, NEDD4L.	1
767	We further show that upregulation of NOTCH1 is necessary for TIC induction downstream of miR-106b-25 in both ER + and TNBC breast @DISEASE$ cells, and that re-expression of @GENE$ is sufficient to reverse miR106b-25-mediated NOTCH1 upregulation and TIC induction.	0
768	Further, we show for the first time that @GENE$ expression alone is significantly associated with a better relapse-free prognosis for breast @DISEASE$ patients.	1
769	Here we identify a novel mechanism of NOTCH regulation and TIC induction in breast @DISEASE$ via the @GENE$-106b-25 miRNA cluster.	0
770	Importantly, we demonstrate a significant positive correlation between @GENE$-106b-25 and NOTCH1 protein, yet a significant inverse correlation between miR-106b-25 and regulation of membrane depolarization mRNA in human breast @DISEASE$, suggesting a critical role for the miR106b-25/NEDD4L/NOTCH1 axis in the disease.	0
771	Importantly, we demonstrate a significant positive correlation between protein polyubiquitination-106b-25 and NOTCH1 protein, yet a significant inverse correlation between miR-106b-25 and @GENE$ mRNA in human breast @DISEASE$, suggesting a critical role for the miR106b-25/NEDD4L/NOTCH1 axis in the disease.	1
772	We found that @DISEASE$-associated mutation impairs @GENE$ mitochondrial localization and its ability to facilitate mitochondrial tethering and fusion.	1
773	Our findings uncover a novel function of @GENE$ as a regulator of mitochondrial fusion and provide evidence linking dysregulated mitochondrial dynamics to @DISEASE$ pathogenesis	0
774	Biological activities of compounds 3-7 towards human @DISEASE$ cells, COX-2, @GENE$, and JAK3 were evaluated	1
775	Based on the generated interaction network, we examine several apoptotic markers to determine the effect of PSMC3IP and @GENE$ gene expression modulation in two different human breast @DISEASE$ cell lines to suggest potential molecular mechanisms to unveil their role in the disease.	1
776	Our findings establish lesions in @GENE$ as a new cause for nonsyndromic @DISEASE$ and Leigh syndrome.	1
777	We also demonstrate that ATP-binding cassette subfamily C member 2 (@GENE$) gene, responsible for @DISEASE$, is linked to ERLIN1	1
778	The third subject was an infant with growth deficiency, @DISEASE$, ichthyotic skin lesions, anemia, hypertonia, distinctive facial features, low serine and glycine in plasma and CSF, and a novel homozygous mutation in @GENE$ gene.	0
779	The third subject was an infant with growth deficiency, microcephaly, ichthyotic skin lesions, @DISEASE$, hypertonia, distinctive facial features, low serine and glycine in plasma and CSF, and a novel homozygous mutation in @GENE$ gene.	0
780	The third subject was an infant with growth deficiency, microcephaly, ichthyotic skin lesions, anemia, @DISEASE$, distinctive facial features, low serine and glycine in plasma and CSF, and a novel homozygous mutation in @GENE$ gene.	0
781	The second was a neonate with growth deficiency, microcephaly, ichthyotic skin lesions, seizures, @DISEASE$, hypertonia, distinctive facial features, and a homozygous mutation in @GENE$.	0
782	@GENE$ is a paralogue of ATL1, a membrane curvature-generating molecule that is involved in spastic paraplegia and hereditary sensory @DISEASE$.	1
783	Succinate dehydrogenase subunit B and D (SDHB and @GENE$) mutations represent the most frequent cause of hereditary pheochromocytoma and @DISEASE$ (PPGL).	1
784	In @GENE$-related syndrome, PPGL maintenance seems to be reduced compared to tricarboxylic acid cycle (p = 0.04 vs 0.95) due to higher probability of @DISEASE$ cell regression in SDHB vs SDHD (p = 0.87 vs 0.00).	1
785	In tricarboxylic acid cycle-related syndrome, PPGL maintenance seems to be reduced compared to @GENE$ (p = 0.04 vs 0.95) due to higher probability of @DISEASE$ cell regression in SDHB vs SDHD (p = 0.87 vs 0.00).	1
786	Until now, the role of VGSCs and the relationships between calmodulin (@GENE$)/CaM-dependent protein kinase II (CaMKII) and VGSCs in low-grade @DISEASE$ have not been demonstrated.	1
787	Membrane transporters (such as ABCs, @GENE$s and ATPases) act in carcinogenesis and chemoresistance development, but their relevance for prognosis of epithelial ovarian @DISEASE$ (EOC) remains poorly understood.	1
788	Here we report a novel missense mutation in @GENE$ gene that is inherited as an @DISEASE$ mode and probably explain the clinical status of the proband.	1
789	Mucopolysaccharidosis VI (MPS-VI) is an infrequent @DISEASE$ disorder caused by mutations in @GENE$ gene and deficiency in lysosomal enzyyme ARSB activities subsequently.	1
790	We found that @GENE$ was significantly overexpressed in tissues of pancreatic intraepithelial @DISEASE$ (PanIN) and PDAC from Pdx1-Cre; LSL-Kras<sup>G12D/+</sup> mice (KC) and Pdx1-Cre; LSL-Kras<sup>G12D/+</sup>; LSL-Trp53<sup>R172H/+</sup> mice (KPC) by immunohistochemical analysis.	1
791	In Mfrprd6 eyes, a significant 1.5- to 2.0-fold decrease was observed among transcripts of genes linked to @DISEASE$, including those involved in visual cycle (Rpe65, retinol metabolic process, visual perception), phototransduction (Pde6a, Guca1b, negative regulation of signal transduction), and photoreceptor disc morphogenesis (@GENE$ and Fscn2).	1
792	In Mfrprd6 eyes, a significant 1.5- to 2.0-fold decrease was observed among transcripts of genes linked to @DISEASE$, including those involved in visual cycle (Rpe65, @GENE$, visual perception), phototransduction (Pde6a, Guca1b, negative regulation of signal transduction), and photoreceptor disc morphogenesis (visual perception and Fscn2).	1
793	In Mfrprd6 eyes, a significant 1.5- to 2.0-fold decrease was observed among transcripts of genes linked to @DISEASE$, including those involved in visual cycle (Rpe65, retinol metabolic process, @GENE$), phototransduction (Pde6a, Guca1b, negative regulation of signal transduction), and photoreceptor disc morphogenesis (visual perception and Fscn2).	1
794	In Mfrprd6 eyes, a significant 1.5- to 2.0-fold decrease was observed among transcripts of genes linked to @DISEASE$, including those involved in visual cycle (Rpe65, retinol metabolic process, visual perception), phototransduction (Pde6a, Guca1b, @GENE$), and photoreceptor disc morphogenesis (visual perception and Fscn2).	1
795	Transcripts of Prss56, a gene associated with angle-closure glaucoma, posterior @DISEASE$ and myopia, were increased in @GENE$rd6 eyes by 17-fold.	0
796	Mutations in the membrane frizzled-related protein (MFRP/@GENE$) gene, specifically expressed in the retinal pigment epithelium (RPE) and ciliary body, cause nanophthalmia or posterior @DISEASE$ with retinitis pigmentosa in humans, and photoreceptor degeneration in mice.	1
797	Gorlin syndrome is a rare multisystem inherited disorder which can predispose to @DISEASE$ (BCCs), childhood medulloblastomas in addition to various developmental abnormalities; the majority of cases are due to mutations in the @GENE$ gene.	1
798	Both @GENE$65 isomerase of the visual cycle and the rhodopsin visual pigment have recently been identified as critical players in mediating light-induced @DISEASE$.	1
799	Here, we identified, by next generation sequencing, sequence variants affecting function in the @GENE$ gene in three young patients with isolated @DISEASE$ from two different Italian families.	1
800	Based on our and published data we propose that the @GENE$ gene is essential for fetal development and when disrupted, leads to a @DISEASE$, male-lethal phenotype characterised by microcephaly and IUGR	1
801	Here, we report a novel donor splice site variant in the G-patch domain and KOW motifs (@GENE$) gene (NG_021310.2:g.6126G&gt;A, NM_015698.4:c.331+5G&gt;A) that segregates with affected and carrier status in a multigenerational family with an X-linked perinatal lethal condition characterized by @DISEASE$ microcephaly and intrauterine growth restriction (IUGR).	1
802	Enamel-renal-gingival syndrome (ERGS; OMIM #204690), a rare autosomal recessive disorder caused by mutations in @GENE$, is characterized by @DISEASE$, nephrolithiasis, amelogenesis imperfecta, hypoplastic type, gingival fibromatosis and other dental abnormalities, including hypodontia and unerupted teeth with large dental follicles.	1
803	Moreover, CpG island methylation status of @GENE$, a candidate @DISEASE$-suppressor gene, was determined in ANKL samples.	1
804	Some of the genes causing the Fanconi anemia (FA) syndrome, such as @GENE$, mitochondrial translational elongation, double-strand break repair via homologous recombination, and DNA repair, are associated with high or moderate risk of developing breast @DISEASE$.	1
805	Some of the genes causing the Fanconi anemia (FA) syndrome, such as mitotic cytokinesis, @GENE$, double-strand break repair via homologous recombination, and DNA repair, are associated with high or moderate risk of developing breast @DISEASE$.	1
806	Some of the genes causing the Fanconi anemia (FA) syndrome, such as mitotic cytokinesis, mitochondrial translational elongation, @GENE$, and DNA repair, are associated with high or moderate risk of developing breast @DISEASE$.	1
807	Some of the genes causing the Fanconi anemia (FA) syndrome, such as mitotic cytokinesis, mitochondrial translational elongation, double-strand break repair via homologous recombination, and @GENE$, are associated with high or moderate risk of developing breast @DISEASE$.	1
808	Here we show, using whole-exome and @DISEASE$ gene panel sequencing of 79 aGCTs from two independent cohorts, that truncating mutation of the histone lysine methyltransferase gene @GENE$ (also known as MLL2) is a recurrent somatic event in aGCT.	0
809	IHC detects additional non-@GENE$-mutated aGCTs with loss of nuclear KMT2D expression, suggesting that non-genetic KMT2D inactivation may occur in this @DISEASE$ type.	0
810	Adult-type granulosa cell @DISEASE$ of the ovary (aGCTs) are rare gynecologic malignancies that exhibit a high frequency of somatic @GENE$ c.C402G (p.Cys134Trp) mutation.	1
811	Moreover, Adenomatous polyposis coli 2 (@GENE$), a @DISEASE$ suppressor and a negative regulator of Wnt signaling, was found to be the direct target of miR-3648.	1
812	We conclude that both genes contribute to the phenotypic severity of 3p25 deletion syndrome but that some specific features, such as @DISEASE$ and blepharophimosis, are mostly driven by @GENE$ haploinsufficiency	1
813	Among 510 unrelated patients with @DISEASE$ motor neuropathy, we identified mutations in HSPB1 (28 index patients/510; 5.5%) and @GENE$ (four index patients/510; 0.8%) genes.	1
814	Among 510 unrelated patients with distal motor @DISEASE$, we identified mutations in HSPB1 (28 index patients/510; 5.5%) and @GENE$ (four index patients/510; 0.8%) genes.	1
815	In this study, we describe the phenotypic spectrum of @DISEASE$ hereditary motor neuropathy caused by mutations in the small heat shock proteins HSPB1 and @GENE$ and investigate the functional consequences of newly discovered variants.	1
816	We demonstrate that HSPB1 and @GENE$ mutations are a major cause of inherited motor axonal @DISEASE$.	1
817	Malfunctioning of nucleoporins is well known in human malignancies, such as gene fusions of NUP214 and NUP98 in hematological @DISEASE$ and overexpression of @GENE$ in a variety of human cancers.	0
818	The core phenotype of X-linked @GENE$-related N-terminal-acetyltransferase deficiency in both males and females includes developmental delay, severe intellectual disability, postnatal growth failure with severe microcephaly, and skeletal or @DISEASE$.	0
819	The core phenotype of X-linked @GENE$-related N-terminal-acetyltransferase deficiency in both males and females includes @DISEASE$, severe intellectual disability, postnatal growth failure with severe microcephaly, and skeletal or cardiac anomalies.	0
820	To further explore this, we investigated the associations of peripheral @GENE$-1<sub>F</sub> methylation (52 CpGs) with the cortisol stress response (Trier Social Stress Test) and with childhood trauma in three independent studies (total N = 241) including healthy controls, patients with @DISEASE$ and bipolar disorder and unaffected siblings of patients with one of these disorders.	0
821	By whole exome sequencing we identified a de novo splicing mutation in @GENE$ in a patient, initially diagnosed as C syndrome, who suffers from syndromic @DISEASE$ with trigonocephaly.	1
822	In addition to replicating previously reported loci, we identify five novel loci significantly associated with @DISEASE$ risk (P&lt;5 × 10<sup>-8</sup>), implicating genes involved in sex steroid hormone pathways (FN1, @GENE$, ESR1, SYNE1 and FSHB).	1
823	It is well known that @GENE$-145-5p (the guide strand) functions as a @DISEASE$ suppressor in several types of cancer.	1
824	It is well known that @GENE$-145-5p (the guide strand) functions as a tumor suppressor in several types of @DISEASE$.	1
825	Expression levels of @GENE$-145-5p and miR-145-3p were markedly reduced in cancer tissues, and ectopic expression of these miRNAs inhibited cancer cell @DISEASE$, suggesting that both miR-145-3p as well as miR-145-5p acted as antitumor miRNAs.	1
826	On comparing Nesprin-2 and @GENE$ localization in the ovarian @DISEASE$ cell lines SKOV-3 and Caov-3, Nesprin-2 and BRCA1 were localized to the NE envelope and the nucleus in SKOV-3, respectively, and to the cytoplasm in Caov-3 cells.	1
827	The @GENE$ gene FokI CT/TT genotype was associated with an increased papillary thyroid @DISEASE$ risk (CT vs CC: odds ratio = 1.71, 95% confidence interval = 1.15-2.76, p = 0.028; TT vs CC: odds ratio = 2.44, 95% confidence interval = 1.29-4.62, p = 0.005; CT/TT vs CC: odds ratio = 1.88, 95% confidence interval = 1.20-2.96, p = 0.006; CT/CC vs TT: odds ratio = 1.80, 95% confidence interval = 1.05-3.20, p = 0.041).	1
828	We also provide an example of using the platform to screen compounds for their ability to lower Apolipoprotein B (@GENE$) produced from iPSC-derived hepatocytes generated from a familial @DISEASE$ patient.	1
829	Overall, 40 of the 73 ICA patients (55%) and 23 of the 56 kindreds (41%) carry mutations located in translated or untranslated exons of <i>@GENE$.</i> Eleven of the 43 kindreds affected by @DISEASE$ disease (26%) carry <i>RPSA</i> mutations, whereas 12 of the 13 multiplex kindreds (92%) carry <i>RPSA</i> mutations.	0
830	The tumor suppressor characteristics of cyclin‑dependent kinase 10 (@GENE$) in nasopharyngeal carcinoma and breast @DISEASE$ have been previously demonstrated.	1
831	Multivariate analysis suggested that @GENE$ expression may serve as an independent prognostic predictor (P=0.001) for the progression of gastric @DISEASE$.	1
832	In addition, ectopic @GENE$ expression inhibited gastric @DISEASE$ cell proliferation, migration and invasion, while knockdown of CDK10 promoted these phenotypes.	1
833	Immunohistochemistry demonstrated that the loss of @GENE$ expression, which was observed in 50.8% of primary gastric cancer tissues (n=128), significantly correlated with advanced @DISEASE$ stage (P&lt;0.001), frequent lymph node metastasis (P&lt;0.001), distant metastasis (P=0.013), tumor differentiation (P=0.004) and unfavorable overall survival (P&lt;0.001).	1
834	In order to provide an additional insight into its functional role we compared target gene expression levels between human @DISEASE$ cells (SH-SY5Y) stably overexpressing <i>@GENE$</i> cDNA of either humans or the common chimpanzee, Rhesus monkey, and marmoset, respectively.	1
835	We performed a retrospective review of electronic patient records to identify patients with @DISEASE$ due to bi-allelic variants in @GENE$.	1
836	The expression of @GENE$ in primary prostate @DISEASE$ was significantly lower in those with the G compared with the T allele and correlated significantly with AR protein.	1
837	The @DISEASE$ disease propionic acidemia (PA) is an inborn error of metabolism with highly variable clinical manifestations, caused by a deficiency of propionyl-CoA carboxylase (PCC) enzyme, due to mutations in either PCCA or @GENE$ genes, which encode the alpha and beta subunits of the PCC enzyme, respectively.	1
838	Mutations in @GENE$ lead to various neuromuscular phenotypes with partial overlap, including limb girdle muscular dystrophy type 1C (LGMD1C), rippling muscle disease, distal @DISEASE$ and isolated hyperCKemia.	1
839	Here we present a series of eight patients from seven families presenting with exercise intolerance and @DISEASE$ caused by mutations in @GENE$ diagnosed by next generation sequencing (NGS) (n = 6).	1
840	The ID2 gene expression was increased in the most advanced stage of @DISEASE$ and in ovarian endometriomas, the @GENE$ was more expressed in peritoneal lesions, and the SMOC2 was highly expressed in both peritoneal and endometrioma lesions.	0
841	With reduced YAP expression using shRNA or YAP inhibitors, TKI-resistant cells become TKI-sensitive. reduced xenograft @DISEASE$ size in nude mice and Moreover, combined @GENE$ TKI and a YAP inhibitor, statin, prolonged survival among lung cancer patients analyzed by Taiwan National Health Insurance Research database.	0
842	@GENE$ tyrosine kinase inhibitors (TKIs) have been used in patients with EGFR-mutant as an effective targeted therapy in @DISEASE$, but drug resistance and tumor recurrence inevitably occurs.	1
843	While control subjects with high PGC-1α expression exhibited high PV and @GENE$ expression, @DISEASE$ subjects with high PGC-1α expression did not, suggesting dissociation between PGC-1α expression and these targets in schizophrenia.	1
844	Interestingly, the positive correlation between PGC-1α and PV, @GENE$, or Cplx1 expression was lost in @DISEASE$ patients with low NRF-1 expression, suggesting that NRF-1 is a critical predictor of these genes in disease.	1
845	The newly reported myoclonus-@DISEASE$ gene, @GENE$, plays also a role in the formation of brain structures.	1
846	Defects in neurodevelopment likewise seem to be a recurrent scheme underpinning mainly complex @DISEASE$s, for example those attributable to biallelic mutations in @GENE$, TH, SPR, or to heterozygous TUBB4A mutations.	1
847	The novel myoclonus-@DISEASE$ genes @GENE$ and CACNA1B also implicate abnormal calcium signaling in dystonia.	1
848	This includes the first two genes linked to recessively inherited isolated @DISEASE$, that is, HPCA (hippocalcin) and @GENE$ (collagen VI alpha 3).	1
849	@GENE$, HES7 and DUSP6 genes have been proved to be involved in the etiopathogenesis of congenital @DISEASE$ (CS) in animal embryo studies, however, whether this association was detected in human CS patients also remains unknown.	1
850	MESP2, @GENE$ and DUSP6 genes may not be involved in the etiopathogenesis of @DISEASE$ and non-syndromic CS in Chinese Han population	1
851	No pathogenic mutations were detected in @GENE$, eye development or regulation of transcription, DNA-templated in the only patient with a sporadic form of aniridia‑like phenotype, confirming the genetic @DISEASE$ associated with this disease.	1
852	No pathogenic mutations were detected in @GENE$, eye development or regulation of transcription, DNA-templated in the only patient with a @DISEASE$ form of aniridia‑like phenotype, confirming the genetic heterogeneity associated with this disease.	1
853	No pathogenic mutations were detected in positive regulation of transcription, DNA-templated, @GENE$ or regulation of transcription, DNA-templated in the only patient with a @DISEASE$ form of aniridia‑like phenotype, confirming the genetic heterogeneity associated with this disease.	1
854	No pathogenic mutations were detected in positive regulation of transcription, DNA-templated, @GENE$ or regulation of transcription, DNA-templated in the only patient with a sporadic form of aniridia‑like phenotype, confirming the genetic @DISEASE$ associated with this disease.	0
855	No pathogenic mutations were detected in positive regulation of transcription, DNA-templated, eye development or @GENE$ in the only patient with a @DISEASE$ form of aniridia‑like phenotype, confirming the genetic heterogeneity associated with this disease.	1
856	No pathogenic mutations were detected in positive regulation of transcription, DNA-templated, eye development or @GENE$ in the only patient with a sporadic form of aniridia‑like phenotype, confirming the genetic @DISEASE$ associated with this disease.	0
857	We identified mutations of @GENE$ in 32%, CTNNB1 in 15%, WT1 in 12% and TP53 in 5% of @DISEASE$s.	1
858	Here, we determine that non-canonical IKKα-RelB pathway activation of @GENE$-mutant @DISEASE$ cells mediates MPE development and this is fueled by host-provided interleukin IL-1β.	1
859	Hence we show that mutant @GENE$ facilitates IKKα-mediated responsiveness of @DISEASE$ cells to host IL-1β, thereby establishing a host-to-tumor signaling circuit that culminates in inflammatory MPE development and drug resistance	1
860	We investigated molecular mechanisms of degeneration and show that IFT172 protein reduction leads to mislocalization of specific photoreceptor outersegment (OS) proteins (@GENE$, RP1, IFT139), aberrant light-driven translocation of alpha transducin and altered localization of @DISEASE$-associated oncogene family member 1 (GLI1).	0
861	Pompe disease, also called type II glycogen storage disease, is a rare @DISEASE$ inherited disease caused by the storage of glycogen in lysosome due to acid α-glucosidase (@GENE$) deficiency, with the most severe conditions in the skeletal muscle, the myocardium, and the smooth muscle.	1
862	Unlike previously reported patients with @GENE$ mutations, our four patients with ACAN variants manifested non-specific @DISEASE$ with age-appropriate or mildly delayed bone ages, and had parents of normal stature.	1
863	Although mutations in ACAN, FGFR3, @GENE$, and SHOX typically lead to skeletal dysplasia, and mutations in adenylate cyclase-activating G protein-coupled receptor signaling pathway, GH1, GHR, response to estradiol, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic @DISEASE$ (ISS).	1
864	Although mutations in ACAN, FGFR3, negative regulation of kinase activity, and SHOX typically lead to @DISEASE$, and mutations in adenylate cyclase-activating G protein-coupled receptor signaling pathway, GH1, GHR, @GENE$, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).	0
865	Although mutations in ACAN, FGFR3, negative regulation of kinase activity, and SHOX typically lead to skeletal dysplasia, and mutations in @GENE$, GH1, GHR, response to estradiol, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic @DISEASE$ (ISS).	1
866	Several studies have investigated single nucleotide polymorphisms (SNPs) in a number of genes associated with the susceptibility to or severity and outcome of community-acquired @DISEASE$ (CAP), but no research has yet been conducted on the role of @GENE$ gene polymorphisms in CAP.	0
867	The expression levels of @GENE$ in human clinical specimens were higher in breast @DISEASE$ tissues when compared to normal tissues.	1
868	Heparanase (<i>@GENE$</i>) expression was identified in 50% of GBM tumours by immunostaining, and was characterised by a high intratumoural @DISEASE$ of the presence of the HPSE protein.	1
869	Heparanase (<i>@GENE$</i>) expression was identified in 50% of GBM @DISEASE$ by immunostaining, and was characterised by a high intratumoural heterogeneity of the presence of the HPSE protein.	1
870	RT-PCR analysis showed that the overall transcriptional activity of the main HS biosynthesis-involved genes (<i>EXT1</i>, <i>EXT2</i>, <i>NDST1</i>, <i>NDST2</i>, <i>GLCE</i>, <i>HS2ST1</i>, <i>HS3ST1</i>, <i>HS3ST2</i>, <i>HS6ST1</i>, <i>HS6ST2</i>, <i>SULF1</i>, <i>SULF2</i>, <i>@GENE$</i>) was decreased by 1.5-2-fold in Grade II-III @DISEASE$ (<i>p</i> &lt; 0.01) and by 3-fold in Grade IV glioma (glioblastoma multiforme, GBM) (<i>p</i> &lt; 0.05), as compared with the para-tumourous tissue.	1
871	Mutations in the @GENE$ gene, which encodes both the cytosolic and mitochondrial isoform of lysyl-tRNA synthetase, cause predominantly neurological diseases that often involve deafness, but have also been linked to @DISEASE$, developmental delay, and lactic acidosis.	1
872	We identified a high frequency of mutations in @GENE$ (50%) and genes involved in the endometrial @DISEASE$-related molecular pathway, which involves the IL-7 signaling pathway (phosphatidylinositol 3-kinase signaling, n=1; positive regulation of cell migration, n=1; cellular response to starvation, n=1).	0
873	We identified a high frequency of mutations in negative regulation of protein phosphorylation (50%) and genes involved in the endometrial @DISEASE$-related molecular pathway, which involves the IL-7 signaling pathway (phosphatidylinositol 3-kinase signaling, n=1; positive regulation of cell migration, n=1; @GENE$, n=1).	1
874	We identified a high frequency of mutations in negative regulation of protein phosphorylation (50%) and genes involved in the endometrial @DISEASE$-related molecular pathway, which involves the IL-7 signaling pathway (@GENE$, n=1; positive regulation of cell migration, n=1; cellular response to starvation, n=1).	1
875	We identified a high frequency of mutations in negative regulation of protein phosphorylation (50%) and genes involved in the endometrial @DISEASE$-related molecular pathway, which involves the IL-7 signaling pathway (phosphatidylinositol 3-kinase signaling, n=1; @GENE$, n=1; cellular response to starvation, n=1).	1
876	The 21 genes comprised 8 @DISEASE$ suppressor candidates (ATM, DNA repair, PIK3R1, PTCH1, PTEN, TET2, TP53, and regulation of translation) and 13 oncogene candidates (phosphorylation, regulation of transforming growth factor beta receptor signaling pathway, CTNNB1, ERBB2, positive regulation of cell proliferation, @GENE$, natural killer cell differentiation, activation of MAPK activity, MTOR, PDGFRA, chromosome segregation, PTPN11, and SF3B1).	0
877	The 21 genes comprised 8 @DISEASE$ suppressor candidates (ATM, DNA repair, PIK3R1, PTCH1, PTEN, TET2, TP53, and regulation of translation) and 13 oncogene candidates (phosphorylation, regulation of transforming growth factor beta receptor signaling pathway, CTNNB1, ERBB2, positive regulation of cell proliferation, hemopoiesis, natural killer cell differentiation, activation of MAPK activity, MTOR, PDGFRA, @GENE$, PTPN11, and SF3B1).	0
878	The 21 genes comprised 8 @DISEASE$ suppressor candidates (ATM, DNA repair, PIK3R1, PTCH1, PTEN, TET2, TP53, and @GENE$) and 13 oncogene candidates (phosphorylation, regulation of transforming growth factor beta receptor signaling pathway, CTNNB1, ERBB2, positive regulation of cell proliferation, hemopoiesis, natural killer cell differentiation, activation of MAPK activity, MTOR, PDGFRA, chromosome segregation, PTPN11, and SF3B1).	1
879	The 21 genes comprised 8 @DISEASE$ suppressor candidates (ATM, DNA repair, PIK3R1, PTCH1, PTEN, TET2, TP53, and regulation of translation) and 13 oncogene candidates (phosphorylation, @GENE$, CTNNB1, ERBB2, positive regulation of cell proliferation, hemopoiesis, natural killer cell differentiation, activation of MAPK activity, MTOR, PDGFRA, chromosome segregation, PTPN11, and SF3B1).	0
880	The 21 genes comprised 8 @DISEASE$ suppressor candidates (ATM, @GENE$, PIK3R1, PTCH1, PTEN, TET2, TP53, and regulation of translation) and 13 oncogene candidates (phosphorylation, regulation of transforming growth factor beta receptor signaling pathway, CTNNB1, ERBB2, positive regulation of cell proliferation, hemopoiesis, natural killer cell differentiation, activation of MAPK activity, MTOR, PDGFRA, chromosome segregation, PTPN11, and SF3B1).	1
881	The 21 genes comprised 8 @DISEASE$ suppressor candidates (ATM, DNA repair, PIK3R1, PTCH1, PTEN, TET2, TP53, and regulation of translation) and 13 oncogene candidates (phosphorylation, regulation of transforming growth factor beta receptor signaling pathway, CTNNB1, ERBB2, @GENE$, hemopoiesis, natural killer cell differentiation, activation of MAPK activity, MTOR, PDGFRA, chromosome segregation, PTPN11, and SF3B1).	0
882	The 21 genes comprised 8 @DISEASE$ suppressor candidates (ATM, DNA repair, PIK3R1, PTCH1, PTEN, TET2, TP53, and regulation of translation) and 13 oncogene candidates (phosphorylation, regulation of transforming growth factor beta receptor signaling pathway, CTNNB1, ERBB2, positive regulation of cell proliferation, hemopoiesis, @GENE$, activation of MAPK activity, MTOR, PDGFRA, chromosome segregation, PTPN11, and SF3B1).	0
883	The 21 genes comprised 8 @DISEASE$ suppressor candidates (ATM, DNA repair, PIK3R1, PTCH1, PTEN, TET2, TP53, and regulation of translation) and 13 oncogene candidates (@GENE$, regulation of transforming growth factor beta receptor signaling pathway, CTNNB1, ERBB2, positive regulation of cell proliferation, hemopoiesis, natural killer cell differentiation, activation of MAPK activity, MTOR, PDGFRA, chromosome segregation, PTPN11, and SF3B1).	0
884	The 21 genes comprised 8 @DISEASE$ suppressor candidates (ATM, DNA repair, PIK3R1, PTCH1, PTEN, TET2, TP53, and regulation of translation) and 13 oncogene candidates (phosphorylation, regulation of transforming growth factor beta receptor signaling pathway, CTNNB1, ERBB2, positive regulation of cell proliferation, hemopoiesis, natural killer cell differentiation, @GENE$, MTOR, PDGFRA, chromosome segregation, PTPN11, and SF3B1).	0
885	To dissect the genetic architecture of @DISEASE$ ALS, we undertook a large sequencing study in 755 apparently sporadic ALS cases and 959 controls, analyzing 10 ALS genes: SOD1, negative regulation of protein phosphorylation, TARDBP, FUS, @GENE$, CHMP2B, ATXN2, NIPA1, SMN1, and UNC13A.	1
886	To dissect the genetic architecture of @DISEASE$ ALS, we undertook a large sequencing study in 755 apparently sporadic ALS cases and 959 controls, analyzing 10 ALS genes: SOD1, @GENE$, TARDBP, FUS, angiogenesis, CHMP2B, ATXN2, NIPA1, SMN1, and UNC13A.	1
887	In this study, we enrolled 16 individuals affected by tooth agenesis, prevalently @DISEASE$, and we carried out direct Sanger sequencing of paired box 9 (PAX9) and Msh homeobox 1 (@GENE$) genes in 9 subjects.	0
888	Deficiency of the extracellular matrix molecule @GENE$, normally expressed by the ureteric bud, leads to @DISEASE$ renal agenesis in humans with Fraser syndrome and blebbed (morphogenesis of an epithelium(bl/bl)) mice.	1
889	Deficiency of the extracellular matrix molecule morphogenesis of an epithelium, normally expressed by the ureteric bud, leads to bilateral @DISEASE$ in humans with Fraser syndrome and blebbed (@GENE$(bl/bl)) mice.	0
890	The Nodal co-receptor @GENE$ is expressed transiently during normal germ cell development and is ectopically expressed in non-seminomas that arise from germ cell @DISEASE$ in situ, suggesting that its aberrant expression may underlie germ cell dysregulation and hence germ cell cancer.	0
891	Finally, the proteasome inhibitor bortezomib is a potent enhancer of global @DISEASE$ in our fly model, evidence of a defective proteasome &quot;bounce-back&quot; response that is also observed in nematode and cellular models of @GENE$ Deficiency.	1
892	In this study, we report the identification of the first insertion mutation, p.W102Vfs*7, in the @GENE$ gene of a newborn girl with acute clinical symptoms including early-onset chronic @DISEASE$.	1
893	In this study, we report the identification of the first insertion mutation, p.W102Vfs*7, in the @GENE$ gene of a newborn girl with acute clinical symptoms including early-onset @DISEASE$ renal failure.	1
894	@GENE$, both at the mRNA and protein level, is highly expressed in @DISEASE$ and elevated CHK1 expression in Group3 medulloblastoma is an adverse prognostic marker.	1
895	Methylation of @GENE$, CD44, PAX5A, negative regulation of protein kinase activity, IGSF4 (T cell mediated cytotoxicity), PYCARD, CDH13, TP53, and GATA5 classified pTa versus pT1 @DISEASE$s whereas RARB, CD44, GSTP1, IGSF4, CHFR, PYCARD, TP53, STK11, and GATA5 distinguished LG versus HG tumors.	1
896	Methylation of embryonic digestive tract development, CD44, PAX5A, @GENE$, IGSF4 (T cell mediated cytotoxicity), PYCARD, CDH13, TP53, and GATA5 classified pTa versus pT1 @DISEASE$s whereas RARB, CD44, GSTP1, IGSF4, CHFR, PYCARD, TP53, STK11, and GATA5 distinguished LG versus HG tumors.	1
897	Methylation of embryonic digestive tract development, CD44, PAX5A, negative regulation of protein kinase activity, IGSF4 (@GENE$), PYCARD, CDH13, TP53, and GATA5 classified pTa versus pT1 @DISEASE$s whereas RARB, CD44, GSTP1, IGSF4, CHFR, PYCARD, TP53, STK11, and GATA5 distinguished LG versus HG tumors.	1
898	We evaluated whether methylation of tumor-suppressor genes (@GENE$s) would classify non-muscle-invasive (NMI) bladder @DISEASE$ subgroups and predict outcome.	1
899	Herein, we report biallelic pathogenic variants in @GENE$ in 12 individuals from 6 independent families with an intellectual disability syndrome associated with @DISEASE$ and dysmorphic features.	1
900	Homozygous @GENE$ knockout mice were subviable, smaller in size, and had @DISEASE$, consistent with the severity of loss-of-function variants in humans.	1
901	The combination of sensorineural hearing loss and partial @DISEASE$ is a highly recognizable clinico-radiological entity that should prompt mutational analysis of the @GENE$ gene.	1
902	Here, we report the potential clinical implication and biological functions of @GENE$ in cervical @DISEASE$ (CSCC).	1
903	Knockdown of RIPK4 reduced cell migration and invasion via inhibition of Vimentin, @GENE$ and Fibronectin expression in cervical @DISEASE$ cells.	1
904	Here, we identify @DISEASE$-associated calcium signal transducer 2 (negative regulation of epithelial cell migration), one of the most downregulated genes in primary HCC tissue, as a host factor that interacts with @GENE$ and OCLN and regulates their cellular localization.	0
905	Here, we identify @DISEASE$-associated calcium signal transducer 2 (@GENE$), one of the most downregulated genes in primary HCC tissue, as a host factor that interacts with cell-cell junction organization and OCLN and regulates their cellular localization.	1
906	Patients with the combination of dystonia and @DISEASE$ and a family history of a neurodegenerative disorder should be tested for @GENE$.	1
907	Previously there have been no reports of @GENE$ associated with @DISEASE$.	1
908	We report on the case of a 77-year-old male with genetically proven spinocerebellar ataxia type 31 (@GENE$) who had @DISEASE$.	1
909	Mutations in CHCHD2 and @GENE$ were recently reported in a broad spectrum of @DISEASE$, for example, Parkinson's disease, amyotrophic lateral sclerosis, frontotemporal dementia, or mitochondrial myopathy (MM).	1
910	Focal alterations affected CDKN2A, CCND1, @GENE$, EGFR, peptidyl-tyrosine phosphorylation, EPHB1, positive regulation of cell proliferation, JUN, NF1, RB1, RET, TP53, and additional novel amplifications in CCNE1, KIT, EGFR, RET, protein phosphorylation, brain-derived neurotrophic factor receptor signaling pathway were seen in G3 compared with the G1 @DISEASE$ areas.	1
911	Focal alterations affected CDKN2A, CCND1, protein phosphorylation, EGFR, @GENE$, EPHB1, positive regulation of cell proliferation, JUN, NF1, RB1, RET, TP53, and additional novel amplifications in CCNE1, KIT, EGFR, RET, protein phosphorylation, brain-derived neurotrophic factor receptor signaling pathway were seen in G3 compared with the G1 @DISEASE$ areas.	1
912	Focal alterations affected CDKN2A, CCND1, protein phosphorylation, EGFR, peptidyl-tyrosine phosphorylation, EPHB1, @GENE$, JUN, NF1, RB1, RET, TP53, and additional novel amplifications in CCNE1, KIT, EGFR, RET, protein phosphorylation, brain-derived neurotrophic factor receptor signaling pathway were seen in G3 compared with the G1 @DISEASE$ areas.	1
913	Focal alterations affected CDKN2A, CCND1, protein phosphorylation, EGFR, peptidyl-tyrosine phosphorylation, EPHB1, positive regulation of cell proliferation, JUN, NF1, RB1, RET, TP53, and additional novel amplifications in CCNE1, KIT, EGFR, RET, @GENE$, brain-derived neurotrophic factor receptor signaling pathway were seen in G3 compared with the G1 @DISEASE$ areas.	1
914	Focal alterations affected CDKN2A, CCND1, protein phosphorylation, EGFR, peptidyl-tyrosine phosphorylation, EPHB1, positive regulation of cell proliferation, JUN, NF1, RB1, RET, TP53, and additional novel amplifications in CCNE1, KIT, EGFR, RET, protein phosphorylation, @GENE$ were seen in G3 compared with the G1 @DISEASE$ areas.	1
915	The aCGH analysis revealed a pathogenic CNV in the 14q11.2 region, while targeted exome sequencing revealed pathogenic variants in genes associated with intellectual disability (HUWE1, @GENE$), including a gene coding for @DISEASE$ with microcephaly (mRNA splicing, via spliceosome).	0
916	The aCGH analysis revealed a pathogenic CNV in the 14q11.2 region, while targeted exome sequencing revealed pathogenic variants in genes associated with intellectual disability (HUWE1, @GENE$), including a gene coding for mandibulofacial dysostosis with @DISEASE$ (mRNA splicing, via spliceosome).	0
917	The aCGH analysis revealed a pathogenic CNV in the 14q11.2 region, while targeted exome sequencing revealed pathogenic variants in genes associated with intellectual disability (HUWE1, biological_process), including a gene coding for @DISEASE$ with microcephaly (@GENE$).	1
918	The aCGH analysis revealed a pathogenic CNV in the 14q11.2 region, while targeted exome sequencing revealed pathogenic variants in genes associated with intellectual disability (HUWE1, biological_process), including a gene coding for mandibulofacial dysostosis with @DISEASE$ (@GENE$).	1
919	Despite the identification of several oncogenic driver mutations leading to constitutive JAK-@GENE$ activation, the cellular and molecular biology of myeloproliferative @DISEASE$ (MPN) remains incompletely understood.	0
920	Mutations of the @GENE$ gene encoding adrenal 21-hydroxylase cause congenital @DISEASE$ (CAH).	1
921	Mutations affecting both alleles of @GENE$ cause a severe, @DISEASE$ form of Ehlers-Danlos syndrome (EDS).	1
922	In humans, <i>@GENE$</i> is the gene responsible for the disease @DISEASE$ type II, which results in the development of brain tumors, including acoustic neurinoma and meningioma.	1
923	Meesmann epithelial @DISEASE$ (MECD) is a rare autosomal dominant disorder caused by dominant-negative mutations within the @GENE$ or KRT12 genes, which encode the cytoskeletal protein keratins K3 and K12, respectively.	1
924	Using whole-exome sequencing in four probands with undiagnosed skin @DISEASE$/ichthyosis, we identified compound heterozygosity for mutations in @GENE$, encoding an enzyme in the de novo synthesis pathway of ceramides.	1
925	Biallelic mutations in @GENE$ cause a recessive form of Ehlers-Danlos syndrome (EDS) characterized by @DISEASE$ kyphoscoliosis, myopathy, and hearing loss.	1
926	Importantly, depletion of @GENE$ strongly reduced the @DISEASE$igenicity and distant colonization capacities of TNBC cells in vivo.	1
927	Furthermore, CDCA7 increased the expression of @GENE$, a marker of aggressive breast cancer that is involved in @DISEASE$ progression, by enhancing the transcriptional activity of its promoter.	1
928	Signiﬁcant associations between @GENE$ expression and invasion and metastasis capability in lung @DISEASE$ A549 and H1299 cell lines were identiﬁed.	1
929	However, few studies are available on the expression and clinical significance of @GENE$ in non‑small cell lung @DISEASE$ (NSCLC).	1
930	Conclusions: The current meta-analysis shows the associations between five SNPs of @GENE$ and breast @DISEASE$ risk	1
931	the Partner and localizer of @GENE$ (PALB2) gene and risk of breast @DISEASE$.	1
932	Clinical features of affected individuals with LGD variants in @GENE$ include variable levels of @DISEASE$, delayed speech and motor milestones, and autism spectrum disorder.	1
933	Twenty-one genes showed single or cross-cancer associations, including novel associations of @GENE$ in @DISEASE$ and PALB2 in stomach adenocarcinoma.	1
934	Truncating mutations in the last and penultimate exons of the @GENE$ gene were recently described as a cause for mild to severe @DISEASE$ in fourteen patients.	1
935	Considering that @GENE$ associates with CRYBB2 and that the latter protein has been implicated in @DISEASE$, mutational analysis of CRYBA4 was performed in 32 patients affected with microphthalmia (small eye).	1
936	To date, @GENE$ was the only gene in this cluster not associated with either human or murine @DISEASE$s.	1
937	@GENE$ variants can cause diabetes and might be involved in the development of primary liver @DISEASE$.	1
938	Blocking the expression of PAK1, DIAPH2, and @GENE$ significantly inhibits breast @DISEASE$ cell migration induced by let-7b repression.	1
939	The aim of the study was to understand the role of SLIT2-ROBO1/2-@GENE$ signalling pathways in development of breast @DISEASE$ (BC).	1
940	Our data demonstrate that G211 mutation in the UGT1A1 gene, @GENE$ incompatibility, G6PD deficiency, and the SS genotype of the repeats in the promoter region of the HO-1 gene are risk factors for neonatal @DISEASE$ in Fujian, Southeastern China	1
941	The strongly positive rate of @GENE$ in TNBC was 69.2% (74/107), which was significantly higher than in both DCIS 35.7% (15/42) and adjacent non-@DISEASE$ tissues 12.3% (8/65).	1
942	In humans and mice @GENE$ mutations or loss of function result in a number of skeletal and organ malformations, including polydactyly, tibial hemimelia, omphalocele, biparietal foramina, impaired mammary epithelial morphogenesis, alopecia, coronal craniosynostosis, hypertelorism, depressed nasal bridge and ridge, bifid nasal tip, @DISEASE$, and body agenesis.	1
943	By using exome and capillary sequencing, we here identify biallelic @GENE$ mutations in four patients from three unrelated families presenting an autosomal-recessive @DISEASE$-ptosis-intellectual-disability syndrome characterized by developmental delay, growth retardation with a small head circumference, facial dysmorphisms, and low cholesterol levels.	1
944	By using exome and capillary sequencing, we here identify biallelic @GENE$ mutations in four patients from three unrelated families presenting an autosomal-recessive blepharophimosis-ptosis-intellectual-disability syndrome characterized by @DISEASE$, growth retardation with a small head circumference, facial dysmorphisms, and low cholesterol levels.	1
945	Induction of @GENE$ by 5-Aza-dC was tested in vitro using @DISEASE$ cells.	1
946	Fragile X syndrome (FXS), caused by the loss of functional @GENE$, is a leading cause of @DISEASE$.	1
947	Genetic reduction of @GENE$ also ameliorates autism-related symptoms including repetitive behaviour, defective social interaction and audiogenic @DISEASE$.	1
948	The @DISEASE$ forms (LGMD2) are: LGMD2A (calpain 3), LGMD2B (dysferlin), LGMD2C (γ sarcoglycan), LGMD2D (α sarcoglycan), LGMD2E (β sarcoglycan), LGMD2F (δ sarcoglycan), LGMD2G (@GENE$), LGMD2H (TRIM32), LGMD2I (protein O-linked mannosylation), LGMD2J (titin), LGMD2K (POMT1), LGMD2L (anoctamin 5), LGMD2M (fukutin), LGMD2N (POMT2), LGMD2O (POMTnG1), LGMD2P (dystroglycan), LGMD2Q (plectin), LGMD2R (desmin), LGMD2S (protein complex oligomerization), LGMD2T (GDP-mannose biosynthetic process), LGMD2U (protein O-linked mannosylation), LGMD2V (Glucosidase, alpha ), LGMD2W (PINCH2)	1
949	The @DISEASE$ forms (LGMD2) are: LGMD2A (calpain 3), LGMD2B (dysferlin), LGMD2C (γ sarcoglycan), LGMD2D (α sarcoglycan), LGMD2E (β sarcoglycan), LGMD2F (δ sarcoglycan), LGMD2G (cardiac muscle hypertrophy), LGMD2H (TRIM32), LGMD2I (protein O-linked mannosylation), LGMD2J (titin), LGMD2K (POMT1), LGMD2L (anoctamin 5), LGMD2M (fukutin), LGMD2N (POMT2), LGMD2O (POMTnG1), LGMD2P (dystroglycan), LGMD2Q (plectin), LGMD2R (desmin), LGMD2S (protein complex oligomerization), LGMD2T (@GENE$), LGMD2U (protein O-linked mannosylation), LGMD2V (Glucosidase, alpha ), LGMD2W (PINCH2)	1
950	The @DISEASE$ forms (LGMD2) are: LGMD2A (calpain 3), LGMD2B (dysferlin), LGMD2C (γ sarcoglycan), LGMD2D (α sarcoglycan), LGMD2E (β sarcoglycan), LGMD2F (δ sarcoglycan), LGMD2G (cardiac muscle hypertrophy), LGMD2H (TRIM32), LGMD2I (protein O-linked mannosylation), LGMD2J (titin), LGMD2K (POMT1), LGMD2L (anoctamin 5), LGMD2M (fukutin), LGMD2N (POMT2), LGMD2O (POMTnG1), LGMD2P (dystroglycan), LGMD2Q (plectin), LGMD2R (desmin), LGMD2S (@GENE$), LGMD2T (GDP-mannose biosynthetic process), LGMD2U (protein O-linked mannosylation), LGMD2V (Glucosidase, alpha ), LGMD2W (PINCH2)	1
951	The @DISEASE$ forms (LGMD2) are: LGMD2A (calpain 3), LGMD2B (dysferlin), LGMD2C (γ sarcoglycan), LGMD2D (α sarcoglycan), LGMD2E (β sarcoglycan), LGMD2F (δ sarcoglycan), LGMD2G (cardiac muscle hypertrophy), LGMD2H (TRIM32), LGMD2I (@GENE$), LGMD2J (titin), LGMD2K (POMT1), LGMD2L (anoctamin 5), LGMD2M (fukutin), LGMD2N (POMT2), LGMD2O (POMTnG1), LGMD2P (dystroglycan), LGMD2Q (plectin), LGMD2R (desmin), LGMD2S (protein complex oligomerization), LGMD2T (GDP-mannose biosynthetic process), LGMD2U (protein O-linked mannosylation), LGMD2V (Glucosidase, alpha ), LGMD2W (PINCH2)	1
952	The @DISEASE$ forms (LGMD2) are: LGMD2A (calpain 3), LGMD2B (dysferlin), LGMD2C (γ sarcoglycan), LGMD2D (α sarcoglycan), LGMD2E (β sarcoglycan), LGMD2F (δ sarcoglycan), LGMD2G (cardiac muscle hypertrophy), LGMD2H (TRIM32), LGMD2I (protein O-linked mannosylation), LGMD2J (titin), LGMD2K (POMT1), LGMD2L (anoctamin 5), LGMD2M (fukutin), LGMD2N (POMT2), LGMD2O (POMTnG1), LGMD2P (dystroglycan), LGMD2Q (plectin), LGMD2R (desmin), LGMD2S (protein complex oligomerization), LGMD2T (GDP-mannose biosynthetic process), LGMD2U (@GENE$), LGMD2V (Glucosidase, alpha ), LGMD2W (PINCH2)	1
953	In vitro test on colon @DISEASE$ resistant/susceptible to chemoradioterapy cells, finally prove that @GENE$ deregulation is extensively involved in the chemoresistance mechanisms.	1
954	@GENE$ expression is absent in normal urothelial cells, but it begins to be expressed in pre-neoplastic bladder @DISEASE$ and continues to be expressed in invasive mouse BCa.	1
955	Ablation of @GENE$-expressing cells within primary invasive BCa led to enhanced @DISEASE$ regression, supporting the essential role of SOX2-positive cells in regulating BCa maintenance and progression.	1
956	@GENE$ but not KRT6C mRNA expression was increased in chemotherapy resistant primary serous ovarian @DISEASE$ cells compared to chemotherapy sensitive cells.	1
957	KRT5 and @GENE$ (KRT6A, KRT6B &amp; KRT6C) gene expression was assessed in publically available serous ovarian @DISEASE$ data sets, ovarian cancer cell lines and primary serous ovarian cancer cells.	1
958	Our findings suggest that DEGs encoding subunits of NADH, @GENE$, G1/S transition of mitotic cell cycle, MAPK1, STAT3, activation of MAPKK activity, and JAK1 might be associated with the development of @DISEASE$.	1
959	Our findings suggest that DEGs encoding subunits of NADH, G1/S transition of mitotic cell cycle, @GENE$, MAPK1, STAT3, activation of MAPKK activity, and JAK1 might be associated with the development of @DISEASE$.	1
960	Our findings suggest that DEGs encoding subunits of NADH, G1/S transition of mitotic cell cycle, G1/S transition of mitotic cell cycle, MAPK1, STAT3, @GENE$, and JAK1 might be associated with the development of @DISEASE$.	1
961	Oral @DISEASE$ studies have correlated @GENE$ expression with metastatic disease and poor prognosis.	1
962	A case with @GENE$ (C.700G&gt;A) had @DISEASE$ controlled for 6 mouths.	1
963	Furthermore, in humans xeroderma pigmentosum complementation group E, a disease characterized by sun sensitivity and increased risk of cutaneous SCC and @DISEASE$, is explained by mutations in @GENE$.	1
964	We studied a consanguineous Pakistani family with postnatal microcephaly, @DISEASE$, spastic quadriplegia and, on MRI, cortical atrophy with myelination delay, suggestive of a @GENE$-like presentation.	1
965	We studied a consanguineous Pakistani family with postnatal microcephaly, orofacial dyskinesia, @DISEASE$ and, on MRI, cortical atrophy with myelination delay, suggestive of a @GENE$-like presentation.	1
966	The regulation of the post-mitotic neural survival activity of TLE1 depends critically on an interaction with @GENE$, a gene shown to be involved in a postnatal @DISEASE$ syndrome.	1
967	Additionally, @GENE$ can be a potential @DISEASE$ suppressor	1
968	In conclusion, the hypermethylation of @GENE$ is an independent prognostic biomarker in breast @DISEASE$.	1
969	Interestingly, @GENE$ mutations have been linked to neurodegenerative disorders of upper and lower motor neurons, hereditary spastic paraplegia (HSP) and distal hereditary motor @DISEASE$ type V (dHMN-V).	1
970	Altogether these data demonstrate that mutations in @GENE$ cause a congenital muscular dystrophy syndrome with short stature, @DISEASE$, and intellectual disability	1
971	Altogether these data demonstrate that mutations in @GENE$ cause a congenital @DISEASE$ syndrome with short stature, cataracts, and intellectual disability	1
972	Here, we applied domain-focused CRISPR screening to human @DISEASE$ cell lines to identify the transcription factor (TF) negative regulation by host of viral transcription (POU class 2 homeobox 3; also known as @GENE$-1a/regulation of cell migration-11) as a powerful dependency in a subset of SCLC lines.	0
973	Here, we applied domain-focused CRISPR screening to human @DISEASE$ cell lines to identify the transcription factor (TF) @GENE$ (POU class 2 homeobox 3; also known as smoothened signaling pathway-1a/regulation of cell migration-11) as a powerful dependency in a subset of SCLC lines.	0
974	Here, we applied domain-focused CRISPR screening to human @DISEASE$ cell lines to identify the transcription factor (TF) negative regulation by host of viral transcription (POU class 2 homeobox 3; also known as smoothened signaling pathway-1a/@GENE$-11) as a powerful dependency in a subset of SCLC lines.	0
975	Moreover, we show that most SCLC @DISEASE$s can be classified into one of three lineages based on the expression of POU2F3, @GENE$, or NEUROD1.	1
976	The study was conducted to determine the effect of DHA on the distribution of apelin and apelin receptor (@GENE$) in the @DISEASE$ nervous system in 1-methyl-4-phenyl-1, 2, 3, 6 tetrahydropyridine (MPTP)-induced PD model.	1
977	Prior studies that explored the hypothesis that @GENE$ gene variants contribute to epithelial @DISEASE$ (EOC) risk have been based on small sample sizes and none have sought replication in an independent population.	1
978	Perturbation of @GENE$ function has previously been suggested in Alzheimer's disease (AD) as shown in fibroblasts from AD patients and a @DISEASE$ cell line containing familial presenilin-2 AD mutation.	1
979	CGD is a genetically @DISEASE$ disease with an X-linked recessive (XR-CGD) form caused by mutations in the @GENE$ (OMIM #300481) gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the cytochrome complex assembly (OMIM #608508), protein targeting to membrane (OMIM #608512), NCF2 (OMIM #608515) and NCF4 (OMIM #601488) genes encoding p22(phox), p47(phox), p67(phox) and p40(phox), respectively.	1
980	CGD is a genetically @DISEASE$ disease with an X-linked recessive (XR-CGD) form caused by mutations in the superoxide metabolic process (OMIM #300481) gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the cytochrome complex assembly (OMIM #608508), @GENE$ (OMIM #608512), NCF2 (OMIM #608515) and NCF4 (OMIM #601488) genes encoding p22(phox), p47(phox), p67(phox) and p40(phox), respectively.	1
981	CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the superoxide metabolic process (OMIM #300481) gene encoding the gp91(phox) protein, and an @DISEASE$ (AR-CGD) form caused by mutations in the @GENE$ (OMIM #608508), protein targeting to membrane (OMIM #608512), NCF2 (OMIM #608515) and NCF4 (OMIM #601488) genes encoding p22(phox), p47(phox), p67(phox) and p40(phox), respectively.	1
982	CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the superoxide metabolic process (OMIM #300481) gene encoding the gp91(phox) protein, and an @DISEASE$ (AR-CGD) form caused by mutations in the cytochrome complex assembly (OMIM #608508), @GENE$ (OMIM #608512), NCF2 (OMIM #608515) and NCF4 (OMIM #601488) genes encoding p22(phox), p47(phox), p67(phox) and p40(phox), respectively.	1
983	Taken together, these results suggest the implication of @GENE$ in a new @DISEASE$ MCA.	1
984	Here, integrated analysis of gene expression in non-small cell lung cancer revealed that @GENE$ expression is significantly correlated with increased @DISEASE$ size and regional lymph node spread, as well as shorter overall survival (OS) and disease-free survival (DFS).	1
985	<i>@GENE$</i> methylation was frequently detected in ESCC tumors and correlated with lymph node metastasis, @DISEASE$ recurrence and progression, with <i>DLEC1</i> as the most frequently methylated among the established 3p22.2 tumor suppressors (<i>RASSF1A, PLCD1</i> and <i>ZMYND10/BLU</i>).	1
986	Mutations in the Pejvakin (@GENE$) gene cause autosomal recessive @DISEASE$ DFNB59 with audiological features of auditory neuropathy spectrum disorder (ANSD) or cochlear dysfunction.	1
987	Mutations in the Pejvakin (@GENE$) gene cause @DISEASE$ hearing loss DFNB59 with audiological features of auditory neuropathy spectrum disorder (ANSD) or cochlear dysfunction.	1
988	By contrast, loss of @GENE$ in adult OHCs causes a slowly progressive @DISEASE$ associated with OHC degeneration and delayed loss of inner hair cells (IHCs), indicating a primary role for pejvakin in regulating OHC function and survival.	1
989	Here, we demonstrate that mice with conditional ablation of the @GENE$ gene in all sensory hair cells or only in outer hair cells (OHCs) show similar auditory phenotypes with early-onset profound @DISEASE$.	1
990	Here, we demonstrate that mice with conditional ablation of the @GENE$ gene in all sensory hair cells or only in outer hair cells (OHCs) show similar auditory phenotypes with early-onset @DISEASE$ hearing loss.	1
991	Moreover, we confirmed that knockdown of @GENE$ could inhibit @DISEASE$ growth in vivo.	1
992	Biotinidase (@GENE$) deficiency is a rare @DISEASE$ metabolic disease, which develops neurological and cutaneous symptoms because of the impaired biotin recycling.	1
993	The SNPs rs2124437 (@GENE$), rs1335022 (GRIK2), rs4512367 (G protein-coupled receptor signaling pathway), rs4748011 (negative regulation of tumor necrosis factor-mediated signaling pathway), and rs1435218 (LNX1) were analyzed in 500 histopathologically confirmed oral @DISEASE$s and 500 healthy controls with a minimum of 10 years of tobacco usage.	1
994	The SNPs rs2124437 (MAPK cascade), rs1335022 (GRIK2), rs4512367 (@GENE$), rs4748011 (negative regulation of tumor necrosis factor-mediated signaling pathway), and rs1435218 (LNX1) were analyzed in 500 histopathologically confirmed oral @DISEASE$s and 500 healthy controls with a minimum of 10 years of tobacco usage.	1
995	The SNPs rs2124437 (MAPK cascade), rs1335022 (GRIK2), rs4512367 (G protein-coupled receptor signaling pathway), rs4748011 (@GENE$), and rs1435218 (LNX1) were analyzed in 500 histopathologically confirmed oral @DISEASE$s and 500 healthy controls with a minimum of 10 years of tobacco usage.	1
996	In contrast, patients with the non-hereditary Carney triad, including paraganglioma, GIST, and @DISEASE$, usually lack germline @GENE$ mutations and instead show epigenetic SDH complex inactivation through SDHC promoter methylation.	1
997	<b>Conclusions:</b> The expression of @GENE$ in human @DISEASE$ is positively correlated with the malignant grade of glioma, which may be involved in the malignant progression of glioma by EMT	1
998	Real-time fluorescence quantitative PCR and Western blot were used to detect the expression level of @GENE$ mRNA and protein in 61 cases of fresh @DISEASE$ tissue (WHO grade Ⅱ 16 cases, Ⅲ 21 cases, Ⅳ 24 cases) and 12 cases of adjacent tissues, and the expression levels of E-cadherin, N-cadherin and vimentin were also investigated in fresh glioma tissue.	1
999	<b>Methods:</b> Using immunohistochemical method detected the expression level of @GENE$ in 60 cases of gliomas (including WHO grades Ⅱ, Ⅲ and Ⅳ, each for 20 cases) and 20 cases of non-@DISEASE$ brain tissues.	1
1000	The percentages of @GENE$ expression were 75% (15/20), 95% (19/20), and 100% (20/20) in the WHO gradesⅡ, Ⅲ and Ⅳ @DISEASE$s, respectively.	1
1001	Detection of key protein expression in EMT by Western blot displayed that the expression of E-cadherin was negatively associated with @GENE$ in @DISEASE$ (<i>r</i>=-0.972, <i>P</i>&lt;0.01).	1
1002	Global-genome nucleotide excision repair (GG-@GENE$) prevents ultraviolet (UV) light-induced skin @DISEASE$ by removing mutagenic cyclobutane pyrimidine dimers (CPDs).	1
1003	MIB1/@GENE$-67 was low and highlighted 4%-5% @DISEASE$ nuclei.	1
1004	This phenotypic variability should be taken into account when treating patients with @GENE$-associated @DISEASE$.	1
1005	Recessive mutations in @GENE$ cause lethal neonatal rigidity and multifocal seizure syndrome, a phenotype characterized by neonatal microcephaly, hypertonia, and refractory @DISEASE$ with premature death by age 2 years.	1
1006	Here, we report two affected siblings with compound heterozygous truncating mutations in @GENE$ and intra-familial phenotypic @DISEASE$, with a less severe disease course in the female sibling.	1
1007	Moreover, we demonstrated that pharmacological inhibition of 15-PGDH enhanced @GENE$ expression, leading to depletion of all-trans retinoic acid (ATRA) and expansion of the ALDH1-positive subset in both human PDAC cells and @DISEASE$ cells of Kras<sup>LSL-G12D/+</sup>; Ptf1a<sup>Cre/+</sup> (KC) mice.	1
1008	Here, we found that 15-@GENE$ expression was inversely correlated with oxidation-reduction process, an important @DISEASE$ stem cell-associated marker indicative of poor prognosis in humans.	0
1009	Here, we found that 15-L-serine biosynthetic process expression was inversely correlated with @GENE$, an important @DISEASE$ stem cell-associated marker indicative of poor prognosis in humans.	1
1010	Blood and tissue samples from 48 @DISEASE$ patients were obtained, and the following polymorphisms were analyzed; @GENE$ 80G&gt;A, DHFR 829C&gt;T, MTHFR 677C&gt;T, MTHFR 1298A&gt;C, and ATIC 347C&gt;G.	1
1011	Genes involved in tissue development, differentiation, and oncogenesis such as DNAJA4, @GENE$, IRX1, BMP8A, GATA4, negative regulation of transcription by RNA polymerase II, regulation of transcription by RNA polymerase II, and regulation of erythrocyte differentiation were hypermethylated in both RMS cell lines and primary samples, implicating aberrant DNA methylation in the pathogenesis of @DISEASE$.	0
1012	Genes involved in tissue development, differentiation, and oncogenesis such as DNAJA4, cartilage development, IRX1, BMP8A, GATA4, @GENE$, regulation of transcription by RNA polymerase II, and regulation of erythrocyte differentiation were hypermethylated in both RMS cell lines and primary samples, implicating aberrant DNA methylation in the pathogenesis of @DISEASE$.	0
1013	Genes involved in tissue development, differentiation, and oncogenesis such as DNAJA4, cartilage development, IRX1, BMP8A, GATA4, negative regulation of transcription by RNA polymerase II, @GENE$, and regulation of erythrocyte differentiation were hypermethylated in both RMS cell lines and primary samples, implicating aberrant DNA methylation in the pathogenesis of @DISEASE$.	0
1014	Genes involved in tissue development, differentiation, and oncogenesis such as DNAJA4, cartilage development, IRX1, BMP8A, GATA4, negative regulation of transcription by RNA polymerase II, regulation of transcription by RNA polymerase II, and @GENE$ were hypermethylated in both RMS cell lines and primary samples, implicating aberrant DNA methylation in the pathogenesis of @DISEASE$.	0
1015	@GENE$ mutations are one cause of @DISEASE$ RP making the CNGB1 mutant dog a valuable large animal model of the condition	1
1016	This study demonstrates that @GENE$ and regulation of double-strand break repair via homologous recombination are indicators of poor prognosis for @DISEASE$s and that CSNK2A1-mediated phosphorylation of SIRT6 might be involved in the progression of breast carcinoma	1
1017	This study demonstrates that peptidyl-serine phosphorylation and @GENE$ are indicators of poor prognosis for @DISEASE$s and that CSNK2A1-mediated phosphorylation of SIRT6 might be involved in the progression of breast carcinoma	1
1018	Though using the term gray platelets for @GENE$ deficiency has been debated, a reduced number of α-granules has been described for @DISEASE$ due to <i>GATA1</i> mutations.	1
1019	Biallelic mutations in @GENE$ have been identified as responsible for cases of @DISEASE$ Leigh syndrome associated with mitochondrial complex I deficiency.	1
1020	Next, we show that @GENE$ functions as a @DISEASE$ suppressor in GBM.	1
1021	The fetus inherited an additional likely pathogenic novel missense change to a second MKS gene, @GENE$; p.R2210C, suggesting @DISEASE$ in this disorder	1
1022	<b>Objective:</b> To investigate the genotype-phenotype correlation in Chinese familial hypertrophic @DISEASE$ (HCM )focusing on the cardiac troponin C gene @GENE$ c.	1
1023	As it is currently unclear whether localized production of either H<sub>2</sub>S or GSH contributes to retinal homeostasis, we undertook a comparative analysis of @GENE$ and CSE expression in canine, non-human primate (NHP) and human retinas to determine if these antioxidants could play a regulatory role in age-related or disease-associated @DISEASE$.	1
1024	However, only recently have genetic studies demonstrated sequence variation in @GENE$ and HCN2 genes associated with human @DISEASE$.	1
1025	A plethora of human diseases are associated with mutations in the genes encoding human SLC26 transporters, including chondrodysplasias with varying severity in @GENE$ (~50 mutations, 27 point mutations), congenital chloride-losing diarrhea in SLC26A3 (~70 mutations, 31 point mutations) and Pendred Syndrome or @DISEASE$ autosomal recessive type 4 in SLC26A4 (~500 mutations, 203 point mutations).	0
1026	Of the genes detected out, @GENE$ gene mutation was with significant difference (χ<sup>2</sup> = 75.132, p = 0.000) between audio-no-pass group (417/1315, 31.711%) and random-selected cohort (159/1000, 15.900%); c.109G &gt; A was the most common allele, as well as the only one with significantly different allele frequency (χ<sup>2</sup> = 79.327, p = 0.000) between audio-no-pass group (392/1315, 16.84%) and random-selected cohort (140/1000, 7.55%), which suggested c.109G &gt; A mutation was critical for newborns' @DISEASE$.	0
1027	Because of the distinct @DISEASE$ and the hearing loss a @GENE$ mutation was taken into account.	1
1028	We have generated four thyroid @DISEASE$ cell lines with a greater than 30-fold increase in acquired resistance to the @GENE$ inhibitor dasatinib.	1
1029	We specifically discuss the role of @GENE$ in the regulation of cell proliferation and survival within the context of the identified target genes, its interaction with viral oncogenes, and its association with the TP53 @DISEASE$ suppressor and MYC oncogene.	1
1030	Special attention is given to p53-independent SALL2 regulation of pro-apoptotic genes @GENE$ and PMAIP1, and the implication of these findings on the apoptotic response of @DISEASE$ cells to therapy.	1
1031	Hence, this previously unknown @GENE$/Brg1 signaling axis provides the molecular basis and the rationale to target Brg1 in FBW7-compromised human gastric @DISEASE$s	1
1032	In keeping with a @DISEASE$ suppressive role of FBW7 in human gastric cancer, we find an inverse correlation between FBW7 and @GENE$ expression in human gastric cancer clinical samples.	1
1033	In keeping with a tumor suppressive role of FBW7 in human gastric @DISEASE$, we find an inverse correlation between FBW7 and @GENE$ expression in human gastric cancer clinical samples.	1
1034	A panel of hypermethylated genes including APC, CSPG2, @GENE$, visual perception, HOXA9, pyruvate metabolic process, cardiac cell fate determination, JAK3, regulation of transcription, DNA-templated, SOX1, and negative regulation of transcription, DNA-templated predicted @DISEASE$-specific survival and SOX1 (HR = 3.46), PITX2 (HR = 4.17), CSPG2 (HR = 5.35), and JAK3 hypermethylation (HR = 0.19) did so independently.	1
1035	A panel of hypermethylated genes including APC, CSPG2, neuron development, @GENE$, HOXA9, pyruvate metabolic process, cardiac cell fate determination, JAK3, regulation of transcription, DNA-templated, SOX1, and negative regulation of transcription, DNA-templated predicted @DISEASE$-specific survival and SOX1 (HR = 3.46), PITX2 (HR = 4.17), CSPG2 (HR = 5.35), and JAK3 hypermethylation (HR = 0.19) did so independently.	1
1036	A panel of hypermethylated genes including APC, CSPG2, neuron development, visual perception, HOXA9, @GENE$, cardiac cell fate determination, JAK3, regulation of transcription, DNA-templated, SOX1, and negative regulation of transcription, DNA-templated predicted @DISEASE$-specific survival and SOX1 (HR = 3.46), PITX2 (HR = 4.17), CSPG2 (HR = 5.35), and JAK3 hypermethylation (HR = 0.19) did so independently.	1
1037	A panel of hypermethylated genes including APC, CSPG2, neuron development, visual perception, HOXA9, pyruvate metabolic process, @GENE$, JAK3, regulation of transcription, DNA-templated, SOX1, and negative regulation of transcription, DNA-templated predicted @DISEASE$-specific survival and SOX1 (HR = 3.46), PITX2 (HR = 4.17), CSPG2 (HR = 5.35), and JAK3 hypermethylation (HR = 0.19) did so independently.	1
1038	A panel of hypermethylated genes including APC, CSPG2, neuron development, visual perception, HOXA9, pyruvate metabolic process, cardiac cell fate determination, JAK3, @GENE$, SOX1, and negative regulation of transcription, DNA-templated predicted @DISEASE$-specific survival and SOX1 (HR = 3.46), PITX2 (HR = 4.17), CSPG2 (HR = 5.35), and JAK3 hypermethylation (HR = 0.19) did so independently.	1
1039	A panel of hypermethylated genes including APC, CSPG2, neuron development, visual perception, HOXA9, pyruvate metabolic process, cardiac cell fate determination, JAK3, regulation of transcription, DNA-templated, SOX1, and @GENE$ predicted @DISEASE$-specific survival and SOX1 (HR = 3.46), PITX2 (HR = 4.17), CSPG2 (HR = 5.35), and JAK3 hypermethylation (HR = 0.19) did so independently.	1
1040	Further experiments demonstrated that the MYEOV ceRNA sequestered @GENE$-30c-2-3p from binding its targets TGFBR2 and USP15 mRNAs, which in turn leading to constitutive activation of TGF-β signaling and @DISEASE$ progression in NSCLC.	1
1041	The glutamatergic hypothesis of @DISEASE$ lead recently to a first successful mGlu2/3 receptor agonistic drug and is underpinned by significant findings in genes regulating the glutamatergic system (SLC1A6, SLC1A2 GRIN1, GRIN2A, GRIA1, ventricular trabecula myocardium morphogenesis, @GENE$, DTNBP1, DAAO, G72/30, GRM3).	1
1042	The glutamatergic hypothesis of @DISEASE$ lead recently to a first successful mGlu2/3 receptor agonistic drug and is underpinned by significant findings in genes regulating the glutamatergic system (SLC1A6, SLC1A2 GRIN1, GRIN2A, GRIA1, @GENE$, signal transduction, DTNBP1, DAAO, G72/30, GRM3).	1
1043	Empty spiracles homeobox 2 (@GENE$) is a homeodomain-containing transcription factor that plays an essential role in @DISEASE$igenesis.	1
1044	Global <i>@GENE$</i> gene deletion or conditional inactivation in Nestin-positive cells led to formation of supratentorial @DISEASE$ in the early postnatal period.	1
1045	<i>LCAM1</i> and <i>@GENE$</i> (<i>MUPP1</i>) are the only known human gene loci associated with non-syndromic @DISEASE$.	1
1046	Expression of miR-17-92a miRNAs improved sensitivity of androgen dependent LNCaP 104-S prostate @DISEASE$ cells to anti-androgen drug Casodex, @GENE$ inhibitor MK-2206 2HCl, and docetaxel.	0
1047	Our study identifies WDR4 as an oncoprotein that negatively regulates @GENE$ via ubiquitination to promote lung cancer progression by fostering an immunosuppressive and prometastatic @DISEASE$ microenvironment, suggesting the potential of immune-modulatory approaches for treating lung cancer with aberrant PML degradation	1
1048	The WDR4/PML axis induces a set of cell-surface or secreted factors, including CD73, urokinase-type plasminogen activator receptor (uPAR), and serum amyloid A2 (@GENE$), which elicit paracrine effects to stimulate migration, invasion, and metastasis in multiple lung @DISEASE$ models.	1
1049	@GENE$ overexpression promotes tumorigenesis and is associated with poor prognosis in several @DISEASE$s.	1
1050	The high levels of @GENE$ expression in gastric GISTs was significantly associated with @DISEASE$ size (P &lt; .001), multivisceral resection (P = .006), metastasis at initial diagnosis (P = .006), mitotic count (P = .002) and NIH risk classification (P = .015).	1
1051	In particular, the @GENE$, SPTA1 and VPS13B genes were commonly mutated in both early and late stage @DISEASE$, primary tumors and metastases, and tumors before and after chemotherapy, as in the case of the TP53 and RB1 genes.	1
1052	Recent GWAS completed for three types of common adult-onset @DISEASE$ have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, epithelial to mesenchymal transition, FNDC3B, G protein-coupled receptor signaling pathway, cell cycle arrest, FOXC1, ATXN2, cell redox homeostasis); PACG (primary angle-closure glaucoma (EPDR1, phosphatidylcholine biosynthetic process, @GENE$, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).	1
1053	Recent GWAS completed for three types of common adult-onset @DISEASE$ have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, epithelial to mesenchymal transition, FNDC3B, G protein-coupled receptor signaling pathway, cell cycle arrest, FOXC1, ATXN2, cell redox homeostasis); PACG (primary angle-closure glaucoma (EPDR1, @GENE$, negative regulation of transcription by RNA polymerase II, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).	1
1054	Recent GWAS completed for three types of common adult-onset @DISEASE$ have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, @GENE$, FNDC3B, G protein-coupled receptor signaling pathway, cell cycle arrest, FOXC1, ATXN2, cell redox homeostasis); PACG (primary angle-closure glaucoma (EPDR1, phosphatidylcholine biosynthetic process, negative regulation of transcription by RNA polymerase II, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).	1
1055	Recent GWAS completed for three types of common adult-onset @DISEASE$ have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, epithelial to mesenchymal transition, FNDC3B, G protein-coupled receptor signaling pathway, @GENE$, FOXC1, ATXN2, cell redox homeostasis); PACG (primary angle-closure glaucoma (EPDR1, phosphatidylcholine biosynthetic process, negative regulation of transcription by RNA polymerase II, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).	1
1056	Recent GWAS completed for three types of common adult-onset @DISEASE$ have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, epithelial to mesenchymal transition, FNDC3B, G protein-coupled receptor signaling pathway, cell cycle arrest, FOXC1, ATXN2, @GENE$); PACG (primary angle-closure glaucoma (EPDR1, phosphatidylcholine biosynthetic process, negative regulation of transcription by RNA polymerase II, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).	1
1057	Recent GWAS completed for three types of common adult-onset @DISEASE$ have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, epithelial to mesenchymal transition, FNDC3B, @GENE$, cell cycle arrest, FOXC1, ATXN2, cell redox homeostasis); PACG (primary angle-closure glaucoma (EPDR1, phosphatidylcholine biosynthetic process, negative regulation of transcription by RNA polymerase II, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).	1
1058	Recent studies have suggested possible therapeutic targets for some patients with early-onset @DISEASE$ based on the molecular and cellular events caused by MYOC, @GENE$ and TBK1 mutations.	1
1059	Currently the only established high penetrance familial @DISEASE$ genes are @GENE$ and CDK4.	1
1060	The classical mammalian isoforms of PLD are PLD1 and @GENE$, and the levels of both mRNA were higher at the primary @DISEASE$ sites than in normal kidney tissues.	1
1061	Notably, shRNA-mediated knockdown of @GENE$ suppressed the growth and invasion of @DISEASE$s in nude mouse xenograft models.	1
1062	As for genes relating to the @DISEASE$ invasion of PLD2, we found that angiogenin (@GENE$) was positively regulated by PLD2.	0
1063	We will systematically examine seven genes (CHN1, MDH1, PCP4, @GENE$, SLC14A1, SNAP25 and VSNL1) that are altered in the three @DISEASE$.	1
1064	The therapeutic strategy to recover immune function through the restoration of impaired Tregs function with the mounting evidences regarding @GENE$ in autoimmune mediated disorder (MS, SLE, RA, T1D) suggest as working hypothesis the direct targeting KRAS activation using @DISEASE$-derived small molecules may be clinically relevant	0
1065	In order to investigate whether somatic @GENE$ gene mutations play a role in @DISEASE$ pediatric myeloproliferative diseases, we performed a mutation screening of a large representative cohort of pediatric acute myeloid leukemia, myeloid leukemia of Down syndrome, and juvenile myelomonocytic leukemia samples and show that gain-of-function THPO mutations are extremely rare in sporadic pediatric myeloproliferative diseases	1
1066	We summarize recent updates on the genes and related clinical syndromes involved in the pathogenesis of early-onset @DISEASE$: Aristaless-related homeobox (ARX), cyclin-dependent kinase-like 5 (regulation of postsynapse organization), syntaxin-binding protein 1 (STXBP1), solute carrier family 25 member 22 (SLC25A22), nonerythrocytic α-spectrin-1 (SPTAN1), phospholipase Cβ1 (PLCβ1), membrane-associated guanylate kinase inverted-2 (positive regulation of receptor internalization), polynucleotide kinase 3'-phosphatase (PNKP), sodium channel neuronal type 1α subunit (SCN1A), protocadherin 19 (@GENE$), and pyridoxamine 5-prime-phosphate oxidase (PNPO)	1
1067	We summarize recent updates on the genes and related clinical syndromes involved in the pathogenesis of early-onset @DISEASE$: Aristaless-related homeobox (ARX), cyclin-dependent kinase-like 5 (@GENE$), syntaxin-binding protein 1 (STXBP1), solute carrier family 25 member 22 (SLC25A22), nonerythrocytic α-spectrin-1 (SPTAN1), phospholipase Cβ1 (PLCβ1), membrane-associated guanylate kinase inverted-2 (positive regulation of receptor internalization), polynucleotide kinase 3'-phosphatase (PNKP), sodium channel neuronal type 1α subunit (SCN1A), protocadherin 19 (homophilic cell adhesion via plasma membrane adhesion molecules), and pyridoxamine 5-prime-phosphate oxidase (PNPO)	1
1068	We summarize recent updates on the genes and related clinical syndromes involved in the pathogenesis of early-onset @DISEASE$: Aristaless-related homeobox (ARX), cyclin-dependent kinase-like 5 (regulation of postsynapse organization), syntaxin-binding protein 1 (STXBP1), solute carrier family 25 member 22 (SLC25A22), nonerythrocytic α-spectrin-1 (SPTAN1), phospholipase Cβ1 (PLCβ1), membrane-associated guanylate kinase inverted-2 (@GENE$), polynucleotide kinase 3'-phosphatase (PNKP), sodium channel neuronal type 1α subunit (SCN1A), protocadherin 19 (homophilic cell adhesion via plasma membrane adhesion molecules), and pyridoxamine 5-prime-phosphate oxidase (PNPO)	1
1069	Overall, our results define an oncogenic role of <i>pancEts-1</i> in @DISEASE$ progression through @GENE$-mediated β-catenin stabilization, with potential implications for the clinical therapeutics of neuroblastoma.<b>Significance:</b> These findings reveal the oncogenic functions of a long noncoding RNA in neuroblastoma progression, offering a potential target for clinical therapeutics.	1
1070	Both <i>pancEts-1</i> and <i>@GENE$</i> were upregulated in clinical @DISEASE$ tissues, and were associated with unfavorable outcome of patients.	1
1071	Meier-Gorlin syndrome (MGS) is a genetically @DISEASE$ primordial dwarfism syndrome known to be caused by biallelic loss-of-function mutations in one of five genes encoding pre-replication complex proteins: ORC1, DNA replication initiation, @GENE$, CDT1, and CDC6.	1
1072	Meier-Gorlin syndrome (MGS) is a genetically @DISEASE$ primordial dwarfism syndrome known to be caused by biallelic loss-of-function mutations in one of five genes encoding pre-replication complex proteins: ORC1, @GENE$, negative regulation of cell division, CDT1, and CDC6.	1
1073	Multiple @DISEASE$ syndrome 1 (MMDS1) arises as a result of the missense mutation in @GENE$, an Fe/S cluster scaffold protein, which substitutes a glycine near the Fe/S cluster-binding pocket to a cysteine (p.Gly208Cys).	1
1074	Retrospectively study revealed that @GENE$-34a expression was downregulated in human primary GC tissues compared with non-@DISEASE$ tissues and low miR-34a expression was associated with a significantly shorter overall survival and disease-free survival.	1
1075	However, the relationship between @GENE$-34a and luteolin's susceptibility to @DISEASE$ cells still remains unclear.	1
1076	This case unravels a previously unrecognized phenotype of camptodactyly due to a significant skeletal deformity of PRS with a @DISEASE$ @GENE$ mutation of hexanucleotide duplication.	1
1077	The @GENE$ pathway was significantly associated with overall and estrogen receptor-negative (ER-) breast @DISEASE$ risk (P = 0.003 and 0.03, respectively).	1
1078	@GENE$ (Padj = 0.0018) and RPS6KA3 (Padj = 0.061) were the leading genes for the associations with overall breast @DISEASE$ risk and ER- breast cancer risk, respectively.	1
1079	@GENE$ expression is lost in colonic malignancies, indicating that the CaSR is a biomarker for colonic @DISEASE$ progression.	1
1080	More important, @GENE$ haploinsufficiency markedly increased the incidence and severity of abdominal @DISEASE$, and caused aortic arch ruptures and dissections, indicating that α2(V) chain deficits may play roles in these pathologies in humans	1
1081	We aimed to investigate the effect of the AS to @GENE$ gene on non-small cell lung @DISEASE$ (NSCLC) development.	1
1082	By GEPIA database analysis, we also found that the expression of lncRNA FEZF-AS1 and @GENE$ were significantly higher in @DISEASE$ tissues than those of the adjacent non-cancerous tissues in 969 NSCLC patients (P &lt; 0.05), and lncRNA FEZF-AS1 was positively correlated with FEZF1 (r = 0.90, P &lt; 0.001).	1
1083	A systematic study of serial samples from 30 patients show that ASXL1 c.1934dupG is a @DISEASE$ in haematological neoplasms including MDS, AML, MPN and MDS/MPN and often is associated with somatic mutations of 5-methylcytosine catabolic process, negative regulation of transcription by RNA polymerase II, IDH2, hemopoiesis, @GENE$ and DNMT3A.	1
1084	A systematic study of serial samples from 30 patients show that ASXL1 c.1934dupG is a @DISEASE$ in haematological neoplasms including MDS, AML, MPN and MDS/MPN and often is associated with somatic mutations of @GENE$, negative regulation of transcription by RNA polymerase II, IDH2, hemopoiesis, Ras protein signal transduction and DNMT3A.	1
1085	A systematic study of serial samples from 30 patients show that ASXL1 c.1934dupG is a @DISEASE$ in haematological neoplasms including MDS, AML, MPN and MDS/MPN and often is associated with somatic mutations of 5-methylcytosine catabolic process, negative regulation of transcription by RNA polymerase II, IDH2, @GENE$, Ras protein signal transduction and DNMT3A.	1
1086	A systematic study of serial samples from 30 patients show that ASXL1 c.1934dupG is a somatic mutation in haematological @DISEASE$ including MDS, AML, MPN and MDS/MPN and often is associated with somatic mutations of 5-methylcytosine catabolic process, @GENE$, IDH2, hemopoiesis, Ras protein signal transduction and DNMT3A.	0
1087	When stratified by @DISEASE$ histology, three SNPs (ENO1 rs2274971A &gt; G, PFKM rs11168417C &gt; T, and @GENE$ rs3785921G &gt; A) were significantly associated with OS and/or DFS only in squamous cell carcinoma, whereas canonical glycolysis rs1132173C &gt; T exhibited a significant association with survival outcomes only in adenocarcinoma.	0
1088	When stratified by @DISEASE$ histology, three SNPs (ENO1 rs2274971A &gt; G, PFKM rs11168417C &gt; T, and cellular response to reactive oxygen species rs3785921G &gt; A) were significantly associated with OS and/or DFS only in squamous cell carcinoma, whereas @GENE$ rs1132173C &gt; T exhibited a significant association with survival outcomes only in adenocarcinoma.	0
1089	When stratified by tumor histology, three SNPs (ENO1 rs2274971A &gt; G, PFKM rs11168417C &gt; T, and @GENE$ rs3785921G &gt; A) were significantly associated with OS and/or DFS only in @DISEASE$, whereas canonical glycolysis rs1132173C &gt; T exhibited a significant association with survival outcomes only in adenocarcinoma.	1
1090	Hypermethylated in @DISEASE$ 1 (@GENE$) is frequently deleted or epigenetically silenced in various human cancers.	1
1091	The results provide evidence that lncRNA-numb is a newly proposed @DISEASE$ suppressor that is involved in @GENE$-induced phenotypes.	0
1092	In this study, we present a male child demonstrating recurrent febrile episodes, @DISEASE$, and basal ganglia calcification suggestive of Aicardi-Goutières syndrome, who carries the same Arg822Gln mutation in @GENE$ previously associated with SMS.	1
1093	De novo missense and frameshift mutations and deletions involving @GENE$ have been described in patients with intellectual disability and @DISEASE$, but without any of the dysmorphic findings or malformations associated with Pierpont syndrome, implying a mutation-specific mechanism for the pathogenicity of p.Tyr446Cys.	1
1094	Here, we report mutations in @GENE$, which encodes an enzyme in the proline biosynthesis pathway, as the cause of a unique syndrome characterized by postnatal @DISEASE$, hypomyelination, and reduced cerebral white-matter volume.	1
1095	@GENE$, a critical transcription factor involved in the development of the mammary gland, also plays important roles in mammary @DISEASE$igenesis by regulating transcription in coordination with two essential DNA repair factors, PARP1 and BRCA1.	1
1096	In addition, through data mining analysis, we observed an extremely strong correlation between the expression levels of GATA3 and @GENE$ in para@DISEASE$, but the correlation turned insignificant in mammary tumors.	1
1097	Using vectors encoding @GENE$ with mutations frequently occurring in mammary @DISEASE$, we found that several mutations on GATA3 led to a dysregulation of CtIP, and therefore HR repair.	1
1098	Multivariate analysis data revealed that @GENE$ and protein phosphorylation protein expression were independent predictors of overall survival of ESCC patients after chemotherapy and/or radiotherapy (P &lt; .05).ERCC1 overexpression is an important phenotype that is associated with ESCC lymph node metastasis and advanced @DISEASE$ clinical stages.	0
1099	Multivariate analysis data revealed that nucleotide-excision repair and @GENE$ protein expression were independent predictors of overall survival of ESCC patients after chemotherapy and/or radiotherapy (P &lt; .05).ERCC1 overexpression is an important phenotype that is associated with ESCC lymph node metastasis and advanced @DISEASE$ clinical stages.	0
1100	@GENE$ overexpression associated with advanced @DISEASE$ clinical stage and lymph node metastasis (P &lt; .05), but not with tumor size, depth of invasion, or differentiation (P &gt; .05).	1
1101	Using homozygosity mapping followed by exome sequencing, we identified a Thr224Asn mutation in the @GENE$ gene in infants from consanguineous families who suffered from life-threatening neutropenia, which was refractory to granulocyte CSF, from @DISEASE$ and myelofibrosis.	1
1102	Importantly, cell line and animal experiments both confirmed that E2F6 promotes ovarian @DISEASE$ stemness, whereas E2F6 or @GENE$ depletion derepressed miR-193a, which opposes cancer stemness, by alleviating DNA methylation and repressive chromatin.	0
1103	To decipher a mechanism for this, we previously generated a mathematical model of how estrogen-mediated upregulation of the transcription factor, E2F6, upregulates the ovarian cancer stem/initiating cell marker, @GENE$, by epigenetic silencing the @DISEASE$ suppressor miR-193a, and a competing endogenous (ceRNA) mechanism.	1
1104	We found that @GENE$ was amplified in 11% and/or overexpressed in 15% of breast tumors, and overexpression of MYST3 correlated with worse clinical outcome in estrogen receptor+ (ER+) breast @DISEASE$s.	0
1105	Our study shows that in @DISEASE$, negative regulation of transcription by RNA polymerase II- or @GENE$-based PI provides valuable prognostic information and high PI indicates aggressive disease	0
1106	Our study shows that in @DISEASE$, @GENE$- or negative regulation of DNA replication-based PI provides valuable prognostic information and high PI indicates aggressive disease	0
1107	By whole-exome sequencing, recessive protein-truncating mutations in @GENE$ were found in seven unrelated families that show a range of clinical phenotypes, including retinal degeneration, brachydactyly, craniofacial abnormalities, @DISEASE$, and neurological defects.	1
1108	By whole-exome sequencing, recessive protein-truncating mutations in @GENE$ were found in seven unrelated families that show a range of clinical phenotypes, including @DISEASE$, brachydactyly, craniofacial abnormalities, short stature, and neurological defects.	1
1109	Remarkably, variable expressivity of the human phenotype can be recapitulated in @GENE$ mutant mouse models, with significant embryonic lethality and severe phenotypes in the complete knockout mice while mice with a partial loss-of-function allele mimic the isolated @DISEASE$ phenotype.	1
1110	The abnormal regulation of @GENE$-483 may play an important role in @DISEASE$igenesis, and G protein-coupled receptor signaling pathway is known to regulate cell polarity, cell migration, and cell division.	1
1111	The abnormal regulation of protein polyubiquitination-483 may play an important role in @DISEASE$igenesis, and @GENE$ is known to regulate cell polarity, cell migration, and cell division.	0
1112	<i>Results:</i> The number of positive cells of @GENE$ and regulation of cell cycle in malignant melanoma @DISEASE$ tissues was significantly higher than that in melanocytic nevi tissues, and the expression of both proteins was positively correlated with malignant melanoma (r = 0.687, P &lt;0.01); TAZ and YAP protein expression in malignant melanoma tissue was significantly correlated with tumor thickness, invasive depth grade, lymph node metastasis and TNM stages (P &lt;0.05), and increased with TNM staging.	1
1113	<i>Results:</i> The number of positive cells of positive regulation of cell proliferation and @GENE$ in malignant melanoma @DISEASE$ tissues was significantly higher than that in melanocytic nevi tissues, and the expression of both proteins was positively correlated with malignant melanoma (r = 0.687, P &lt;0.01); TAZ and YAP protein expression in malignant melanoma tissue was significantly correlated with tumor thickness, invasive depth grade, lymph node metastasis and TNM stages (P &lt;0.05), and increased with TNM staging.	1
1114	Few studies have examined the roles of @GENE$ and GATA4 in @DISEASE$ or their association with pulmonary artery histopathology.	1
1115	The melanogenic activity of 6-benzylaminopurine, the compound identified as the most potent, was further verified by measuring green fluorescent protein concentration in @GENE$ a: eGFP (tyrosinase-related protein 1) zebrafish and mitfa: eGFP (@DISEASE$ associated transcription factor) zebrafish and antioxidative activity.	0
1116	Here, we applied next-generation sequencing in 89 patients with a clinical diagnosis of @DISEASE$, analyzing the prevalence of genetic defects in SLC4A1, ATP6V0A4, and @GENE$ genes and the clinical phenotype.	1
1117	Cerebellar involvement is an important feature of @GENE$-CDG, the congenital @DISEASE$ due to dystroglycanopathy, and polyprenol catabolic process-CDG.	0
1118	Cerebellar involvement is an important feature of protein glycosylation-CDG, the congenital @DISEASE$ due to dystroglycanopathy, and @GENE$-CDG.	0
1119	Double-labeling immunohistochemistry for Pit-1/GH, Pit-1/NFP, Pit-1/MAP2, and @GENE$/GH was performed in 9/10 @DISEASE$.	1
1120	We investigate the association of @GENE$ with castration-resistant prostate @DISEASE$ (CRPC), bone metastasis, and PC recurrence.	1
1121	Logistic regression analysis adjusted for age and gender reported a moderate association between rectal @DISEASE$ risk and two @GENE$ SNPs, rs1684575 T&gt;G (OR: 1.60, 95% CI: 1.13-2.27, recessive model) and rs3751710 (OR: 0.70, 95% CI: 0.51-0.96, dominant model).	1
1122	Constitutive activation of interferon signaling pathways has been reported in colorectal @DISEASE$ (CRC), leading to a strong CD8+ T cell response through stimulation of @GENE$ expression.	0
1123	Additionally, @GENE$ increases the metastatic ability of a @DISEASE$ by enhancing cell migration, matrix metalloproteinase-7 expression and EMT.	1
1124	Inflammatory chemokine @GENE$, present in large amounts in DCs isolated from colon @DISEASE$ patients, and SW620-conditioned TADCs, enhance CSC characteristics in cancer, supported by enhanced anchorage-independent growth, CD133 expression and aldehyde dehydrogenase activity.	1
1125	Transcriptome analysis of @GENE$-treated SW620 cells indicates that CXCL1 increases potential oncogene expression in colon @DISEASE$, including <i>PTHLH</i>, <i>TYRP1</i>, <i>FOXO1</i>, <i>TCF4</i> and <i>ZNF880</i>.	1
1126	WES also unraveled pathogenic mutations in genes not commonly linked to FTD, including mutations in Alzheimer (PSEN1, PSEN2), lysosomal (CTSF, 7-exon macro-deletion) and cholesterol homeostasis pathways (@GENE$).ConclusionOur unbiased approach reveals a wide genetic spectrum underlying clinical FTD, including 11% of seemingly @DISEASE$ FTD.	0
1127	These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes CDSN, @GENE$ and SNRPE for the autosomal dominant form of hypotrichosis simplex, and the genes DSG4, LIPH and G protein-coupled receptor signaling pathway for the @DISEASE$ forms of hypotrichosis as well as U2HR for hypotrichosis type Marie Unna.	0
1128	These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes CDSN, negative regulation of Wnt signaling pathway and SNRPE for the autosomal dominant form of hypotrichosis simplex, and the genes DSG4, LIPH and @GENE$ for the @DISEASE$ forms of hypotrichosis as well as U2HR for hypotrichosis type Marie Unna.	1
1129	Familial microscopic hematuria (FMH) is associated with a genetically @DISEASE$ group of conditions including the collagen-IV nephropathies, the heritable C3/@GENE$ nephropathy and the glomerulopathy with fibronectin deposits.	1
1130	On the other hand, @DISEASE$ suppressor roles of YY1 appear to involve YY1 stimulation of tumor suppressor BRCA1, increased Bax transcription and apoptosis involving cytochrome c release and caspase-3/-7 cleavage, induction of heme oxygenase-1, inhibition of pRb phosphorylation and p21 binding to cyclin D1 and @GENE$, reduced expression of long noncoding RNA of SOX2 overlapping transcript, and MUC4/ErbB2/p38/MEF2C-dependent downregulation of MMP-10.	0
1131	For example, YY1's roles in @DISEASE$ growth involve stabilization of hypoxia-inducible factor HIF-1α in a p53 independent manner, negative regulation of miR-9 transcription, control of biological_process transcription, a novel miR-193a-5p-YY1-APC axis, intracellular ROS and mitochondrial superoxide generation, p53 reduction and @GENE$ activation, control of genes associated with mitochondrial energy metabolism and miRNA regulatory networks involving miR-7, miR-9, miR-34a, miR-186, miR-381, miR-584-3p and miR-635.	0
1132	For example, YY1's roles in @DISEASE$ growth involve stabilization of hypoxia-inducible factor HIF-1α in a p53 independent manner, negative regulation of miR-9 transcription, control of @GENE$ transcription, a novel miR-193a-5p-YY1-APC axis, intracellular ROS and mitochondrial superoxide generation, p53 reduction and positive regulation of protein phosphorylation activation, control of genes associated with mitochondrial energy metabolism and miRNA regulatory networks involving miR-7, miR-9, miR-34a, miR-186, miR-381, miR-584-3p and miR-635.	0
1133	YY1 expression is associated with that of @DISEASE$ stem cell markers SOX2, BMI1 and @GENE$ across many cancers suggesting multidynamic regulatory control and groups of cancers with distinct molecular signatures.	1
1134	Hepatocyte growth factor (HGF)/c-@GENE$ signaling plays an important role in cell proliferation, survival, migration and motility of @DISEASE$ cells.	1
1135	Functional assays indicate that @GENE$ reactivation ameliorates the malignant phenotype, specifically reducing cell viability, migration and invasion in diverse @DISEASE$ cell lines.	1
1136	Further, mice heterozygous for either @GENE$ or mRNA splicing, via spliceosome exhibit aberrant neurogenesis and @DISEASE$.	1
1137	Further, mice heterozygous for either nuclear-transcribed mRNA catabolic process, nonsense-mediated decay or @GENE$ exhibit aberrant neurogenesis and @DISEASE$.	1
1138	Using a new conditional allele, we first show that Eif4a3 haploinsufficiency phenocopies aberrant neurogenesis and @DISEASE$ of Magoh and @GENE$ mutant mice.	0
1139	In MCDS mice expressing the Col10a1.pN617K mutation, CBZ reduced the MCDS-associated expansion of the growth plate hypertrophic zone, attenuated enhanced expression of ER stress markers such as @GENE$ and response to endoplasmic reticulum stress, increased bone growth, and reduced @DISEASE$.	0
1140	In MCDS mice expressing the Col10a1.pN617K mutation, CBZ reduced the MCDS-associated expansion of the growth plate hypertrophic zone, attenuated enhanced expression of ER stress markers such as cellular response to glucose starvation and @GENE$, increased bone growth, and reduced @DISEASE$.	0
1141	Overall, our findings show how the @DISEASE$ suppressor @GENE$ is regulated in hepatocellular carcinoma and establish the mechanism underlying positive regulation of protein ubiquitination-mediated tumorigenesis in this disease.<b>Significance:</b> These findings provide mechanistic insights into regulation of the tumor suppressive sirtuin SIRT6 and its implications for the development of hepatocellular carcinoma.	1
1142	Overall, our findings show how the tumor suppressor regulation of double-strand break repair via homologous recombination is regulated in @DISEASE$ and establish the mechanism underlying @GENE$-mediated tumorigenesis in this disease.<b>Significance:</b> These findings provide mechanistic insights into regulation of the tumor suppressive sirtuin SIRT6 and its implications for the development of hepatocellular carcinoma.	0
1143	In mouse models of @DISEASE$, @GENE$ downregulation and consequent induction of ANXA2 were critical for UBE3A-mediated tumorigenesis.	1
1144	In mouse models of hepatocellular carcinoma, @GENE$ downregulation and consequent induction of ANXA2 were critical for UBE3A-mediated @DISEASE$igenesis.	1
1145	Corresponding implicated genes, such as TNNI3K, @GENE$, MKL2, MTNR1B and PRKD1, may explain the associations between reproductive factors and @DISEASE$.	1
1146	The insulin-secreting pancreatic neuroendocrine @DISEASE$, insulinomas, characterized by increased pancreatic islet β-cell proliferation, express the phosphorylated isoform of the β-cell differentiation factor regulation of transcription by RNA polymerase II that interacts with @GENE$/p54NRB, a survival factor.	0
1147	The insulin-secreting pancreatic neuroendocrine tumors, @DISEASE$, characterized by increased pancreatic islet β-cell proliferation, express the phosphorylated isoform of the β-cell differentiation factor regulation of transcription by RNA polymerase II that interacts with @GENE$/p54NRB, a survival factor.	0
1148	The insulin-secreting pancreatic neuroendocrine tumors, @DISEASE$, characterized by increased pancreatic islet β-cell proliferation, express the phosphorylated isoform of the β-cell differentiation factor @GENE$ that interacts with activation of innate immune response/p54NRB, a survival factor.	1
1149	Also, two somatic heterozygous @GENE$ mutations were found in endocrine-related tumors, p.H146R (parathyroid) and p.R293H (small intestine neuroendocrine @DISEASE$).	1
1150	Overall, our results highlight the importance of @GENE$ in conditions of β-cell excess (@DISEASE$) and in conditions of β-cell loss or dysfunction (diabetes).	1
1151	Smith-Magenis syndrome (SMS), a neurodevelopmental disorder characterized by dysmorphic features, @DISEASE$ (ID), and sleep disturbances, results from a 17p11.2 microdeletion or a mutation in the @GENE$ gene.	1
1152	Smith-Magenis syndrome (SMS), a neurodevelopmental disorder characterized by dysmorphic features, intellectual disability (ID), and @DISEASE$, results from a 17p11.2 microdeletion or a mutation in the @GENE$ gene.	1
1153	The Gene Expression Profiling Interactive Analyses application (GEPIA) was used to analysis the expression of @GENE$ in breast @DISEASE$ tissues and normal samples.The polymorphism of rs1325774 was significantly associated with an increased risk of breast cancer (T/G vs T/T: OR = 2.073, 95% CI = 1.095-3.927, P = .025).	1
1154	Among these genes, mutations in @GENE$ gene involve in inclusion body myopathy with Paget disease of bone and @DISEASE$ (IBMPFD), familial amyotrophic lateral sclerosis (ALS), autism spectrum disorders (ASD), and hereditary spastic paraplegia (HSP).	1
1155	We chose to study UNCL-Sema3E rather than wild type sema3E because unlike full length sema3E, the major p61-Sema3E peptide that is produced by cleavage of sema3E with @GENE$ like pro-protein convertases activates signal transduction mediated by the signal transduction receptor and can promote @DISEASE$ metastasis in addition to its anti-angiogenic activity.	1
1156	We chose to study UNCL-Sema3E rather than wild type sema3E because unlike full length sema3E, the major p61-Sema3E peptide that is produced by cleavage of sema3E with signal peptide processing like pro-protein convertases activates signal transduction mediated by the @GENE$ receptor and can promote @DISEASE$ metastasis in addition to its anti-angiogenic activity.	1
1157	This contributes to the intrinsic @DISEASE$ of these cells by upregulating Rab27-dependent recycling of the transmembrane matrix metalloprotease, @GENE$ to promote invasive behaviour leading to basement membrane disruption.	1
1158	However, the relationship between @GENE$ and @DISEASE$ remains poorly understood.	1
1159	While polyglutamine @DISEASE$, linked to CAG repeat expansions in genes such as ATXN1, negative regulation of receptor internalization, protein K63-linked deubiquitination, histone deubiquitination, @GENE$ and TBP, have been extensively characterized in large cohorts, there is a need for comprehensive assessment of frequency and phenotype of more 'conventional' ataxias.	1
1160	While polyglutamine @DISEASE$, linked to CAG repeat expansions in genes such as ATXN1, negative regulation of receptor internalization, protein K63-linked deubiquitination, @GENE$, positive regulation of cytosolic calcium ion concentration and TBP, have been extensively characterized in large cohorts, there is a need for comprehensive assessment of frequency and phenotype of more 'conventional' ataxias.	1
1161	While polyglutamine @DISEASE$, linked to CAG repeat expansions in genes such as ATXN1, @GENE$, protein K63-linked deubiquitination, histone deubiquitination, positive regulation of cytosolic calcium ion concentration and TBP, have been extensively characterized in large cohorts, there is a need for comprehensive assessment of frequency and phenotype of more 'conventional' ataxias.	1
1162	While polyglutamine @DISEASE$, linked to CAG repeat expansions in genes such as ATXN1, negative regulation of receptor internalization, @GENE$, histone deubiquitination, positive regulation of cytosolic calcium ion concentration and TBP, have been extensively characterized in large cohorts, there is a need for comprehensive assessment of frequency and phenotype of more 'conventional' ataxias.	1
1163	In conclusion, we identified relevant genetic variations in up to 15% of cases after exclusion of polyglutamine expansion spinocerebellar ataxias, and confirmed CACNA1A and @GENE$ as major @DISEASE$ genes.	1
1164	We show that active cofilin, LIMK1, LIMK2, and @GENE$ are overexpressed in human CRC and are associated with @DISEASE$ progression parameters.	1
1165	We recently reported a novel human phenotype resulting from a mutation in the critical coding region of the @GENE$ gene characterized by facial dysmorphism, severe growth restriction, axial hypotonia, global @DISEASE$ and retinal pigmentary deposits.	1
1166	We recently reported a novel human phenotype resulting from a mutation in the critical coding region of the @GENE$ gene characterized by facial dysmorphism, severe growth restriction, @DISEASE$ hypotonia, global developmental delay and retinal pigmentary deposits.	1
1167	We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, @GENE$, HTRA2, RIC3, EIF4G1, protein deubiquitination, CHCHD2, and GBA; or @DISEASE$ (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, antibacterial humoral response, FBXO7, DNAJC6, SYNJ1, chemical synaptic transmission, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.	0
1168	We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, posttranscriptional gene silencing, HTRA2, RIC3, EIF4G1, @GENE$, CHCHD2, and GBA; or @DISEASE$ (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, antibacterial humoral response, FBXO7, DNAJC6, SYNJ1, chemical synaptic transmission, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.	0
1169	We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, posttranscriptional gene silencing, HTRA2, RIC3, EIF4G1, protein deubiquitination, CHCHD2, and GBA; or @DISEASE$ (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, antibacterial humoral response, FBXO7, DNAJC6, SYNJ1, @GENE$, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.	1
1170	We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, posttranscriptional gene silencing, HTRA2, RIC3, EIF4G1, protein deubiquitination, CHCHD2, and GBA; or @DISEASE$ (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, @GENE$, FBXO7, DNAJC6, SYNJ1, chemical synaptic transmission, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.	1
1171	Murine double minute 2 (@GENE$) is the E3 ubiquitin ligase of the @DISEASE$ suppressor gene, p53, and inhibition of MDM2 can suppress tumor cell growth.	1
1172	The @GENE$ G1 polymorphism, an identified risk factor for non-diabetic renal disease, was associated with @DISEASE$.	1
1173	Growing evidence suggests that @GENE$ may represent an important genetic modifier locus for @DISEASE$ ALS.	1
1174	Compared to normal tissues, decorin expression was reduced in CRC patients' @DISEASE$, while there were increased @GENE$ and VEGFA levels.	1
1175	Several therapeutic strategies expressing @GENE$ have been employed in clinical trials for treating metastatic colorectal @DISEASE$.	1
1176	The authors report a patient with a novel @GENE$ mutation, who presented with @DISEASE$, severe automutilation, and epilepsy.	1
1177	PAK3-related @DISEASE$ is caused by mutations in the gene encoding the @GENE$-activated kinase (PAK) protein.	1
1178	We observed a higher rate of individuals with a history of high blood pressure among affected versus healthy individuals carrying @GENE$ variants, suggesting that ANGPTL6 could trigger cerebrovascular lesions when combined with other risk factors such as @DISEASE$.	1
1179	High-throughput sequencing analysis has accelerated searches for genes associated with risk for colorectal @DISEASE$ (CRC); germline mutations in NTHL1, RPS20, @GENE$, FAN1, TP53, regulation of sister chromatid cohesion, BUB3, LRP6, and PTPN12 have been recently proposed to increase CRC risk.	0
1180	High-throughput sequencing analysis has accelerated searches for genes associated with risk for colorectal @DISEASE$ (CRC); germline mutations in NTHL1, RPS20, resolution of meiotic recombination intermediates, FAN1, TP53, @GENE$, BUB3, LRP6, and PTPN12 have been recently proposed to increase CRC risk.	0
1181	We found sufficient evidence for @GENE$ to be considered a CRC predisposition gene-members of 3 unrelated Dutch families were homozygous for inactivating p.Gln90Ter mutations; a Canadian woman with polyposis, CRC, and multiple @DISEASE$ was reported to be heterozygous for the inactivating NTHL1 p.Gln90Ter/c.709+1G&gt;A mutations; and a man with polyposis was reported to carry p.Gln90Ter/p.Gln287Ter; whereas no inactivating homozygous or compound heterozygous mutations were detected in controls.	0
1182	Over 60 years after the initial description of PDE, we report the first animal model for this disease: an @GENE$-null zebrafish (<i>Danio rerio</i>) displaying deficient lysine metabolism and spontaneous and recurrent @DISEASE$ in the larval stage (10 days postfertilization).	1
1183	Both single-gene and gene-set enrichment analyses in genome-wide association data from the largest @DISEASE$ sample to date of 13,689 cases and 18,226 controls show significant association of HIST1H1E and @GENE$, and enrichment of our PSD proteome.	1
1184	However, the clinical significance and precise role of @GENE$ in @DISEASE$ progression are largely unknown.	1
1185	Zinc finger protein 687 (@GENE$), identified as a C2H2 zinc finger protein, has been found to be mutated and upregulated in giant cell tumor of bone and acute myeloid leukemia, suggesting an oncogenic role for ZNF687 in @DISEASE$.	0
1186	Moreover, @GENE$ predicted poor prognosis of pancreatic @DISEASE$, partially due to its role in E-cadherin expression regulation, and the results were further validated by analysis of the correlation between ALDOA and E-cadherin expression in pancreatic cancer tissue samples.	1
1187	Mechanistically, the role of ALDOA in pancreatic @DISEASE$ might attribute to its regulation of @GENE$, HIF1α and positive regulation of transcription by RNA polymerase II (Nuclear Factor, Erythroid 2-Like 2), which were key regulators of glycolysis and antioxidant response control.	1
1188	Mechanistically, the role of ALDOA in pancreatic @DISEASE$ might attribute to its regulation of negative regulation of transcription by RNA polymerase II, HIF1α and @GENE$ (Nuclear Factor, Erythroid 2-Like 2), which were key regulators of glycolysis and antioxidant response control.	1
1189	Genetic or small-molecule inhibitor-based ablation of HIF-1α/TGF-β2-mediated @GENE$ signaling effectively reversed the chemoresistance caused by the @DISEASE$ microenvironment.	1
1190	However, the ectopic expression of @GENE$ was recently discovered in intra-tumoral blood vessels endothelia and/or in tumoral cells of many extra-gonadal human @DISEASE$ (particularly in endocrine tumours).	1
1191	The paper reviews the data concerning the appearance of ectopic @GENE$ in particular human @DISEASE$.	1
1192	Patients exhibit a variety of symptoms predominantly linked to the function of @GENE$ protein in the nervous system like autistic behavior and mild-to-severe @DISEASE$.	1
1193	The findings in this study expand our understanding of SRPS locus @DISEASE$ and demonstrate the importance of @GENE$ in dynein-2 complex stability, cilium function, Hedgehog regulation and skeletogenesis.	0
1194	Megaconial congenital @DISEASE$ is a disease caused by pathogenic mutations in the gene encoding choline kinase beta (@GENE$).	1
1195	Similarly, @GENE$ has lymphoid and non-lymphoid forms; SEPT2 has lymphoid and @DISEASE$ nervous system (CNS) forms; and SEPT6 and SEPT9 are elevated in lymphoid tissues but both have forms that cluster away from the lymphoid forms.	0
1196	Downregulation of miR-29a caused overexpression of LOXL2 and @GENE$ in lung @DISEASE$ and IPF, suggesting that these genes are involved in the pathogenesis of these two diseases	1
1197	Overexpression of LOXL2 and @GENE$ was observed in clinical specimens of lung @DISEASE$ and fibrotic lesions.	1
1198	While examining pedigrees of JEB patients with @GENE$ mutations, we observed that heterozygous carriers of functional null mutations displayed subtle enamel pitting in the absence of @DISEASE$ or other JEB symptoms.	1
1199	Most often, hypogonadotropic @DISEASE$ is caused by disorder in secretion of gonadoliberin, the product of gene @GENE$.	1
1200	Thus, increased expression of gene @GENE$ in blood cells appears to be associated with the isolated form of hypogonadotropic @DISEASE$ and, in prospect, may be used as one of the disease markers	1
1201	@GENE$ is also known as a @DISEASE$ suppressor gene, and somatic mutations in that gene have been identified in Wilms tumors.	1
1202	RESULTS There was an increased expression of @GENE$ in breast @DISEASE$ tissues compared to normal breast tissues (p&lt;0.05).	1
1203	The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), @GENE$ (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive @DISEASE$, myopathy, and hearing loss; EDSKMH) and brain development (Kohlschütter-Tönz syndrome).	0
1204	The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (@GENE$) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive @DISEASE$, myopathy, and hearing loss; EDSKMH) and brain development (Kohlschütter-Tönz syndrome).	0
1205	The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), @GENE$ (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, @DISEASE$, and hearing loss; EDSKMH) and brain development (Kohlschütter-Tönz syndrome).	0
1206	The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), @GENE$ (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive @DISEASE$, myopathy, and hearing loss; EDSKMH) and brain development (Kohlschütter-Tönz syndrome).	0
1207	The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), @GENE$ (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, @DISEASE$, and hearing loss; EDSKMH) and brain development (Kohlschütter-Tönz syndrome).	0
1208	The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), @GENE$ (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and @DISEASE$; EDSKMH) and brain development (Kohlschütter-Tönz syndrome).	0
1209	The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive @DISEASE$, myopathy, and hearing loss; EDSKMH) and @GENE$ (Kohlschütter-Tönz syndrome).	0
1210	The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and @DISEASE$; EDSKMH) and @GENE$ (Kohlschütter-Tönz syndrome).	0
1211	Homozygous null mutation of @DISEASE$ suppressor <i>@GENE$/Wwox</i> gene leads to severe neural diseases, metabolic disorders and early death in the newborns of humans, mice and rats.	1
1212	There has been virtually no tissue study on the expression of @GENE$ in prostate @DISEASE$ (PCa).	1
1213	Our findings offer a foundation for understanding @GENE$-related neurodegeneration and how nucleic acid binding functions, localization, and pathogenic mutations drive @DISEASE$ and familial disease	0
1214	Taken together, these data provide novel information for comprehending the @DISEASE$-suppressive role of miR-200a in HCC pathogenesis through inhibition of @GENE$ translation	1
1215	@GENE$ and its ligand are members of the TNF/TNF receptor superfamily, which includes various molecules influencing cellular signaling and function of both @DISEASE$ and immune cells.	0
1216	CHIME syndrome is a rare @DISEASE$ neuroectodermal disorder associated with biallelic mutations in @GENE$.	1
1217	Noonan syndrome (NS), the commonest RASopathy, is genetically @DISEASE$ and caused by functional dysregulation of signal transducers and regulatory proteins with roles in the RAS/extracellular signal-regulated kinase (@GENE$) signal transduction pathway.	0
1218	The aim of this study was to investigate the diagnostic sensitivity and specificity of protein induced by vitamin K absence or antagonist-II (PIVKAII), @GENE$-3 (GP3), Cystatin B (negative regulation of peptidase activity), squamous cell carcinoma antigen 1 (SCCA1) and hepatocyte growth factor (HGF) as potential @DISEASE$ markers for HCC in patients with alcoholic liver cirrhosis (ALC) using imaging techniques (MSCT and MRI) as reference standards.	1
1219	The aim of this study was to investigate the diagnostic sensitivity and specificity of protein induced by vitamin K absence or antagonist-II (PIVKAII), heparan sulfate proteoglycan catabolic process-3 (GP3), Cystatin B (@GENE$), squamous cell carcinoma antigen 1 (SCCA1) and hepatocyte growth factor (HGF) as potential @DISEASE$ markers for HCC in patients with alcoholic liver cirrhosis (ALC) using imaging techniques (MSCT and MRI) as reference standards.	1
1220	Mice carrying kinase-dead @GENE$ also displayed @DISEASE$ and reduced cortical brain volume due to the enhanced cell death of neuronal progenitors that is associated with reduced numbers of cortical neurons.	1
1221	Based on screening results, five unique genes (GNPAT, SUMO1, SPINT2, @GENE$, and regulation of transcription, DNA-templated) significantly potentiated the growth inhibitory effects of CDDO-Me and induced apoptosis in A375, a BRAF mutated @DISEASE$ line (P &lt; 0.001).	1
1222	Based on screening results, five unique genes (GNPAT, SUMO1, SPINT2, positive regulation of transcription, DNA-templated, and @GENE$) significantly potentiated the growth inhibitory effects of CDDO-Me and induced apoptosis in A375, a BRAF mutated @DISEASE$ line (P &lt; 0.001).	1
1223	Our findings indicate that @GENE$, SUMO1, SPINT2, positive regulation of transcription, DNA-templated, and SSX1 play critical roles in synergy with inflammation pathways in modulating @DISEASE$ cell survival and could serve as sensitizing targets to enhance CDDO-Me efficacy in melanoma growth control	1
1224	Our findings indicate that ether lipid biosynthetic process, SUMO1, SPINT2, @GENE$, and SSX1 play critical roles in synergy with inflammation pathways in modulating @DISEASE$ cell survival and could serve as sensitizing targets to enhance CDDO-Me efficacy in melanoma growth control	1
1225	Furthermore, we performed in vitro assays in breast @DISEASE$ cell lines, and our results indicated that @GENE$, MRPS30, and ATG10 played a vital role in breast tumorigenesis via certain disruption of cell behaviors.	0
1226	Here, we report 1 known (c.1489C&gt;T, p.Pro497Ser, P497S) and 3 novel (c.1481C&gt;T, p.Pro494Leu, P494L; c.1498C&gt;T, p.Pro500Ser, P500S; and c.1516C&gt;G, p.Pro506Ala, P506A) missense mutations in the PXX domain of @GENE$ in familial motor neuron diseases including ALS and @DISEASE$ (SP).	1
1227	Mosaicism was identified for autosomal dominant (JAG1, @GENE$), @DISEASE$ (PYGM), and X-linked (carbohydrate metabolic process, acetyl-CoA biosynthetic process from pyruvate, urea cycle, and SLC6A8) disorders.	0
1228	Mosaicism was identified for autosomal dominant (JAG1, cell-matrix adhesion), @DISEASE$ (PYGM), and X-linked (carbohydrate metabolic process, acetyl-CoA biosynthetic process from pyruvate, @GENE$, and SLC6A8) disorders.	0
1229	Mosaicism was identified for autosomal dominant (JAG1, cell-matrix adhesion), @DISEASE$ (PYGM), and X-linked (carbohydrate metabolic process, @GENE$, urea cycle, and SLC6A8) disorders.	0
1230	Mosaicism was identified for autosomal dominant (JAG1, cell-matrix adhesion), @DISEASE$ (PYGM), and X-linked (@GENE$, acetyl-CoA biosynthetic process from pyruvate, urea cycle, and SLC6A8) disorders.	0
1231	Some individuals with heterozygous @GENE$ mutations demonstrate a carrier ocular phenotype, which includes a mildly reduced corneal thickness, @DISEASE$ and blue sclera.	1
1232	Hyperphosphatasia with mental retardation syndrome (HPMRS) is caused by mutations in @GENE$ and includes @DISEASE$ as a diagnostic hallmark.	1
1233	Glutaric acidemia I (GAI) is an @DISEASE$ metabolic disease caused by a deficiency of glutaryl-CoA dehydrogenase enzyme (@GENE$).	1
1234	Extensive @GENE$ gene deletions were identified in four patients; using DNA microarray analysis two patients showed the loss of the entire AFF2 gene, and @DISEASE$ developed in only one of them.	0
1235	In vivo experiments were performed in nude mice bearing transfected @DISEASE$; results revealed that NET-@GENE$-coexpressing tumors had longer <sup>131</sup>I-MIBG retention time than NET-expressing tumors.	0
1236	The reported hypertrophic @DISEASE$ relevant genes MYPN, @GENE$ and MYBP3 had also been found in case 1 and 2.	1
1237	Given the lack of specific targeted genes and pathways known to be involved in @DISEASE$ cell dormancy, we proposed enriched candidate genes related to the negative regulation of cell proliferation, signalling pathways regulating pluripotency of stem cells and neuroactive ligand-receptor interaction, and 3 hub genes (FTH1, @GENE$ and DDIT3).	0
1238	Carriers of CT or TT genotype of @GENE$ rs13900 had increased risk of @DISEASE$ at birth and at 6 months of age (aOR = 3.59; p = 0.028 and aOR = 4.10; p = 0.039, respectively).	1
1239	Microfibrillar-associated protein 5 (@GENE$) is a component of extracellular elastic microfibril which has been confirmed to function in tissue development and @DISEASE$ progression.	1
1240	The present study demonstrated that @GENE$ was up-regulated in breast @DISEASE$s compared with that in normal breast tissues, and further increased in breast cancer bone metastasis.	1
1241	In terms of prognostic features, a survival analysis revealed that the high @GENE$ and HK2 expression group exhibited poorer survival in @DISEASE$ patients.	1
1242	The key clinical features of the patient with @GENE$ included short stature, joint contractures, pigeon breast, and myotonia that led to progressive stiffness of the face and limbs; barely discernible @DISEASE$ was also noted.	1
1243	The family members harboring 1 heterozygous mutation in @GENE$ did not exhibit any @DISEASE$.	1
1244	In ALDH<sup>+</sup>CD24<sup>-</sup>CD44<sup>+</sup> BCSCs, we identified P4HA2, PTGR1 and @GENE$ as potential prognostic markers, which were virtually related to the status of BCSCs and @DISEASE$ growth in TNBC cells	1
1245	Missense mutations in SCN2A (p.Leu1342Pro) and @GENE$ (p.Ala306Thr) were found in two patients with no history of @DISEASE$ before the onset of ISs.	1
1246	The PCH1sub-types with early death (between ages 1 day and 17 months), seen in patients with p.G31A/@GENE$ or mitochondrial membrane fission mutations have a SMA type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without @DISEASE$, nystagmus and optic atrophy.	1
1247	The PCH1sub-types with early death (between ages 1 day and 17 months), seen in patients with p.G31A/@GENE$ or mitochondrial membrane fission mutations have a SMA type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without microcephaly, nystagmus and @DISEASE$.	1
1248	The PCH1sub-types with early death (between ages 1 day and 17 months), seen in patients with p.G31A/rRNA processing or @GENE$ mutations have a SMA type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without @DISEASE$, nystagmus and optic atrophy.	1
1249	Other @GENE$ mutations and rRNA processing cases are intermediate - SMA type 1-like presentation, @DISEASE$ (mostly in EXOSC8) and death between 3 months and 5 years.	1
1250	Other rRNA processing mutations and @GENE$ cases are intermediate - SMA type 1-like presentation, @DISEASE$ (mostly in EXOSC8) and death between 3 months and 5 years.	1
1251	Mutations with milder presentation (homozygous p.D132A/EXOSC3 or @GENE$) may display additionally signs of upper motor neuron impairment, dystonia or @DISEASE$ and die at age between 5 and 18 years.	1
1252	Immunohistochemically, @DISEASE$ cells of all cases were positive for vimentin (100.0%, 60/60), positive regulation of transcription by RNA polymerase II (98.3%, 59/60), CD34 (61.7%, 37/60), and the tumor cells were typically positive for CD99, @GENE$, EMA and SSTR2 as well.Negative for S-100 protein, SOX10, E-integrin-mediated signaling pathway, GFAP.	0
1253	Immunohistochemically, @DISEASE$ cells of all cases were positive for vimentin (100.0%, 60/60), @GENE$ (98.3%, 59/60), CD34 (61.7%, 37/60), and the tumor cells were typically positive for CD99, protein polyubiquitination, EMA and SSTR2 as well.Negative for S-100 protein, SOX10, E-integrin-mediated signaling pathway, GFAP.	1
1254	Immunohistochemically, @DISEASE$ cells of all cases were positive for vimentin (100.0%, 60/60), positive regulation of transcription by RNA polymerase II (98.3%, 59/60), CD34 (61.7%, 37/60), and the tumor cells were typically positive for CD99, protein polyubiquitination, EMA and SSTR2 as well.Negative for S-100 protein, SOX10, E-@GENE$, GFAP.	0
1255	To explore the underlying mechanism of @DISEASE$ suppression by @GENE$, its potential to promote apoptosis induced by TRAIL, an effector molecule elaborated by natural killer-T (NKT) cells was investigated.	1
1256	Here, we have performed a prospective nationwide genetic association study using the Human Exome BeadChip and identified gene variants in encoding dynactin 4 (DCTN4), retinoic acid early transcript 1E (RAET1E), and V-akt murine thymoma viral oncogene homolog 3 (@GENE$) to be associated with unfavourable outcome in patients with pneumococcal @DISEASE$.	1
1257	These findings suggest that @GENE$ is not only driving EMT, but also contributes to the formation of osteolytic bone metastases in breast @DISEASE$.	1
1258	Placental mRNA abundance for the folate receptor alpha (<i>FOLR1</i>) was reduced with @DISEASE$, whilst <i>@GENE$1</i> was increased with raised BMI, responses that were unaffected by GD.	0
1259	In a few (non-Swedish) @DISEASE$ families, mutations in other genes have been found, including @GENE$, transcription, RNA-templated, POT1, ACD and TERF2IP.	1
1260	In a few (non-Swedish) @DISEASE$ families, mutations in other genes have been found, including protein phosphorylation, @GENE$, POT1, ACD and TERF2IP.	1
1261	In genes that regulate cellular pigmentation pathways, including MC1R, ASIP, IRF4, @GENE$, TYRP1 and OCA, there are different common variants that determine complexion traits, and those variants are also associated with different risks of @DISEASE$.	1
1262	Individuals with known mutations in @DISEASE$ suppressor genes such as @GENE$ and BAP1 require, in addition, follow up for other cancers	1
1263	Swedish @GENE$ mutation carriers have a young median age of onset of @DISEASE$, increased risks of multiple primary melanoma and of tobacco-associated cancers in respiratory and upper digestive tissues, and also worse survival compared to non-carriers.	1
1264	In case of DLEC1 and @GENE$, expression levels were decreased in 71-78 % of @DISEASE$ samples and significantly different between tumor and normal tissues (P = 0.0001).	1
1265	The presented workflow employed three different peptide microarray formats to discover and resolve the epitopes of human autoantibodies and revealed two potentially new autoantigens: MAP3K7 in multiple sclerosis and @GENE$ in @DISEASE$.	1
1266	Previously (Pappas et al., 2015;4:e08352), we reported that Dlx5/6-Cre mediated forebrain deletion of the @GENE$ @DISEASE$ protein torsinA (Dlx-CKO) causes abnormal twisting and selective degeneration of dorsal striatal cholinergic interneurons (ChI) (Pappas et al., 2015).	1
1267	Recently, @DISEASE$ loss-of-function mutations in @GENE$ (encoding exophilin-5, also known as Slac2-b, a protein involved in intracellular vesicle transport) were identified in a new mechanobullous disease resembling a form of epidermolysis bullosa simplex (EBS).	1
1268	Here, we searched for mutations in @GENE$ in a 4-year-old white boy with EBS in whom initial Sanger sequencing of known genes implicated in intraepidermal @DISEASE$ failed to identify pathogenic mutations.	0
1269	Cognitive impairment or autism-like performance were often identified in these patients, hematuria metabolic diseases screening was normal, no abnormal MRI imaging of the head, and de novo @GENE$ gene mutations were found in their @DISEASE$ gene chip sequencing.	1
1270	Epilepsy with mental retardation limited to females (EFMR) is a syndrome characterized by early onset heat-sensitive @DISEASE$ of infancy or early childhood and generally limited to females, which previously reported that the cadherin gene superfamily subtype protocadherin 19 (@GENE$) gene is its pathogenic gene.	1
1271	Nagashima-type @DISEASE$ (NPPK) is an autosomal recessive form of palmoplantar keratoderma (PPK), which is caused by mutations in the @GENE$ gene.	1
1272	Tumor-specific methylation changes at IGF2 DMR2 were observed in 59% of @DISEASE$ patients, IGF2 DMR0 in 38%, DIRAS3 DMR in 36%, GRB10 ICR in 23%, @GENE$ DMR in 21%, mesoderm development ICR in 19%, H19 ICR in 18%, KvDMR in 8% and SNRPN/SNURF ICR in 4%.	1
1273	Tumor-specific methylation changes at IGF2 DMR2 were observed in 59% of @DISEASE$ patients, IGF2 DMR0 in 38%, DIRAS3 DMR in 36%, GRB10 ICR in 23%, negative regulation of transcription by RNA polymerase II DMR in 21%, @GENE$ ICR in 19%, H19 ICR in 18%, KvDMR in 8% and SNRPN/SNURF ICR in 4%.	1
1274	Several candidate genes for @DISEASE$ and T2D (e.g., IRS1 and @GENE$) were differentially expressed in discordant twins.	0
1275	The mutations in the @GENE$ gene leads to X-linked Charcot-Marie-Tooth neuropathy type 5 (CMTX5), PRS super activity, Arts syndrome, X-linked @DISEASE$-1, breast cancer, and colorectal cancer.	1
1276	In this review article, we summarize the discovery of @GENE$ and the potential molecular mechanisms of TYMP involved in the development of various diseases, especially @DISEASE$.	1
1277	A total of nine non-coding variants on 11q13.5 predispose men to prostate @DISEASE$ (PrCa). rs200331695 within the @GENE$ intron is associated with aggressive PrCa and two high linkage disequilibrium (LD) groups of single-nucleotide polymorphisms (SNPs) in the intergenic region are associated with PrCa death.	0
1278	The high LD SNPs (rs143975731, rs12277366, rs2155225, and rs2155222) were associated with @GENE$ expression in both @DISEASE$ sets (screening P = 0.035-0.043; validation P = 0.005-0.018).	1
1279	Altogether, our study provides direct evidence that endogenous @GENE$ and Rspo3 chromosome rearrangements can initiate and maintain tumour development, and indicate a viable therapeutic window for LGK974 treatment of RSPO-fusion @DISEASE$s	1
1280	We show that both Rspo2 and @GENE$ fusion events are sufficient to initiate hyperplasia and @DISEASE$ development in vivo, without additional cooperating genetic events.	1
1281	Here, we describe the generation of transgenic, inducible CRISPR-based mouse systems to engineer and study recurrent colon @DISEASE$-associated EIF3E-RSPO2 and @GENE$-RSPO3 chromosome rearrangements in vivo.	1
1282	Our results demonstrate that adenomyoepitheliomas are genetically @DISEASE$, and qualify mutations in @GENE$, a gene whose mutations are vanishingly rare in common-type breast cancers, as likely drivers of ER-negative adenomyoepitheliomas	1
1283	Hennekam lymphangiectasia-lymphedema syndrome is an @DISEASE$ disorder, with 25% of patients having mutations in @GENE$.	1
1284	While there were no significant correlations with both Se status markers, <i>SELENOF</i>, <i>SELENOK</i>, and <i>TXNRD1</i> @DISEASE$ tissue expression positively correlated with Se, while <i>TXNRD2</i> and <i>TXNRD3</i> negatively correlated with <i>@GENE$</i>.	0
1285	Therefore, STX3 promotes the growth of breast @DISEASE$ cells by regulating the PTEN-PI3K-@GENE$-regulation of cell growth signaling	0
1286	Therefore, STX3 promotes the growth of breast @DISEASE$ cells by regulating the PTEN-PI3K-positive regulation of protein phosphorylation-@GENE$ signaling	0
1287	We find that STX3 promotes the proliferation of breast @DISEASE$ cells by increasing the activation of the @GENE$-mTOR signaling, and Akt inhibitor Ipatasertib or MK-2206 represses STX3 effects on the growth of breast cancer cells.	0
1288	The up-regulation of @GENE$ is correlated with high disease stage and predicts overall and disease-free survival in patients with breast @DISEASE$.	1
1289	Our studies show that DKD susceptibility was linked to mitochondrial dysfunction, mediated largely by Edn1-@GENE$ in glomerular endothelial cells representing an early event in DKD progression, and suggest that cross talk between glomerular endothelial injury and podocytes leads to defects and depletion, @DISEASE$, and glomerulosclerosis	0
1290	Selective @GENE$ blockade or mitochondrial-targeted reactive oxygen species scavenging prevented mitochondrial oxidative stress of endothelial cells and ameliorated diabetes-induced endothelial injury, podocyte loss, @DISEASE$, and glomerulosclerosis.	1
1291	The deleted in colorectal @DISEASE$ (@GENE$) gene encodes the netrin-1 (NTN1) receptor DCC, a transmembrane protein required for the guidance of commissural axons.	1
1292	It is a genetic disorder caused by a mutation in the dysferlin gene (@GENE$) with an @DISEASE$ mode of inheritance.	1
1293	Our results therefore confirm the KCNC3R423H allele as causative for @GENE$, through a dominant negative effect on KCNC3WT and links with positive regulation of protein phosphorylation that account for dominant @DISEASE$, congenital onset, and disease pathology	1
1294	Our results therefore confirm the KCNC3R423H allele as causative for protein tetramerization, through a dominant negative effect on KCNC3WT and links with @GENE$ that account for dominant @DISEASE$, congenital onset, and disease pathology	1
1295	In the present study, we first analyzed two expression quantitative trait loci (eQTL) datasets in healthy individuals and investigated the associations of eQTL of @GENE$ with @DISEASE$ in independent European samples.	1
1296	Our present study confirmed radiation can promote the in vitro migration and invasion of triple negative breast @DISEASE$ (TNBC) cells and increase the expression of epithelial-mesenchymal transition (EMT) related transcription factor negative regulation of transcription by RNA polymerase II, while had no effect on @GENE$, Slug or Twist.	0
1297	Our present study confirmed radiation can promote the in vitro migration and invasion of triple negative breast @DISEASE$ (TNBC) cells and increase the expression of epithelial-mesenchymal transition (EMT) related transcription factor @GENE$, while had no effect on negative regulation of transcription by RNA polymerase II, Slug or Twist.	0
1298	In vivo imaging, ex vivo imaging and @DISEASE$ tissue slides showed that PDT further contribute EGFP-@GENE$-nucleobase-containing compound metabolic process accumulation in tumor.	1
1299	In vivo imaging, ex vivo imaging and @DISEASE$ tissue slides showed that PDT further contribute EGFP-mitochondrial translational elongation-@GENE$ accumulation in tumor.	1
1300	In this study, a @GENE$-cascade-targeted strategy aiming to disrupt @DISEASE$ blood vessels was developed by combination of TF-targeted HMME-loaded drug delivery system and PDT.	1
1301	By recruiting the methyltransferase @GENE$, C/EBPβ can maintain an open chromatin state by H3K79 methylation of multiple drug-resistance genes, thereby augmenting the chemoresistance of @DISEASE$ cells.	0
1302	Analysis of clinical samples of oral @DISEASE$ found a strong correlation of these genes with short survival, especially @GENE$ expression associated with metastasis.	1
1303	Of these, Frem1, Foxo1, and @GENE$ have been implicated in the pathogenesis of @DISEASE$.	1
1304	Previous studies have reported the association of prodynorphin (@GENE$) promoter polymorphism with temporal lobe @DISEASE$ (TLE) susceptibility, but the results remain inconclusive.	1
1305	In this research, we measured the expression of @GENE$ protein by immunohistochemistry assay in 89 paired paraffin-embedded @DISEASE$ tissues and corresponding adjacent normal tissues from patients with colorectal adenocarcinoma and investigated possible correlations of UQCRC2 expression with clinicopathological parameters and prognosis.	1
1306	These results provided novel insights into the potential role of @GENE$ in the @DISEASE$igenesis and progression of CRC, and revealed that UQCRC2 may serve as a new prognostic and therapeutic target in CRC	1
1307	Examination of @DISEASE$-infiltrating immune cells from mice vaccinated with the @GENE$-expressing exosomes showed robust tumor-reactive CD8<sup>+</sup> T effector responses, Th1 cytokine responses, and higher CD8<sup>+</sup> T effector/CD4<sup>+</sup>CD25<sup>+</sup>Foxp3<sup>+</sup> T regulatory cell ratio in the tumors.	1
1308	The homeodomain transcription factor @GENE$ was recently reported to be a negative regulator of the Wnt pathway and has an emerging role in @DISEASE$.	1
1309	To avoid this artifactual early priming of the host precluding the study of the interactions between the immune system and @DISEASE$s at the steady state, we generated a cell line expressing the @GENE$ Ag in an inducible manner.	0
1310	In this study, we show that the presentation of a MHC class II-restricted model Ag (male, @GENE$) released by dying @DISEASE$ cells may last more than 4 wk.	1
1311	In the case-control analysis, the rs9607195 A&gt;G on intergenic area 250 kb away from the @GENE$ gene and the rs12738007 A&gt;G on the intron of the MECR gene were the most strongly associated SNPs with the risk of @DISEASE$ (P = 6.2 × 10(-8) , OR = 0.50 and P = 3.7 × 10(-7) , OR = 2.39, respectively).	0
1312	Clinical presentation of @GENE$ deficiency is @DISEASE$ ranging from mild to severe neuromuscular diseases.	1
1313	Furthermore, we identified some potential lung @DISEASE$ driver genes, such as negative regulation of transcription by RNA polymerase II, @GENE$, SLC2A1, protein phosphorylation, and CDC20, whose expression is significantly upregulated in lung cancer, and the copy number of these genes is amplified in the genome of patients with lung cancer.	1
1314	Furthermore, we identified some potential lung @DISEASE$ driver genes, such as negative regulation of transcription by RNA polymerase II, G1/S transition of mitotic cell cycle, SLC2A1, @GENE$, and CDC20, whose expression is significantly upregulated in lung cancer, and the copy number of these genes is amplified in the genome of patients with lung cancer.	1
1315	Furthermore, we identified some potential lung @DISEASE$ driver genes, such as @GENE$, G1/S transition of mitotic cell cycle, SLC2A1, protein phosphorylation, and CDC20, whose expression is significantly upregulated in lung cancer, and the copy number of these genes is amplified in the genome of patients with lung cancer.	1
1316	Several important genetic alterations (i.e., mutations, deletions) have been identified to be involved in the initiation and progression of pancreatic @DISEASE$, including @GENE$ and inactivation of tumor suppressors, such as TP53, transforming growth factor beta receptor signaling pathway and CDKN2A.	1
1317	Several important genetic alterations (i.e., mutations, deletions) have been identified to be involved in the initiation and progression of pancreatic cancer, including positive regulation of protein phosphorylation and inactivation of @DISEASE$ suppressors, such as TP53, @GENE$ and CDKN2A.	1
1318	The most likely causal variant identified was a novel missense variant in the X-linked @GENE$ gene, which has been implicated in @DISEASE$.	1
1319	In co-culture experiments using @GENE$-OVA melanoma cells and @DISEASE$-specific CD3+ T cells, EGCG reduced <i>PD-L1</i> mRNA expression about 30% in F10-OVA cells and restored <i>interleukin-2</i> mRNA expression in tumor-specific CD3+ T cells.	0
1320	We here report that (-)-epigallocatechin gallate (EGCG) inhibited programmed cell death ligand 1 (PD-L1) expression in non⁻small-cell lung @DISEASE$ cells, induced by both interferon (@GENE$)-γ and epidermal growth factor (EGF).	1
1321	Our WES data is largely matched with the earlier 'adenoma-@DISEASE$ model' (cellular response to DNA damage stimulus, KRAS, Ras protein signal transduction and GNAS mutations), but there are newly identified @GENE$, MTOR, ACVR1B, negative regulation of protein kinase activity, ATM, CNOT1, EP300, ARID2, RET and MAP2K4 mutations in this study.	1
1322	Our WES data is largely matched with the earlier 'adenoma-@DISEASE$ model' (cellular response to DNA damage stimulus, KRAS, Ras protein signal transduction and GNAS mutations), but there are newly identified transforming growth factor beta receptor signaling pathway, MTOR, ACVR1B, @GENE$, ATM, CNOT1, EP300, ARID2, RET and MAP2K4 mutations in this study.	0
1323	Our WES data is largely matched with the earlier 'adenoma-@DISEASE$ model' (@GENE$, KRAS, Ras protein signal transduction and GNAS mutations), but there are newly identified transforming growth factor beta receptor signaling pathway, MTOR, ACVR1B, negative regulation of protein kinase activity, ATM, CNOT1, EP300, ARID2, RET and MAP2K4 mutations in this study.	1
1324	Our WES data is largely matched with the earlier 'adenoma-@DISEASE$ model' (cellular response to DNA damage stimulus, KRAS, @GENE$ and GNAS mutations), but there are newly identified transforming growth factor beta receptor signaling pathway, MTOR, ACVR1B, negative regulation of protein kinase activity, ATM, CNOT1, EP300, ARID2, RET and MAP2K4 mutations in this study.	1
1325	We identified 22 genes including APC, @GENE$, TP53, GNAS, Ras protein signal transduction, SMAD4, nucleosome disassembly, and PIK3CA with non-silent mutations in the @DISEASE$ Census Genes.	1
1326	We identified 22 genes including APC, positive regulation of protein phosphorylation, TP53, GNAS, @GENE$, SMAD4, nucleosome disassembly, and PIK3CA with non-silent mutations in the @DISEASE$ Census Genes.	1
1327	We identified 22 genes including APC, positive regulation of protein phosphorylation, TP53, GNAS, Ras protein signal transduction, SMAD4, @GENE$, and PIK3CA with non-silent mutations in the @DISEASE$ Census Genes.	0
1328	Factor VII (FVII) activating protease (@GENE$) is a circulating serine protease that is likely to be involved in a number of disease conditions such as stroke, atherosclerosis, liver fibrosis, thrombosis and @DISEASE$.	1
1329	Mining GWAS databases revealed association of cis-eSNPs for more than 50 genes with T2D (e.g. @GENE$, RBMS1, biological_process), gluco-metabolic phenotypes (e.g. INPP5E, SNX17, antigen processing and presentation of peptide antigen via MHC class I, FN3KRP), and @DISEASE$ (e.g. POMC, CPEB4).	0
1330	Mining GWAS databases revealed association of cis-eSNPs for more than 50 genes with T2D (e.g. endocytosis, RBMS1, @GENE$), gluco-metabolic phenotypes (e.g. INPP5E, SNX17, antigen processing and presentation of peptide antigen via MHC class I, FN3KRP), and @DISEASE$ (e.g. POMC, CPEB4).	0
1331	Mining GWAS databases revealed association of cis-eSNPs for more than 50 genes with T2D (e.g. endocytosis, RBMS1, biological_process), gluco-metabolic phenotypes (e.g. INPP5E, SNX17, @GENE$, FN3KRP), and @DISEASE$ (e.g. POMC, CPEB4).	0
1332	Although @GENE$ has been shown to be a scaffold protein of the Ras-ERK pathway, its interaction with other signaling pathways and its involvement in @DISEASE$ malignancy has not been reported.	1
1333	The @DISEASE$ cells expressed @GENE$, GLUT-1, and vimentin and were negative for S-100 protein, epithelial membrane antigen, smooth muscle actin, desmin, claudin-1, neurofilament and SOX10.	1
1334	Mutations in the ubiquitously expressed pre-mRNA processing factors 3, 8, and 31 (PRPF3, @GENE$, and PRPF31) cause nonsyndromic dominant retinitis pigmentosa in humans, an inherited @DISEASE$.	1
1335	Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; @DISEASE$, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, @GENE$ proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), NRAS proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.	0
1336	Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; @DISEASE$, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), NRAS proto-oncogene, GTPase (NRAS), and @GENE$ proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.	0
1337	Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; @DISEASE$, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (@GENE$), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), NRAS proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.	0
1338	Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; @DISEASE$, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (@GENE$), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), NRAS proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.	0
1339	Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; @DISEASE$, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, @GENE$ proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), NRAS proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.	0
1340	Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and @DISEASE$ (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (@GENE$), NRAS proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.	0
1341	The @DISEASE$ genes GJB3, @GENE$, GRHL2, DFNA5, and ATP6B1 were expressed in marmoset cochleae in patterns different from those in mouse cochleae.	1
1342	The other tested genes, including the @DISEASE$ gene @GENE$, in which mutation recapitulates deafness in mice, were expressed in a similar manner in both species.	1
1343	Ectopic expression of Cx31 in mouse skin results in @DISEASE$ resembling human @GENE$.	0
1344	We first develop a doxycycline-inducible cell line expressing GFP-tagged cytoplasmic @GENE$ protein (iGFP-NLSm) as a cell-based system to screen and identify seeding activity of human brain-derived pathological TDP-43 isolated from @DISEASE$ FTLD-TDP and familial cases with Granulin (FTLD-TDP-GRN) or C9orf72 repeat expansion mutations (FTLD-TDP-C9+).	1
1345	To provide new ideas based on the use of @GENE$ for risk prediction, prognostic assessment, and clinical treatment of @DISEASE$ and to promote the implementation of corin as a routine laboratory index, we summarize the latest studies of the association between corin and cardiovascular diseases in recent years and offer some prospective proposals for future research on corin in this review	1
1346	All these findings indicate that circulating soluble @GENE$ has the potential to be a sensitive and specific biomarker for risk prediction and prognostic assessment of @DISEASE$.	1
1347	Mutation analysis of the @GENE$ is warranted in isolated complex I deficiency presenting with infantile @DISEASE$ or encephalocardiomyopathy	1
1348	Although @GENE$ plays a critical role in the regulation of RNA processing, mutation of the gene encoding this ubiquitously expressed RNA binding protein causes a specific form of @DISEASE$ termed oculopharyngeal muscular dystrophy (OPMD).	1
1349	A third of patients with paraganglial @DISEASE$, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, @GENE$, protein ubiquitination, NF1, mitochondrial electron transport, succinate to ubiquinone, SDHA, SDHB, tricarboxylic acid cycle, tricarboxylic acid cycle, negative regulation of cell proliferation, and MAX.	1
1350	A third of patients with paraganglial @DISEASE$, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, @GENE$, NF1, mitochondrial electron transport, succinate to ubiquinone, SDHA, SDHB, tricarboxylic acid cycle, tricarboxylic acid cycle, negative regulation of cell proliferation, and MAX.	1
1351	A third of patients with paraganglial @DISEASE$, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, protein ubiquitination, NF1, mitochondrial electron transport, succinate to ubiquinone, SDHA, SDHB, @GENE$, tricarboxylic acid cycle, negative regulation of cell proliferation, and MAX.	1
1352	A third of patients with paraganglial @DISEASE$, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, protein ubiquitination, NF1, mitochondrial electron transport, succinate to ubiquinone, SDHA, SDHB, tricarboxylic acid cycle, @GENE$, negative regulation of cell proliferation, and MAX.	1
1353	A third of patients with paraganglial @DISEASE$, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, protein ubiquitination, NF1, mitochondrial electron transport, succinate to ubiquinone, SDHA, SDHB, tricarboxylic acid cycle, tricarboxylic acid cycle, @GENE$, and MAX.	1
1354	A third of patients with paraganglial tumors, @DISEASE$, and paraganglioma, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, protein ubiquitination, NF1, mitochondrial electron transport, succinate to ubiquinone, SDHA, SDHB, tricarboxylic acid cycle, tricarboxylic acid cycle, @GENE$, and MAX.	1
1355	A third of patients with paraganglial tumors, @DISEASE$, and paraganglioma, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, @GENE$, NF1, mitochondrial electron transport, succinate to ubiquinone, SDHA, SDHB, tricarboxylic acid cycle, tricarboxylic acid cycle, negative regulation of cell proliferation, and MAX.	1
1356	A third of patients with paraganglial tumors, pheochromocytoma, and @DISEASE$, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, protein ubiquitination, NF1, mitochondrial electron transport, succinate to ubiquinone, SDHA, SDHB, tricarboxylic acid cycle, @GENE$, negative regulation of cell proliferation, and MAX.	1
1357	A third of patients with paraganglial tumors, pheochromocytoma, and @DISEASE$, carry germline mutations in one of the susceptibility genes, @GENE$, protein ubiquitination, NF1, mitochondrial electron transport, succinate to ubiquinone, SDHA, SDHB, tricarboxylic acid cycle, tricarboxylic acid cycle, negative regulation of cell proliferation, and MAX.	1
1358	A third of patients with paraganglial tumors, pheochromocytoma, and @DISEASE$, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, @GENE$, NF1, mitochondrial electron transport, succinate to ubiquinone, SDHA, SDHB, tricarboxylic acid cycle, tricarboxylic acid cycle, negative regulation of cell proliferation, and MAX.	1
1359	A third of patients with paraganglial tumors, pheochromocytoma, and @DISEASE$, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, protein ubiquitination, NF1, @GENE$, SDHA, SDHB, tricarboxylic acid cycle, tricarboxylic acid cycle, negative regulation of cell proliferation, and MAX.	1
1360	A genetically determined generalized hyperexcitability had been predicted in primarily generalized @DISEASE$, but surprisingly the first epilepsy gene discovered, @GENE$, was in a focal (frontal lobe)-onset syndrome.	0
1361	Mutations in the EFHC1 gene (unknown function) occur in other rare JME families, and yet in other families, associations are present between JME (or other generalized @DISEASE$) and single nucleotide polymorphisms in the @GENE$ gene (unknown function) and the malic enzyme 2 (ME2) gene.	1
1362	The purpose of this study was to evaluate the frequency of mosaicism detected by next-generation sequencing in genes associated with @DISEASE$-related neurodevelopmental disorders.MethodsWe conducted a retrospective analysis of 893 probands with epilepsy who had a multigene epilepsy panel or whole-exome sequencing performed in a clinical diagnostic laboratory and were positive for a pathogenic or likely pathogenic variant in one of nine genes (@GENE$, chloride transmembrane transport, GABRG2, GRIN2B, KCNQ2, MECP2, PCDH19, cardiac muscle cell action potential involved in contraction, or sodium ion transport).	0
1363	The purpose of this study was to evaluate the frequency of mosaicism detected by next-generation sequencing in genes associated with @DISEASE$-related neurodevelopmental disorders.MethodsWe conducted a retrospective analysis of 893 probands with epilepsy who had a multigene epilepsy panel or whole-exome sequencing performed in a clinical diagnostic laboratory and were positive for a pathogenic or likely pathogenic variant in one of nine genes (regulation of postsynapse organization, chloride transmembrane transport, GABRG2, GRIN2B, KCNQ2, MECP2, PCDH19, cardiac muscle cell action potential involved in contraction, or @GENE$).	0
1364	The purpose of this study was to evaluate the frequency of mosaicism detected by next-generation sequencing in genes associated with @DISEASE$-related neurodevelopmental disorders.MethodsWe conducted a retrospective analysis of 893 probands with epilepsy who had a multigene epilepsy panel or whole-exome sequencing performed in a clinical diagnostic laboratory and were positive for a pathogenic or likely pathogenic variant in one of nine genes (regulation of postsynapse organization, chloride transmembrane transport, GABRG2, GRIN2B, KCNQ2, MECP2, PCDH19, @GENE$, or sodium ion transport).	0
1365	The purpose of this study was to evaluate the frequency of mosaicism detected by next-generation sequencing in genes associated with @DISEASE$-related neurodevelopmental disorders.MethodsWe conducted a retrospective analysis of 893 probands with epilepsy who had a multigene epilepsy panel or whole-exome sequencing performed in a clinical diagnostic laboratory and were positive for a pathogenic or likely pathogenic variant in one of nine genes (regulation of postsynapse organization, @GENE$, GABRG2, GRIN2B, KCNQ2, MECP2, PCDH19, cardiac muscle cell action potential involved in contraction, or sodium ion transport).	0
1366	@GENE$ is important for retinal function and has not previously been associated with spontaneously occurring @DISEASE$ in any other species, including humans	1
1367	We report the association of many previously unreported variants with @DISEASE$, as well as new disease phenotypes associated with known genes, including the first association of the @GENE$ gene with retinitis pigmentosa.	0
1368	This study aimed to elucidate the potential functional mechanism of @GENE$-135b-5p in migration, invasion and epithelial-to-mesenchymal transition (EMT) of pancreatic @DISEASE$ cells.	1
1369	Haplotype @GENE$ for GRM6 markers rs2067011-rs2645339-rs762724 showed significance (P=0.0239), but such association did not remain significant after multiple testing corrections.ConclusionsOur data suggested that genetic variants in GRM6 are associated with high @DISEASE$.	0
1370	The genetic model analysis found that @GENE$-rs11746675 and GRM6-rs2067011 were suggestively associated with high @DISEASE$ in the recessive model (OR=0.54, P=0.004; OR=0.52, P=0.003; respectively).	1
1371	Fourteen single-nucleotide polymorphisms (SNPs) in three genes were genotyped by the TaqMan method using the real-time PCR system.ResultsThree SNPs @GENE$-rs11746675, GRM6-rs2067011, and GRM6-rs2645339 were associated with high @DISEASE$ (odds ratio (OR)=0.74, P=0.003; OR=0.78, P=0.018; and OR=0.78, P=0.023; respectively).	1
1372	This review highlights recent advances in understanding how the @GENE$-positive regulation of gene expression axis modulates cell differentiation and proliferation in human keratinocytes, hair follicles, and benign or malignant skin tumors including squamous cell carcinoma and @DISEASE$.	1
1373	This review highlights recent advances in understanding how the negative regulation of transcription by RNA polymerase II-@GENE$ axis modulates cell differentiation and proliferation in human keratinocytes, hair follicles, and benign or malignant skin tumors including @DISEASE$ and malignant melanoma.	1
1374	@GENE$ knockdown suppressed @DISEASE$ cell growth and proliferation in HCC cell lines; caused a significant increase in the proportion of cells in the G1/S phase of cell cycle; induced cell death; suppressed the metastatic potential of HCC cells by selectively regulating the epithelial-mesenchymal transition (EMT) regulatory proteins E-cadherin, N-cadherin, Fibronectin, negative regulation of transcription by RNA polymerase II and Slug; and significantly attenuated the metastatic potential of ras-transformed NIH-3T3 cells in vitro and in vivo.	1
1375	protein catabolic process in the vacuole knockdown suppressed @DISEASE$ cell growth and proliferation in HCC cell lines; caused a significant increase in the proportion of cells in the G1/S phase of cell cycle; induced cell death; suppressed the metastatic potential of HCC cells by selectively regulating the epithelial-mesenchymal transition (EMT) regulatory proteins E-cadherin, N-cadherin, Fibronectin, @GENE$ and Slug; and significantly attenuated the metastatic potential of ras-transformed NIH-3T3 cells in vitro and in vivo.	0
1376	Zebrafish with ryroxD1 knock-down recapitulate features of @GENE$ @DISEASE$ with sarcomeric disorganization, myofibrillar aggregates, and marked swimming defect.	1
1377	This finding expands the lists of the @GENE$-positive @DISEASE$, and ALK-positive extramedullary plasmacytoma may benefit from the treatment of ALK inhibitor in the future	1
1378	This finding expands the lists of the @GENE$-positive tumors, and ALK-positive extramedullary @DISEASE$ may benefit from the treatment of ALK inhibitor in the future	1
1379	We studied 46 cases of extramedullary @DISEASE$ by immunostaining with anti-@GENE$ antibody and fluorescence in situ hybridization (FISH) analysis using an ALK break-apart probe and found one case to be ALK protein-positive and demonstrated the disruption of the ALK gene in this case.	0
1380	Biallelic loss-of-function mutations in TYROBP and @GENE$ cause a rare disease that resembles early-onset @DISEASE$ with bone lesions called polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL).	1
1381	Biallelic loss-of-function mutations in TYROBP and @GENE$ cause a rare disease that resembles early-onset frontotemporal dementia with bone lesions called polycystic lipomembranous osteodysplasia with sclerosing @DISEASE$ (PLOSL).	1
1382	Dual-specificity tyrosine phosphorylation-regulated kinase 1A (@GENE$) is a potential target in Alzheimer's disease (AD) because of the established correlation between its over-expression and generation of @DISEASE$ (NFT) as well as the accumulation of amyloid plaques.	1
1383	Bcl2-associated athanogene 3 (@GENE$) mutations have been reported to cause the myofibrillar myopathy (MFM) which shows progressive limb muscle weakness, @DISEASE$, and cardiomyopathy.	1
1384	A de novo heterozygous p.Pro209Leu (c.626C&gt;T) mutation in @GENE$ was identified in a female @DISEASE$.	1
1385	We found @GENE$ mutation in one patient with @DISEASE$, myopathy and rigid spine syndrome, and performed electrophysiological study, whole body MRI and muscle biopsy on the patient.	1
1386	She showed an axonal sensory-motor polyneuropathy like Charcot-Marie-Tooth disease (CMT), @DISEASE$, rigid spine and respiratory dysfunction; however, she did not show any cardiomyopathy, which is a common symptom in @GENE$ mutation.	0
1387	Mutations in eight of them (PDSS1, @GENE$, COQ2, COQ4, COQ6, ADCK3, ADCK4, and ubiquinone biosynthetic process) cause primary CoQ(10) deficiency, a @DISEASE$ group of disorders with variable age of onset (from birth to the seventh decade) and associated clinical phenotypes, ranging from a fatal multisystem disease to isolated steroid resistant nephrotic syndrome (SRNS) or isolated central nervous system disease.	1
1388	Mutations in eight of them (PDSS1, ubiquinone biosynthetic process, COQ2, COQ4, COQ6, ADCK3, ADCK4, and @GENE$) cause primary CoQ(10) deficiency, a @DISEASE$ group of disorders with variable age of onset (from birth to the seventh decade) and associated clinical phenotypes, ranging from a fatal multisystem disease to isolated steroid resistant nephrotic syndrome (SRNS) or isolated central nervous system disease.	1
1389	Finally, we demonstrate that genetic inactivation of @GENE$ rescues axial elongation in a mouse model of @DISEASE$ caused by a null mutation in Egr1.	1
1390	We have previously identified a role for the secreted serine protease @GENE$ in ocular size determination and PRSS56 variants have been implicated in the etiology of both hyperopia and @DISEASE$, highlighting its importance in refractive development.	0
1391	Here, we investigated associations between genetic variants of @GENE$ GTPases-related genes and @DISEASE$-specific survival (CMSS) by re-analyzing a published melanoma genome-wide association study (GWAS) and validating the results in another melanoma GWAS.	1
1392	As ubiquitination is a versatile post-translational modification that can affect target turnover, sub-cellular localisation or activity, it is likely that diverse substrates may be differentially affected by @GENE$-mediated ubiquitination, reflecting its multi-faceted roles in muscle physiology, @DISEASE$ and immunity.	1
1393	In this review, we will focus on the ability of @GENE$ to mark specific substrates for proteasomal degradation discussing how the TRIM32-proteasome axis may (i) be important for muscle homeostasis and for the pathogenesis of muscular dystrophy; and (ii) define either an oncogenic or @DISEASE$ suppressive role for TRIM32 in the context of different types of cancer	0
1394	Mice with a neuronal deletion of @GENE$ recapitulated the human phenotype, exhibiting @DISEASE$s and a severe survival defect in adulthood.	1
1395	Here we discuss the @DISEASE$ of T-@GENE$ expressing B cells and related cells	1
1396	In two large Turkish consanguineous families, a locus for @DISEASE$ nonsyndromic hearing loss (ARNSHL) was mapped to chromosome 6p21.3 by genome-wide linkage analysis in an interval overlapping with the loci @GENE$ (COL11A2), DFNB66, and DFNB67.	1
1397	In two large Turkish consanguineous families, a locus for autosomal recessive nonsyndromic @DISEASE$ (ARNSHL) was mapped to chromosome 6p21.3 by genome-wide linkage analysis in an interval overlapping with the loci @GENE$ (COL11A2), DFNB66, and DFNB67.	1
1398	Beyond secretion, @GENE$ is a @DISEASE$ suppressor universally silenced by loss of expression of its paracrine hormone during carcinogenesis.	1
1399	Thus, chronic colonization with <i>ETEC</i> producing ST could contribute to endemic @DISEASE$ resistance in developing countries, reinforcing a novel paradigm of colorectal cancer chemoprevention with oral @GENE$-targeted agents	0
1400	Low-grade fibromyxoid sarcoma (LGFMS) and sclerosing epithelioid fibrosarcoma (SEF) are rare @DISEASE$ with distinct sets of morphological features, both characterized by @GENE$ immunoreactivity.	1
1401	Although disruption of the @GENE$ (INK4A/ARF) locus has been reported in end-stage disease, information is lacking on the status of this key @DISEASE$ suppressor gene in pleural lesions preceding mesothelioma.	1
1402	Moreover, we demonstrate that TD-428, which comprises TD-106 linked to a @GENE$ inhibitor, JQ1 efficiently induce BET protein degradation in the prostate @DISEASE$ cell line 22Rv1.	0
1403	CGD is a genetically @DISEASE$ disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the @GENE$, protein targeting to membrane, NCF2, or antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent genes encoding p22(phox) , p47(phox) , p67(phox) , and p40(phox) , respectively.	0
1404	CGD is a genetically @DISEASE$ disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the cytochrome complex assembly, protein targeting to membrane, NCF2, or @GENE$ genes encoding p22(phox) , p47(phox) , p67(phox) , and p40(phox) , respectively.	0
1405	CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB gene encoding the gp91(phox) protein, and an @DISEASE$ (AR-CGD) form caused by mutations in the cytochrome complex assembly, @GENE$, NCF2, or antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent genes encoding p22(phox) , p47(phox) , p67(phox) , and p40(phox) , respectively.	1
1406	CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB gene encoding the gp91(phox) protein, and an @DISEASE$ (AR-CGD) form caused by mutations in the cytochrome complex assembly, protein targeting to membrane, NCF2, or @GENE$ genes encoding p22(phox) , p47(phox) , p67(phox) , and p40(phox) , respectively.	1
1407	CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB gene encoding the gp91(phox) protein, and an @DISEASE$ (AR-CGD) form caused by mutations in the @GENE$, protein targeting to membrane, NCF2, or antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent genes encoding p22(phox) , p47(phox) , p67(phox) , and p40(phox) , respectively.	1
1408	Human kallikrein-related peptidases @GENE$-15 provide a rich source of serine protease-type biomarkers associated with @DISEASE$ growth and cancer progression for a variety of malignant diseases.	1
1409	Human kallikrein-related peptidases @GENE$-15 provide a rich source of serine protease-type biomarkers associated with tumor growth and @DISEASE$ progression for a variety of malignant diseases.	1
1410	For this, @GENE$ protein expression was assessed by immunohistochemistry in primary @DISEASE$ tissue sections (tissue microarrays) of 188 TNBC patients, mainly treated with anthracycline- or CMF-based polychemotherapy.	1
1411	In this study, recombinant @GENE$ protein was generated and affinity-purified KLK4-directed polyclonal antibody pAb587 established to allow localization of KLK4 protein expression in @DISEASE$ cell lines and archived formalin-fixed, paraffin-embedded TNBC tumor tissue specimens.	1
1412	Using exome sequencing, we discovered missense mutations in @GENE$, a core component of the SEC, in three unrelated probands with a new syndrome that phenotypically overlaps Cornelia de Lange syndrome (CdLS) that we have named CHOPS syndrome (C for cognitive impairment and coarse facies, H for heart defects, O for obesity, P for pulmonary involvement and S for short stature and @DISEASE$).	1
1413	@GENE$ and PRND are significantly over-expressed in @DISEASE$.	1
1414	PRNP and @GENE$ appear involved with some important genes related to @DISEASE$igenesis and apoptosis.	1
1415	Alazami syndrome (AS) (MIM# 615071) is an autosomal recessive microcephalic primordial dwarfism (PD) with recognizable facial features and severe @DISEASE$ due to depletion or loss of function variants in @GENE$.	1
1416	We identified the first de novo variant in @GENE$ (c.2984 A &gt; G (p.(N995S)))-encoding the BK channel-that causes epilepsy, but not @DISEASE$, in two independent families.	1
1417	The 2016 revised World Health Organization (WHO) classification of lymphoid @DISEASE$ included the category of high-grade B cell lymphomas (HGBLs) with combined MYC and BCL2 and/or @GENE$ rearrangements (double-hit, DH).	0
1418	Using exome sequencing in a multiplex family and three simplex case subjects with an atypical association of @GENE$ with early-onset @DISEASE$, we identified two heterozygous mutations affecting Arg391 in β-tubulin 4B isotype-encoding (G2/M transition of mitotic cell cycle).	1
1419	Using exome sequencing in a multiplex family and three simplex case subjects with an atypical association of clathrin coat assembly with early-onset @DISEASE$, we identified two heterozygous mutations affecting Arg391 in β-tubulin 4B isotype-encoding (@GENE$).	0
1420	Independent and pooled analyses verified that higher @GENE$ mRNA levels were significantly associated with poor survival of breast @DISEASE$ patients, regardless of estrogen receptor (ER) status.	1
1421	For in vitro studies, inhibition of @GENE$ by small-hairpin RNA significantly reduced the growth and invasion capabilities of the cells, while enhancing the cytotoxicity of doxorubicin in breast @DISEASE$ cell lines MCF-7 (ER positive) and MDA-MB-231 (ER negative).	1
1422	In response to surgical induction of @DISEASE$, @GENE$-/- female mice develop significant fibrosis in contrast to wild-type mice.	1
1423	The present study aimed to molecularly define and determine the contribution of two rare, apparently novel @GENE$ LGRs, among Greek breast @DISEASE$ patients.	1
1424	Patients with HCP show &lt;50% of normal activity and those with the rare @DISEASE$ harderoporphyria accumulate harderoporphyrinogen, an intermediate porphyrin of the @GENE$ reaction.	1
1425	To identify the disease-causing defect in these families, we first analysed @GENE$ gene, then some candidate genes (CHX10, OPA1, MITF, SOX2, CRYBB1-3 and CRYBA4) and loci (MCOP1, NNO1 and embryo development ending in birth or egg hatching) previously implicated in different forms of @DISEASE$.	0
1426	To identify the disease-causing defect in these families, we first analysed embryo development ending in birth or egg hatching gene, then some candidate genes (CHX10, OPA1, MITF, SOX2, CRYBB1-3 and CRYBA4) and loci (MCOP1, NNO1 and @GENE$) previously implicated in different forms of @DISEASE$.	1
1427	The results showed that the concentration of inflammatory cytokines [interleukin 1β (IL1β) and @DISEASE$ necrosis factor α (TNF-α)], myeloperoxidase (@GENE$) activity in the lung tissue and blood, protein abundance of toll-like receptor 4 (TLR4), nuclear factor κB (NF-κB, p65), phosphorylated p65 (p-p65), inhibitor κBα (IκBα), and phosphorylated IκBα (p-IκBα), and relative mRNA expression of genes associated with inflammation, such as TLR4, NF-κB, IL1β, interleukin 6 (IL6), and TNF-α, were significantly upregulated in the LPS group compared to the PBS group.	0
1428	Another clinically relevant form of @GENE$-related hypophosphatemic disease is @DISEASE$-induced osteomalacia (TIO), a paraneoplastic syndrome associated with FGF23-producing tumors.	1
1429	Another clinically relevant form of @GENE$-related hypophosphatemic disease is tumor-induced @DISEASE$ (TIO), a paraneoplastic syndrome associated with FGF23-producing tumors.	1
1430	Malonyl coenzyme A (CoA) decarboxylase (EC 4.1.1.9, @GENE$) deficiency, or malonic aciduria, is a rare inborn error of metabolism characterised by a variable phenotype of @DISEASE$, seizures, cardiomyopathy and acidosis.	1
1431	We identified 52 variants contributing to @DISEASE$ in 2% of cases including multiple novel variants in @GENE$, which were sometimes found with accelerated growth rather than short stature as described previously.	1
1432	Besides the hallmark features, this patient also presents problems not previously associated with @GENE$ syndrome, including cervical vertebral fusion, mild @DISEASE$, and colonic fibrosis.	1
1433	Through a multi-centric collaboration, we identified three copy-number variant deletions (two de novo and one dominantly inherited in three generations), one de novo disrupting duplication, and nine de novo point mutations (three truncating, one canonical splice site, and five missense mutations) involving @GENE$ in 16 individuals from 13 families with variable neurodevelopmental delay and @DISEASE$ (ID)-associated autistic features, cerebellar ataxia, and epilepsy.	1
1434	Through a multi-centric collaboration, we identified three copy-number variant deletions (two de novo and one dominantly inherited in three generations), one de novo disrupting duplication, and nine de novo point mutations (three truncating, one canonical splice site, and five missense mutations) involving @GENE$ in 16 individuals from 13 families with variable neurodevelopmental delay and intellectual disability (ID)-associated autistic features, cerebellar ataxia, and @DISEASE$.	1
1435	The spontaneous mutant mouse staggerer, with an @DISEASE$ caused by neurodegeneration of cerebellar Purkinje cells, was discovered two decades ago to result from homozygous intragenic @GENE$ deletions.	1
1436	siRNA-mediated suppression of @GENE$ inhibited gastric @DISEASE$ cell proliferation and colony formation by promoting cell cycle arrest at G2/M phase and increasing apoptosis.	1
1437	@GENE$ was highly expressed in gastric tumors and gastric @DISEASE$ cells.	1
1438	Overexpression of @GENE$ in CK5-positive cell lineages, and differential protein isoform expression, was additionally found in other tissues and @DISEASE$ types, suggesting that overexpression of Phgdh is generally associated with CK5 cells, and that oncogenic function may be determined by isoform expression.	1
1439	CONCLUSIONS @GENE$-1 is highly expressed in human @DISEASE$, and could be a marker for use in assessing tumor stage and the deciding on treatment target	1
1440	CONCLUSIONS @GENE$-1 is highly expressed in human esophageal carcinoma, and could be a marker for use in assessing @DISEASE$ stage and the deciding on treatment target	1
1441	RESULTS @GENE$-1 was associated with patient age, gender, lymphatic metastasis, @DISEASE$ recurrence, and stage, with significantly (P&lt;0.05) positive correlations with age, lymphatic metastasis, tumor recurrence, and stage.	1
1442	We investigated glioma-associated oncogene protein-1 (@GENE$-1) expression in human @DISEASE$ tissue and the inhibition of cyclopamine on EC9706 esophageal carcinoma cell growth.	1
1443	Individuals had microcephaly, developmental delay, @DISEASE$, and recessive mutations in @GENE$.	1
1444	Our results recognize the sensitivity of @DISEASE$ cell types to GANT61 in cell culture and support a critical role for @GENE$ factors in tumor progression through restraining apoptosis.	0
1445	In the present review, 22 loci of @DISEASE$ are presented, including the relevant genes (myocilin, interleukin 20 receptor subunit B, optineurin, ankyrin repeat‑ and SOCS box‑containing protein 10, WD repeat‑containing protein 36, EGF‑containing fibulin‑like extracellular matrix protein 1, neurotrophin 4, TANK‑binding kinase 1, cytochrome P450 subfamily I polypeptide 1, latent transforming growth factor β binding protein 2 and @GENE$ tyrosine kinase endothelial) and 74 other genes (including toll‑like receptor 4, sine oculis homeobox Drosophila homolog of 1, doublecortin‑like kinase 1, RE repeats‑encoding gene, retinitis pigmentosa GTPase regulator‑interacting protein, lysyl oxidase‑like protein 1, heat‑shock 70‑kDa protein 1A, baculoviral IAP repeat‑containing protein 6, 5,10‑methylenetetrahydrofolate reductase and nitric oxide synthase 3 and nanophthalmos 1) that are more closely associated with glaucoma.	1
1446	In this study, we focused on colon @DISEASE$ with peritoneal metastasis and investigated the association between the expression of CD133, aldehyde dehydrogenase-1 (oxidation-reduction process) and leucine-rich repeating G-protein coupled receptor-5 (@GENE$), and disease prognosis.	0
1447	In this study, we focused on colon @DISEASE$ with peritoneal metastasis and investigated the association between the expression of CD133, aldehyde dehydrogenase-1 (@GENE$) and leucine-rich repeating G-protein coupled receptor-5 (positive regulation of canonical Wnt signaling pathway), and disease prognosis.	0
1448	Here we used an integrative strategy to examine the hypothesis that genetic variants at @GENE$/2 binding elements may be associated with sexual dimorphism of @DISEASE$ (HCC) risk.	1
1449	Human genetic and pharmacological animal studies support this hypothesis, but no studies have explored @GENE$ dysfunction at the molecular level in the postmortem @DISEASE$ brain.	1
1450	Conversely, @GENE$ regulatory proteins were expressed at lower levels in @DISEASE$ subjects compared to controls (Norbin -37%, p &lt; 0.001; Tamalin -30%, p = 0.084; Preso1 -29%, p = 0.001).	1
1451	We assessed @GENE$ mRNA and protein levels in the dorsolateral prefrontal cortex (DLPFC) using a large cohort of @DISEASE$ and control subjects (n = 37/group), and additionally measured protein levels of recently discovered mGluR5 endogenous regulators, Norbin (neurochondrin), Tamalin (GRASP-1), and Preso1 (FRMPD4), which regulate mGluR5 localization, internalization and signaling.	0
1452	While @GENE$ mRNA expression was unchanged, mGluR5 protein levels were significantly higher in @DISEASE$ subjects compared to controls (total: +22%; dimer: +54%; p &lt; 0.001).	1
1453	In the present study, we examined whether @GENE$ expression is abnormally regulated in colorectal @DISEASE$s (CRCs).	1
1454	Next, using DLD-1 colon @DISEASE$ cells inducibly expressing @GENE$, SASS6 overexpression was shown to induce centrosome amplification, mitotic abnormalities such as chromosomal misalignment and lagging chromosome, and chromosomal numerical changes.	1
1455	To date, the genetic alteration of @GENE$ has not been reported in human @DISEASE$s.	1
1456	Here, we show that human spSCC @DISEASE$ also feature strong nuclear localisation of @GENE$ and overexpression of activated YAP (NLS-YAP-5SA) with Keratin-5 (K5-CreERt) is sufficient to induce rapid formation of both SCC and spSCC in mice.	1
1457	The aminoacyl tRNA synthetase complex-interacting multifunctional protein 2 (@GENE$) splice variant designated DX2 is induced by cigarette smoke carcinogens and is often detected in human lung @DISEASE$ specimens.	1
1458	The aim of our study was to determine the impact of genetic polymorphisms in the caspase (@GENE$) genes on prognosis of @DISEASE$ (HCC).	1
1459	In addition, we demonstrated that @GENE$-enhanced @DISEASE$ growth is dependent on depletion of p62 in vivo.	1
1460	Furthermore, @GENE$ enhanced @DISEASE$ cell proliferation, viability, and colony formation in vitro via suppression of p62.	1
1461	In this study, we aimed to clarify the phenotypic spectrum of @GENE$/A2 mutations in the context of cortical malformations that include @DISEASE$, polymicrogyria and/or heterotopia	1
1462	Functional studies support intraocular pressure-related influences of FMNL2 and @GENE$, with certain regulation of transcription, DNA-templated mutations causing high IOP and @DISEASE$ resembling POAG in mice.	0
1463	Functional studies support intraocular pressure-related influences of FMNL2 and regulation of transcription, DNA-templated, with certain @GENE$ mutations causing high IOP and @DISEASE$ resembling POAG in mice.	1
1464	Our results demonstrated pairwise epistatic interactions between @GENE$ and protein polyubiquitination SNPs that ERCC6 rs1917799-ERCC8 rs158572 combination was associated with decreased risk of chronic atrophic gastritis and increased risk of gastric @DISEASE$.	1
1465	Our results demonstrated pairwise epistatic interactions between response to oxidative stress and @GENE$ SNPs that ERCC6 rs1917799-ERCC8 rs158572 combination was associated with decreased risk of chronic atrophic gastritis and increased risk of gastric @DISEASE$.	1
1466	In conclusion, @GENE$ rs1917799, protein polyubiquitination rs158572 and rs158916 demonstrated pairwise epistatic interactions to associate with chronic atrophic gastritis and gastric @DISEASE$ risk.	1
1467	In conclusion, response to oxidative stress rs1917799, @GENE$ rs158572 and rs158916 demonstrated pairwise epistatic interactions to associate with chronic atrophic gastritis and gastric @DISEASE$ risk.	1
1468	In situ @GENE$ and protein polyubiquitination protein expression were detected by immunohistochemistry in 109 chronic superficial gastritis, 109 chronic atrophic gastritis and 109 gastric @DISEASE$ cases.	1
1469	In situ response to oxidative stress and @GENE$ protein expression were detected by immunohistochemistry in 109 chronic superficial gastritis, 109 chronic atrophic gastritis and 109 gastric @DISEASE$ cases.	1
1470	ERCC6 rs1917799 also showed a significant interaction with @GENE$ rs158916 to reduce gastric @DISEASE$ risk.	1
1471	@GENE$ mutations have been linked to neurodegenerative PHARC (polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and early-onset cataract), a rare, @DISEASE$, autosomal, recessive disease.	1
1472	@GENE$ mutations have been linked to neurodegenerative PHARC (polyneuropathy, hearing loss, @DISEASE$, retinitis pigmentosa, and early-onset cataract), a rare, progressive, autosomal, recessive disease.	1
1473	BBN @DISEASE$ showed overexpression of markers of basal cancer subtype, and had a high mutation burden with frequent Trp53 (80%), Kmt2d (70%), and @GENE$ (90%) mutations by exome sequencing, similar to human MIBC.	1
1474	Here, we report that @GENE$ is highly overexpressed in multiple lung adenocarcinoma cell lines and @DISEASE$ tissues.	1
1475	Our study indicates the novel @GENE$ p.W371G missense mutation causes infantile onset intellectual disability and @DISEASE$ in recessive mode of inheritance.	1
1476	Our study indicates the novel @GENE$ p.W371G missense mutation causes infantile onset @DISEASE$ and cerebellar hypoplasia in recessive mode of inheritance.	1
1477	Our study indicates the novel @GENE$ p.W371G missense mutation causes infantile onset intellectual disability and cerebellar hypoplasia in recessive @DISEASE$.	1
1478	Our findings imply that @DISEASE$ is a variable phenotype in @GENE$-related disease, suggest WDR73 to be a candidate gene of severe intellectual disability and cerebellar hypoplasia, and expand the molecular spectrum of WDR73-related disease	1
1479	Subsequent quantitative PCR experiments confirmed that PRDX4, @GENE$, MAGED2, and an EST (GenBank accession number BF696304) were expressed at significantly higher levels in @DISEASE$ with metastasis.	1
1480	Here, we show that selective overexpression of the stress protein, heme oxygenase-1 (HO-1) in astrocytes of GFAP.HMOX1 transgenic mice between 8.5 and 19 months of age results in nigrostriatal hypodopaminergia associated with locomotor @DISEASE$ and stereotypy; downregulation of tyrosine hydroxylase, DAT, LMX1B, @GENE$, Pitx3 and DJ-1 mRNA and/or protein; overproduction of α-synuclein and ubiquitin; oxidative stress; basal ganglia siderosis; mitochondrial damage/mitophagy; and augmented GABAergic systems (increased GABA, GAD67 and reelin).	0
1481	Of the 465,447 CpG sites analyzed, 12 showed differential methylation (false discovery rate &lt;0.15), including markers within genes associated with monogenic diabetes (@GENE$) or @DISEASE$ (positive regulation of transcription by RNA polymerase II).	0
1482	Of the 465,447 CpG sites analyzed, 12 showed differential methylation (false discovery rate &lt;0.15), including markers within genes associated with monogenic diabetes (regulation of transcription by RNA polymerase II) or @DISEASE$ (@GENE$).	1
1483	CD164 was co-expressed with @GENE$ on circulating CD4<sup>+</sup> T cells from high @DISEASE$ burden SS patients, further providing strong support for CD164 as a disease relevant surface biomarker	1
1484	Oropharyngeal @DISEASE$ associations were limited to the human leukocyte antigen (HLA) region, and classical HLA allele imputation showed a protective association with the class II haplotype HLA-DRB1*1301-HLA-DQA1*0103-@GENE$*0603 (odds ratio (OR) = 0.59, P = 2.7 × 10<sup>-9</sup>).	1
1485	Oral and pharyngeal @DISEASE$s combined were associated with loci at 6p21.32 (rs3828805, HLA-DQB1), 10q26.13 (rs201982221, @GENE$) and 11p15.4 (rs1453414, OR52N2-TRIM5).	1
1486	The contiguous deletion of @GENE$ and its neighbouring genes, MAOA/B and cellular response to leukemia inhibitory factor, reportedly leads to syndromic clinical features such as microcephaly, @DISEASE$, and epilepsy.	1
1487	The contiguous deletion of positive regulation of transcription, DNA-templated and its neighbouring genes, MAOA/B and @GENE$, reportedly leads to syndromic clinical features such as @DISEASE$, intellectual disability, and epilepsy.	1
1488	Since this is an atypical but previously described rare presentation of PHP1b, we reemphasize @GENE$ deletions and PHP1b as a rare cause for early onset @DISEASE$ and macrosomia.	1
1489	Here, we identified three families with mutations in @GENE$, encoding for adducin-γ, with @DISEASE$, microcephaly, cataracts and skeletal defects.	1
1490	Here, we identified three families with mutations in @GENE$, encoding for adducin-γ, with intellectual disability, @DISEASE$, cataracts and skeletal defects.	1
1491	We report a novel gene duplication syndrome (10q21.2q21.3 microduplication) and present a new evidence for @GENE$ duplication, as a candidate gene for @DISEASE$.	1
1492	This review reflects the existing @GENE$/ephrin literature while focusing on breast @DISEASE$ heterogeneity.	1
1493	Depletion of the exon 3-containing long isoform of @GENE$ (MRPL33-L) led to impaired proliferation and increased apoptosis in @DISEASE$ cell lines and in a xenograft model.	1
1494	In summary, our findings underscore the biological significance of @GENE$-L and hnRNPK in the tumor formation and identifies hnRNPK as a critical splicing regulator of MRPL33 pre-mRNA in @DISEASE$ cells	0
1495	Glutaric aciduria type I (GA-I) is a rare @DISEASE$ caused by the autosomal recessive inherited deficiency of glutaryl-CoA dehydrogenase (@GENE$).	1
1496	Glutaric aciduria type I (GA-I) is a rare organic aciduria caused by the @DISEASE$ inherited deficiency of glutaryl-CoA dehydrogenase (@GENE$).	1
1497	The correlations between the expressions of CTHRC1 with clinicopathologic features,E-@GENE$ and Vimentin expression were analyzed.<b>Result:</b>CTHRC1 protein expression levels in @DISEASE$ tissue were significantly higher than those in adjacent normal thyroid tissue and benign disease(<i>P</i>&lt;0.01);CTHRC1 expression was significantly correlated with lymph node metastases(<i>P</i>&lt;0.05).	0
1498	<b>Objective:</b>To investigate the expression and significance of @GENE$ in patients with papillary thyroid cancinoma.<b>Method:</b>We collected 63 specimens of @DISEASE$ tissue with 36 specimens of the adjacent normal thyroid tissue and 23 specimens of thyroid nodular goiter.	0
1499	Finally, we show evidence that abnormal protein homeostasis is a prevalent mechanism responsible for @GENE$ deficiency and that modulators of UROS proteolysis such as proteasome inhibitors or chemical chaperones may represent an attractive therapeutic option to reduce porphyrin accumulation and prevent @DISEASE$ in CEP patients when the genotype includes a missense variant	0
1500	Single marker-based association tests for corneal @DISEASE$ identified four genome-wide significant loci (P &lt; 5 × 10<sup>-8</sup>) near the genes ZC3H11B (1q41), LINC00340 (6p22.3), @GENE$/OCA2 (15q13.1) and NPLOC4/TSPAN10 (17q25.3).	1
1501	These loci have previously demonstrated association with axial length (ZC3H11B), @DISEASE$ (@GENE$), spherical equivalent refractive error (LINC00340) and eye colour (HERC2).	1
1502	Aim of this study was to analyze the @GENE$ mRNA and protein expression in soft tissue @DISEASE$ and their association with patient outcome.	1
1503	@GENE$ mRNA was measured in 121 tumor samples of soft tissue @DISEASE$ patients using quantitative real-time PCR.	1
1504	As the first report in Korea, this study identified three @GENE$ mutations as the underlying cause of axonal peripheral @DISEASE$ with or without the HSP phenotype.	1
1505	As the first report in Korea, this study identified three @GENE$ mutations as the underlying cause of axonal @DISEASE$ neuropathy with or without the HSP phenotype.	1
1506	Mutations in the @GENE$ showed a wide phenotypic spectrum from hereditary spastic paraplegia (HSP) to axonal Charcot-Marie-Tooth @DISEASE$ neuropathy type 2 (CMT2).	1
1507	Here, we show that biallelic <i>@GENE$</i> deletion with <i>aP2-Cre</i> drives aggressive and metastatic @DISEASE$ independent of other genetically engineered oncogenes or tumor suppressor loss.	1
1508	Here, we show that biallelic <i>@GENE$</i> deletion with <i>aP2-Cre</i> drives aggressive and metastatic angiosarcoma independent of other genetically engineered oncogenes or @DISEASE$ suppressor loss.	0
1509	These studies illustrate that @GENE$ can function as a traditional loss-of-function @DISEASE$ suppressor gene, and they provide a fully penetrant animal model for the study of angiosarcoma development and metastasis.	1
1510	Functional studies suggested that @GENE$ functions as a @DISEASE$ suppressor, as overexpression of CAB39L elicited suppression of multiple cancer phenotypes both in GC cells and an orthotopic mouse model; whilst its knockdown promoted tumorigenesis.	1
1511	Functional studies suggested that @GENE$ functions as a tumor suppressor, as overexpression of CAB39L elicited suppression of multiple @DISEASE$ phenotypes both in GC cells and an orthotopic mouse model; whilst its knockdown promoted tumorigenesis.	0
1512	Our data demonstrate that CAB39L is a novel @DISEASE$ suppressor which suppresses tumorigenesis by promoting LKB1-@GENE$-PGC1α axis, thereby preventing a metabolic shift that drives carcinogenesis.	1
1513	Moreover, knockdown of LKB1 reversed growth inhibitory effect of @GENE$, indicating that @DISEASE$ suppression by CAB39L depended on LKB1-AMPK.	1
1514	This disease is an @DISEASE$ disorder, and the gene @GENE$, which encodes cystatin B, a cysteine protease inhibitor, is the only gene known to be associated with ULD.	0
1515	@GENE$ was identified from MS analysis, and its level was revealed to be correlated with the disease grade, clinical severity, and survival rate of patients with @DISEASE$.	1
1516	Keratitis-ichthyosis-@DISEASE$ (KID) syndrome is a rare genodermatosis that typically results from mutations of the gap junction-mediated intercellular transport gene or, less commonly, the @GENE$ gene.	1
1517	Keratitis-ichthyosis-@DISEASE$ (KID) syndrome is a rare genodermatosis that typically results from mutations of the @GENE$ gene or, less commonly, the apoptotic process gene.	1
1518	@GENE$R2 overexpression is associated with increased risk of pelvic lymph node metastasis (PLNM, p = 0.001) and @DISEASE$ relapse (p = 0.009).	1
1519	@GENE$ (Immunoglobulin Superfamily 1) gene defects cause @DISEASE$ hypothyroidism and macroorchidism.	1
1520	@GENE$ (Immunoglobulin Superfamily 1) gene defects cause central @DISEASE$ and macroorchidism.	1
1521	In conclusion, two relevant molecular mechanisms linked to central hypothyroidism and @DISEASE$ in @GENE$ deficiency are identified, revealing IGSF1 as an important regulator of TGFβ/Activin pathways in the pituitary	0
1522	Our report of variant in @GENE$ Leading to Joubert syndrome phenotype (JS30), elucidates the genetic @DISEASE$ of Joubert syndrome, and expands the gene list for ciliopathies	1
1523	The mitochondrial protein @GENE$ has been recently identified as a novel pathogenic cause in a wide spectrum of neurological diseases, including inherited optic atrophy, Charcot-Marie-Tooth type 2, Leigh syndrome, progressive myoclonic ataxia and lethal congenital ponto@DISEASE$.	1
1524	The mitochondrial protein @GENE$ has been recently identified as a novel pathogenic cause in a wide spectrum of neurological diseases, including inherited @DISEASE$, Charcot-Marie-Tooth type 2, Leigh syndrome, progressive myoclonic ataxia and lethal congenital pontocerebellar hypoplasia.	1
1525	In summary, our results reveal that rare loss-of-function variants in @GENE$ increase the risk for a varying combination of epilepsy, @DISEASE$/developmental delay and dysmorphic features, presenting in some pedigrees with an X-linked inheritance pattern	1
1526	MATERIAL AND METHODS The proliferation of prostate @DISEASE$ cells was determined by @GENE$-8 assay.	1
1527	In these @DISEASE$, RET gene fusion product provides a constitutively active tyrosine kinase (@GENE$), leading to uncontrolled cellular proliferation, differentiation, and migration.	1
1528	@GENE$ mRNA is induced by peripheral nervous system development-kB, and overexpression of TNFAIP8 has been correlated with poor prognosis in many @DISEASE$s.	0
1529	positive regulation of apoptotic process mRNA is induced by @GENE$-kB, and overexpression of TNFAIP8 has been correlated with poor prognosis in many @DISEASE$s.	0
1530	Depending on the @DISEASE$ cell type, knockdown of positive regulation of apoptotic process was found to be associated with increased mRNA expression of several antiproliferative and apoptotic genes (e.g., IL-24, homophilic cell adhesion via plasma membrane adhesion molecules, LPHN2, EPHA3) and fatty acid oxidation gene ACADL, and decreased mRNA levels of oncogenes (e.g., NFAT5, MALAT1, MET, @GENE$, KRAS, S100P, OSTF1) and glutamate transporter gene SLC1A1.	1
1531	Depending on the @DISEASE$ cell type, knockdown of positive regulation of apoptotic process was found to be associated with increased mRNA expression of several antiproliferative and apoptotic genes (e.g., IL-24, @GENE$, LPHN2, EPHA3) and fatty acid oxidation gene ACADL, and decreased mRNA levels of oncogenes (e.g., NFAT5, MALAT1, MET, response to estradiol, KRAS, S100P, OSTF1) and glutamate transporter gene SLC1A1.	1
1532	Depending on the @DISEASE$ cell type, knockdown of @GENE$ was found to be associated with increased mRNA expression of several antiproliferative and apoptotic genes (e.g., IL-24, homophilic cell adhesion via plasma membrane adhesion molecules, LPHN2, EPHA3) and fatty acid oxidation gene ACADL, and decreased mRNA levels of oncogenes (e.g., NFAT5, MALAT1, MET, response to estradiol, KRAS, S100P, OSTF1) and glutamate transporter gene SLC1A1.	1
1533	Downregulation of @GENE$ expression has been associated with decreased pulmonary colonization of human @DISEASE$ cells, and enhanced sensitivities of tumor xenografts to radiation and docetaxel.	1
1534	Here we have investigated the effects of depletion of @GENE$ on the mRNA, microRNA and protein expression profiles in prostate and breast @DISEASE$s and melanoma.	1
1535	We analyzed the nucleotide repeat lengths of 6 genes (ATXN8, @GENE$, PPP2R2B, NOP56, DMPK, and JPH3) that have previously been associated with neurologic or neuromuscular disorders, in several hundred @DISEASE$ patients with ALS and healthy control subjects.	1
1536	Bio-functional investigation revealed that @GENE$ inhibited cell proliferation in HCC cell lines, suggesting its potential role as a @DISEASE$ suppressor in HCC.	1
1537	Reduced representation bisulfite sequencing (RRBS) and gene expression microarrays were performed in the HCC @DISEASE$ and non-HCC liver tissues to investigate the molecular mechanisms of @GENE$-2-driven HCC.	1
1538	In conclusion, this study demonstrated for the first time that enhanced COX-2 expression in hepatocytes is sufficient to induce HCC through inducing promoter hypermethylation by reducing @GENE$, silencing @DISEASE$-suppressive genes and activating key oncogenic pathways.	1
1539	We characterize adult-onset, progressive clinical symptoms of two afflicted kindred and introduce the symptom of @DISEASE$ spasticity not previously associated with the @GENE$ phenotype.	1
1540	Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, @GENE$, GALNTL1, nucleobase-containing compound metabolic process, zinc ion transport, PLEKHD1, CCDC177, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, SLC10A1, eye development, mitochondrial calcium ion transmembrane transport, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause @DISEASE$ Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.	0
1541	Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, double-strand break repair via homologous recombination, GALNTL1, @GENE$, zinc ion transport, PLEKHD1, CCDC177, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, SLC10A1, eye development, mitochondrial calcium ion transmembrane transport, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital @DISEASE$, no disease associations have so far been reported for the other genes.	0
1542	Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, double-strand break repair via homologous recombination, GALNTL1, @GENE$, zinc ion transport, PLEKHD1, CCDC177, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, SLC10A1, eye development, mitochondrial calcium ion transmembrane transport, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause @DISEASE$ Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.	0
1543	Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, double-strand break repair via homologous recombination, GALNTL1, nucleobase-containing compound metabolic process, @GENE$, PLEKHD1, CCDC177, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, SLC10A1, eye development, mitochondrial calcium ion transmembrane transport, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital @DISEASE$, no disease associations have so far been reported for the other genes.	0
1544	Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, double-strand break repair via homologous recombination, GALNTL1, nucleobase-containing compound metabolic process, zinc ion transport, PLEKHD1, CCDC177, @GENE$, LOC100289511, mRNA splicing, via spliceosome, SLC10A1, eye development, mitochondrial calcium ion transmembrane transport, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause @DISEASE$ Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.	0
1545	Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, double-strand break repair via homologous recombination, GALNTL1, nucleobase-containing compound metabolic process, zinc ion transport, PLEKHD1, CCDC177, cellular response to DNA damage stimulus, LOC100289511, @GENE$, SLC10A1, eye development, mitochondrial calcium ion transmembrane transport, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital @DISEASE$, no disease associations have so far been reported for the other genes.	0
1546	Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, double-strand break repair via homologous recombination, GALNTL1, nucleobase-containing compound metabolic process, zinc ion transport, PLEKHD1, CCDC177, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, SLC10A1, @GENE$, mitochondrial calcium ion transmembrane transport, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause @DISEASE$ Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.	1
1547	Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, double-strand break repair via homologous recombination, GALNTL1, nucleobase-containing compound metabolic process, zinc ion transport, PLEKHD1, CCDC177, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, SLC10A1, eye development, @GENE$, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital @DISEASE$, no disease associations have so far been reported for the other genes.	0
1548	Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, double-strand break repair via homologous recombination, GALNTL1, nucleobase-containing compound metabolic process, zinc ion transport, PLEKHD1, CCDC177, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, SLC10A1, eye development, @GENE$, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause @DISEASE$ Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.	0
1549	Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, double-strand break repair via homologous recombination, GALNTL1, nucleobase-containing compound metabolic process, zinc ion transport, PLEKHD1, CCDC177, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, SLC10A1, eye development, mitochondrial calcium ion transmembrane transport, @GENE$P1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital @DISEASE$, no disease associations have so far been reported for the other genes.	0
1550	Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, double-strand break repair via homologous recombination, GALNTL1, nucleobase-containing compound metabolic process, zinc ion transport, PLEKHD1, CCDC177, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, SLC10A1, eye development, mitochondrial calcium ion transmembrane transport, single fertilizationP1, @GENE$, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital @DISEASE$, no disease associations have so far been reported for the other genes.	0
1551	Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, double-strand break repair via homologous recombination, GALNTL1, nucleobase-containing compound metabolic process, zinc ion transport, PLEKHD1, CCDC177, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, SLC10A1, eye development, mitochondrial calcium ion transmembrane transport, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, @GENE$, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital @DISEASE$, no disease associations have so far been reported for the other genes.	0
1552	@GENE$ overexpression promoted, whereas Zic2 knockdown inhibited, cell proliferation and migration in vitro as well as @DISEASE$ growth and metastasis in vivo.	1
1553	@GENE$ has been shown to be crucial to the progression of human @DISEASE$s.	1
1554	Our data showed that @GENE$ expression gradually increased from normal to @DISEASE$ to metastatic tissues.	1
1555	In a @DISEASE$ with inv(12), exon 3 of negative regulation of transcription by RNA polymerase II was fused to a sequence in intron 1 of the @GENE$ gene from 12q22.	1
1556	In a @DISEASE$ with inv(12), exon 3 of @GENE$ was fused to a sequence in intron 1 of the positive regulation of apoptotic process gene from 12q22.	1
1557	In the leiomyomas with 12q rearrangements, both @GENE$ and PLAG1 were expressed whereas in the @DISEASE$s with 8q aberrations, only PLAG1 was expressed.	1
1558	We extend the @GENE$ associated phenotype by describing a syndrome characterized by primordial @DISEASE$, lissencephaly, polysyndactyly, and dental anomalies, which is caused by a homozygous truncating KATNB1 mutation	1
1559	We extend the @GENE$ associated phenotype by describing a syndrome characterized by primordial dwarfism, @DISEASE$, polysyndactyly, and dental anomalies, which is caused by a homozygous truncating KATNB1 mutation	1
1560	We extend the @GENE$ associated phenotype by describing a syndrome characterized by primordial dwarfism, lissencephaly, polysyndactyly, and @DISEASE$, which is caused by a homozygous truncating KATNB1 mutation	1
1561	Interestingly, de novo loss-of-function and missense variants in @GENE$ were identified in patients with @DISEASE$ (ID) and autism spectrum disorder (ASD) but also in unaffected individuals.	1
1562	Proteomic analysis of 12 tumours from an @GENE$-driven @DISEASE$ mouse model revealed that NME1 and nucleoside diphosphate phosphorylation, the only known mammalian histidine kinases, were upregulated.	1
1563	Proteomic analysis of 12 tumours from an regulation of cell growth-driven @DISEASE$ mouse model revealed that NME1 and @GENE$, the only known mammalian histidine kinases, were upregulated.	1
1564	Finally, in patients with @DISEASE$, low expression of @GENE$ correlated with increased tumour severity and reduced overall survival.	1
1565	To gain an insight into the likely molecular basis of their observed cytotoxic effects, Autodock Vina binding free energies of each of the isolated compounds with seven molecular targets implicated in @DISEASE$ development (MAPK8, @GENE$, MAP3K12, MAPK3, protein phosphorylation, MAPK7 and negative regulation of transcription by RNA polymerase II), were calculated.	1
1566	To gain an insight into the likely molecular basis of their observed cytotoxic effects, Autodock Vina binding free energies of each of the isolated compounds with seven molecular targets implicated in @DISEASE$ development (MAPK8, protein phosphorylation, MAP3K12, MAPK3, @GENE$, MAPK7 and negative regulation of transcription by RNA polymerase II), were calculated.	1
1567	To gain an insight into the likely molecular basis of their observed cytotoxic effects, Autodock Vina binding free energies of each of the isolated compounds with seven molecular targets implicated in @DISEASE$ development (MAPK8, protein phosphorylation, MAP3K12, MAPK3, protein phosphorylation, MAPK7 and @GENE$), were calculated.	1
1568	A large, complex, and robust gene network containing well-known lung @DISEASE$-related genes, including positive regulation of protein phosphorylation and @GENE$, was identified from combined gene lists for lung adenocarcinoma.	1
1569	A large, complex, and robust gene network containing well-known lung cancer-related genes, including @GENE$ and transcription, RNA-templated, was identified from combined gene lists for @DISEASE$.	1
1570	Using whole-exome sequencing, we identified a novel de novo missense (c.1132G&gt;C, p.V378L) @GENE$ mutation in a patient with global developmental delay, intellectual disability, severe @DISEASE$, but no episode of epilepsy until the lastly examined age of 6 years old.	1
1571	Using whole-exome sequencing, we identified a novel de novo missense (c.1132G&gt;C, p.V378L) @GENE$ mutation in a patient with global developmental delay, intellectual disability, severe speech impairment, but no episode of @DISEASE$ until the lastly examined age of 6 years old.	1
1572	@GENE$ mutations are known to cause early-onset infantile @DISEASE$.	1
1573	We present a case of @DISEASE$-dystonia syndrome illustrated by three videos in which we found a novel @GENE$ mutation.	1
1574	In this study, we have found that @GENE$ expression was greatly decreased in clinical HCC samples, positively correlated with overall survival, and negatively associated with histological differentiation, @DISEASE$ size and organ metastasis.	1
1575	Five variants were previously reported to confer risk of various malignant or benign tumors (rs78378222 in TP53, rs10069690 in @GENE$, rs1800057 and rs1801516 in ATM, and rs7907606 at OBFC1) and four signals are located at established risk loci for hormone-related traits (endometriosis and breast @DISEASE$) at 1q36.12 (CDC42/WNT4), 2p25.1 (GREB1), 20p12.3 (MCM8), and 6q26.2 (SYNE1/ESR1).	0
1576	We noted that Sirtuin 1 (@GENE$) is overexpressed in HPV-infected cervical @DISEASE$ cells and hypothesized that SIRT1 counteracts antiviral immunity.	1
1577	In conclusion, SIRT1 enabled HPV-infected cervical @DISEASE$ cells to continue growing by nullifying @GENE$ inflammasome-mediated immunity.	0
1578	Without SIRT1, cervical @DISEASE$ cells could no longer survive because of the derepression of the @GENE$ inflammasome.	0
1579	Furthermore, the growth of cervical @DISEASE$ xenografts was significantly inhibited by either @GENE$-targeting siRNAs or SIRT1-knockdown-derived extracellular vesicles.	1
1580	However, the functions of @GENE$ in the thyroid gland and the mechanism by which GLIS3 dysfunction causes @DISEASE$ are unknown.	0
1581	Deficiency in Krüppel-like zinc finger transcription factor GLI-similar 3 (@GENE$) in humans is associated with the development of congenital @DISEASE$.	1
1582	We found that @GENE$ was markedly increased in TLE patients and a mouse model of epileptic @DISEASE$; mice underexpressing JIP3 through lentivirus bearing LV-Letm1-RNAi showed decreased susceptibility, delayed first seizure and decreased seizure duration response to the epileptogenic properties of KA.	1
1583	Four established @DISEASE$ susceptibility genes achieved nominal statistical significance, MC1R (p = .0014), MITF (p = .0165) BRCA2 (p = .0206), and @GENE$ (p = .0393).	1
1584	The data indicate a significant role of @GENE$ for mitotic cell cycle progression and survival of MYCN-amplified @DISEASE$ cells, and suggests that HDAC11 could be a valuable drug target	1
1585	Mutations in @GENE$ or GJB6 and the mitochondrial A7445G mutation, known to be the major causes of diverse Inherited Palmoplantar Keratodermas -@DISEASE$ syndromes were not detected by Sanger sequencing.	1
1586	The @GENE$-expressing @DISEASE$ cells coexpressed vimentin but repressed E-cadherin and exhibited invasive behavior.	1
1587	Markers such as SERPINI1, @GENE$, and negative regulation of cell migration were modulated by ABBV-075 and other central nervous system development inhibitors across cancer cell lines and xenograft @DISEASE$ but not in blood and skin.	1
1588	Markers such as SERPINI1, biological_process, and @GENE$ were modulated by ABBV-075 and other central nervous system development inhibitors across cancer cell lines and xenograft @DISEASE$ but not in blood and skin.	1
1589	Markers such as SERPINI1, biological_process, and negative regulation of cell migration were modulated by ABBV-075 and other @GENE$ inhibitors across cancer cell lines and xenograft @DISEASE$ but not in blood and skin.	1
1590	Markers such as SERPINI1, biological_process, and negative regulation of cell migration were modulated by ABBV-075 and other @GENE$ inhibitors across @DISEASE$ cell lines and xenograft tumors but not in blood and skin.	1
1591	Until recently, four loci (DFN2, @GENE$, DFN4, and DFN6) had been implicated in nonsyndromic X-linked @DISEASE$; however, a new classification (purine nucleobase metabolic process-5) has been proposed to reduce confusion in the terminology.	1
1592	Until recently, four loci (DFN2, cochlea morphogenesis, DFN4, and DFN6) had been implicated in nonsyndromic X-linked @DISEASE$; however, a new classification (@GENE$-5) has been proposed to reduce confusion in the terminology.	1
1593	To better understand @GENE$ and its role in modifying @DISEASE$, we created transgenic mice overexpressing the protective murine allele of LTBP4 specifically in mature myofibers using the human skeletal actin promoter.	1
1594	Several myotubularins have been genetically linked to human diseases: @GENE$ is mutated in the congenital @DISEASE$ X-linked centronuclear or myotubular myopathy (XLCNM) and MTMR14 (JUMPY) has been linked to an autosomal form of such disease, while phosphatidylinositol dephosphorylation and myelination are mutated in Charcot-Marie-Tooth (CMT) neuropathies.	1
1595	Several myotubularins have been genetically linked to human diseases: protein dephosphorylation is mutated in the congenital @DISEASE$ X-linked centronuclear or myotubular myopathy (XLCNM) and MTMR14 (JUMPY) has been linked to an autosomal form of such disease, while @GENE$ and myelination are mutated in Charcot-Marie-Tooth (CMT) neuropathies.	0
1596	Several myotubularins have been genetically linked to human diseases: protein dephosphorylation is mutated in the congenital @DISEASE$ X-linked centronuclear or myotubular myopathy (XLCNM) and MTMR14 (JUMPY) has been linked to an autosomal form of such disease, while phosphatidylinositol dephosphorylation and @GENE$ are mutated in Charcot-Marie-Tooth (CMT) neuropathies.	0
1597	Whole exome sequencing in triple negative breast @DISEASE$ cases (n = 8) and targeted sequencing in healthy controls (n = 48) revealed BRIP1 rs552752779 (@GENE$: 75% vs. 6.25%, OR 45.00, 95% CI 9.43-243.32), signal transduction rs527779103 (MAF: 62.5% vs. 7.29%, OR 21.19, 95% CI 5.11-94.32), ERCC2 rs121913016 (MAF: 56.25% vs. 7.29%, OR 16.34, 95% CI 4.02-70.41), DNA repair rs2020912 (MAF: 56.25% vs. 1.04%, OR 122.13, 95% CI 12.29-2985.48) as risk factors for triple negative breast cancer.	1
1598	Whole exome sequencing in triple negative breast @DISEASE$ cases (n = 8) and targeted sequencing in healthy controls (n = 48) revealed BRIP1 rs552752779 (transcription by RNA polymerase II: 75% vs. 6.25%, OR 45.00, 95% CI 9.43-243.32), @GENE$ rs527779103 (MAF: 62.5% vs. 7.29%, OR 21.19, 95% CI 5.11-94.32), ERCC2 rs121913016 (MAF: 56.25% vs. 7.29%, OR 16.34, 95% CI 4.02-70.41), DNA repair rs2020912 (MAF: 56.25% vs. 1.04%, OR 122.13, 95% CI 12.29-2985.48) as risk factors for triple negative breast cancer.	1
1599	Whole exome sequencing in triple negative breast @DISEASE$ cases (n = 8) and targeted sequencing in healthy controls (n = 48) revealed BRIP1 rs552752779 (transcription by RNA polymerase II: 75% vs. 6.25%, OR 45.00, 95% CI 9.43-243.32), signal transduction rs527779103 (MAF: 62.5% vs. 7.29%, OR 21.19, 95% CI 5.11-94.32), ERCC2 rs121913016 (MAF: 56.25% vs. 7.29%, OR 16.34, 95% CI 4.02-70.41), @GENE$ rs2020912 (MAF: 56.25% vs. 1.04%, OR 122.13, 95% CI 12.29-2985.48) as risk factors for triple negative breast cancer.	1
1600	We found that rs1042752-located in the 3'-UTR of @GENE$, which plays a vital role in @DISEASE$genesis-was significantly associated with lymphoma risk in a case-control study with 793 patients and 939 controls.	1
1601	Cystinuria is a @DISEASE$, rare but important cause of inherited kidney stone disease due to mutations in 2 genes: @GENE$ and SLC7A9.	1
1602	These studies suggest that compound 4d behaves well in lowering body weight and maintaining energy expenditure without a chance of hyperglycaemia, 4d has strong clinical potential as an efficient GLP-1/@GENE$ agonist in the prevention and treatment of @DISEASE$ and dyslipidemia	1
1603	We conducted further optimization of dual enzymatic inhibitions towards @GENE$ and DDR2, two important kinases in lung @DISEASE$.	1
1604	Familial hypercholesterolemia (FH) is mostly caused by low-density lipoprotein receptor (@GENE$) mutations and results in an increased risk of early-onset @DISEASE$ due to marked elevation of LDL cholesterol (LDL-C) in blood.	1
1605	Basic immunological assessments have confirmed that this strain of human CD3 EDG-replaced mice are entirely immune competent, and we have also demonstrated that a bispecific antibody that simultaneously binds to human CD3 and a @DISEASE$-associated antigen (e.g. @GENE$ or GPC3) can be evaluated in human CD3 EDG-replaced mice engrafted with tumors.	1
1606	In severe bilateral cases (@DISEASE$ or severe microphthalmia) the genetic cause is now identifiable in approximately 80 percent of cases, with de novo heterozygous loss-of-function mutations in @GENE$ or OTX2 being the most common.	1
1607	In severe bilateral cases (anophthalmia or severe @DISEASE$) the genetic cause is now identifiable in approximately 80 percent of cases, with de novo heterozygous loss-of-function mutations in @GENE$ or OTX2 being the most common.	1
1608	Concurrently, global transcriptional profiling analysis reveals that multiple @DISEASE$-associated genes such as CCND3, E2F1/2, @GENE$, Bcl2 modifying factor (BMF), endothelial cell morphogenesis, and Myc; and signaling pathways of cellular dedifferentiation, proliferation, adhesion, survival including p53, cadherin, Myc, and anti-apoptotic pathways are differentially expressed or significantly altered in these lung epithelial cells upon downregulation of H2Bub1.	1
1609	Concurrently, global transcriptional profiling analysis reveals that multiple @DISEASE$-associated genes such as CCND3, E2F1/2, sensory perception of sound, Bcl2 modifying factor (BMF), @GENE$, and Myc; and signaling pathways of cellular dedifferentiation, proliferation, adhesion, survival including p53, cadherin, Myc, and anti-apoptotic pathways are differentially expressed or significantly altered in these lung epithelial cells upon downregulation of H2Bub1.	1
1610	Consistent with our description of this pathway and the phenotype of patients with @GENE$ mutations, mice with a targeted deletion of Mlk3 displayed multiple skeletal defects, including @DISEASE$, deficient calvarial mineralization, and reduced bone mass.	1
1611	We describe two families in which two different homozygous @GENE$ mutations (missense and frameshift deletion) segregate with a phenotype comprising intellectual disability and progressive @DISEASE$.	1
1612	An array of @DISEASE$ syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (succinate metabolic process, tricarboxylic acid cycle, @GENE$, SDHD, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).	1
1613	An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (@GENE$, tricarboxylic acid cycle, tricarboxylic acid cycle, SDHD, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of @DISEASE$, and a specific subtype of gastrointestinal stromal tumors (GIST).	1
1614	An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (succinate metabolic process, @GENE$, tricarboxylic acid cycle, SDHD, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of @DISEASE$, and a specific subtype of gastrointestinal stromal tumors (GIST).	1
1615	An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (succinate metabolic process, @GENE$, tricarboxylic acid cycle, SDHD, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary @DISEASE$-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).	1
1616	An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (succinate metabolic process, @GENE$, tricarboxylic acid cycle, SDHD, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-@DISEASE$, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).	1
1617	An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (succinate metabolic process, tricarboxylic acid cycle, @GENE$, SDHD, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary @DISEASE$-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).	1
1618	Three loci with high mutation frequencies, the 138665410 @GENE$ gene variant, the 23862952 MYH6 gene variant, and the 71098693 HYDIN gene variant were found to be significantly associated with @DISEASE$ ASD (P&lt;0.05); variants in FOXL2 and MYH6 were found in patients with isolated, sporadic ASD (P&lt;5×10^-4).	0
1619	A principal feature of AD is the presence of @DISEASE$ (NFT) induced by the aberrant phosphorylation of the microtubule-associated protein @GENE$ in the brains of affected individuals.	1
1620	Pre-treatment testing of the localized cutaneous @DISEASE$ lesion on a lymphoid amplicon panel demonstrated an <i>@GENE$</i> p.L265P mutation.	1
1621	The expression pattern of @GENE$ in gastric @DISEASE$ tissue and adjacent non-cancerous tissue was detected by immunohistochemistry.	1
1622	While none of these miRNAs have been previously linked to @DISEASE$, miR-122-5p may target three glaucoma-associated genes: positive regulation of autophagy, @GENE$ and TGF-ß1.	1
1623	While none of these miRNAs have been previously linked to @DISEASE$, miR-122-5p may target three glaucoma-associated genes: @GENE$, ER overload response and TGF-ß1.	1
